{"id": "BioInfer.d591.s0_BioInfer.d591.s0.p0", "text": "The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, talin, vinculin and actin.", "text_with_entity_marker": "The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the [E1]fibronectin receptor[/E1], talin, [E2]vinculin[/E2] and actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin receptor", "entity_1_idx": [[205, 225]], "entity_1_idx_in_text_with_entity_marker": [209, 229], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[234, 242]], "entity_2_idx_in_text_with_entity_marker": [247, 255], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d591.s0_BioInfer.d591.s0.p1", "text": "The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, talin, vinculin and actin.", "text_with_entity_marker": "The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, talin, [E1]vinculin[/E1] and [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[234, 242]], "entity_1_idx_in_text_with_entity_marker": [238, 246], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[247, 252]], "entity_2_idx_in_text_with_entity_marker": [260, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d591.s0_BioInfer.d591.s0.p2", "text": "The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, talin, vinculin and actin.", "text_with_entity_marker": "The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, [E1]talin[/E1], [E2]vinculin[/E2] and actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[227, 232]], "entity_1_idx_in_text_with_entity_marker": [231, 236], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[234, 242]], "entity_2_idx_in_text_with_entity_marker": [247, 255], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d591.s0_BioInfer.d591.s0.p3", "text": "The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, talin, vinculin and actin.", "text_with_entity_marker": "The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the [E1]fibronectin receptor[/E1], talin, vinculin and [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin receptor", "entity_1_idx": [[205, 225]], "entity_1_idx_in_text_with_entity_marker": [209, 229], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[247, 252]], "entity_2_idx_in_text_with_entity_marker": [260, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d591.s0_BioInfer.d591.s0.p4", "text": "The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, talin, vinculin and actin.", "text_with_entity_marker": "The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the [E1]fibronectin receptor[/E1], [E2]talin[/E2], vinculin and actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin receptor", "entity_1_idx": [[205, 225]], "entity_1_idx_in_text_with_entity_marker": [209, 229], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[227, 232]], "entity_2_idx_in_text_with_entity_marker": [240, 245], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d591.s0_BioInfer.d591.s0.p5", "text": "The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, talin, vinculin and actin.", "text_with_entity_marker": "The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, [E1]talin[/E1], vinculin and [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[227, 232]], "entity_1_idx_in_text_with_entity_marker": [231, 236], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[247, 252]], "entity_2_idx_in_text_with_entity_marker": [260, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p20", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor ([E1]ADF[/E1]), gelsolin, [E2]profilin[/E2], and thymosin beta4 (Tbeta4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[160, 163]], "entity_1_idx_in_text_with_entity_marker": [164, 167], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[176, 184]], "entity_2_idx_in_text_with_entity_marker": [189, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p21", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, [E1]actin depolymerizing factor[/E1] ([E2]ADF[/E2]), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin depolymerizing factor", "entity_1_idx": [[131, 158]], "entity_1_idx_in_text_with_entity_marker": [135, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ADF", "entity_2_idx": [[160, 163]], "entity_2_idx_in_text_with_entity_marker": [173, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p22", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized [E1]actin[/E1] and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 ([E2]Tbeta4[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[67, 72]], "entity_1_idx_in_text_with_entity_marker": [71, 76], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Tbeta4", "entity_2_idx": [[206, 212]], "entity_2_idx_in_text_with_entity_marker": [219, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p23", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, [E1]profilin[/E1], and thymosin beta4 ([E2]Tbeta4[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[176, 184]], "entity_1_idx_in_text_with_entity_marker": [180, 188], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Tbeta4", "entity_2_idx": [[206, 212]], "entity_2_idx_in_text_with_entity_marker": [219, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p24", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, [E1]actin depolymerizing factor[/E1] (ADF), gelsolin, profilin, and thymosin beta4 ([E2]Tbeta4[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin depolymerizing factor", "entity_1_idx": [[131, 158]], "entity_1_idx_in_text_with_entity_marker": [135, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Tbeta4", "entity_2_idx": [[206, 212]], "entity_2_idx_in_text_with_entity_marker": [219, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p25", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized [E1]actin[/E1] and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, [E2]profilin[/E2], and thymosin beta4 (Tbeta4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[67, 72]], "entity_1_idx_in_text_with_entity_marker": [71, 76], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[176, 184]], "entity_2_idx_in_text_with_entity_marker": [189, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p26", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized [E1]actin[/E1] and at least four proteins which can bind actin monomers, [E2]actin depolymerizing factor[/E2] (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[67, 72]], "entity_1_idx_in_text_with_entity_marker": [71, 76], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[131, 158]], "entity_2_idx_in_text_with_entity_marker": [144, 171], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p27", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, [E1]actin depolymerizing factor[/E1] (ADF), gelsolin, [E2]profilin[/E2], and thymosin beta4 (Tbeta4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin depolymerizing factor", "entity_1_idx": [[131, 158]], "entity_1_idx_in_text_with_entity_marker": [135, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[176, 184]], "entity_2_idx_in_text_with_entity_marker": [189, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p0", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although [E1]profilin[/E1] released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of [E2]actin[/E2] released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[264, 269]], "entity_2_idx_in_text_with_entity_marker": [277, 282], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p1", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although [E1]profilin[/E1] released actin at the appropriate time to stimulate [E2]actin[/E2] assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[70, 75]], "entity_2_idx_in_text_with_entity_marker": [83, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p2", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although [E1]profilin[/E1] released [E2]actin[/E2] at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[27, 32]], "entity_2_idx_in_text_with_entity_marker": [40, 45], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p3", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although [E1]profilin[/E1] released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized [E2]actin[/E2] content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[210, 215]], "entity_2_idx_in_text_with_entity_marker": [223, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p4", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although [E1]profilin[/E1] released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of [E2]profilin[/E2] in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[143, 151]], "entity_2_idx_in_text_with_entity_marker": [156, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p5", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although [E1]profilin[/E1] released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized [E2]actin[/E2] associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[369, 374]], "entity_2_idx_in_text_with_entity_marker": [382, 387], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p6", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although [E1]profilin[/E1] released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from [E2]profilin[/E2] too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[284, 292]], "entity_2_idx_in_text_with_entity_marker": [297, 305], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p7", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released actin at the appropriate time to stimulate [E1]actin[/E1] assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of [E2]actin[/E2] released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[264, 269]], "entity_2_idx_in_text_with_entity_marker": [277, 282], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p8", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released [E1]actin[/E1] at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of [E2]actin[/E2] released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[264, 269]], "entity_2_idx_in_text_with_entity_marker": [277, 282], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p9", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized [E1]actin[/E1] content in unstimulated PMN and the quantity of [E2]actin[/E2] released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[210, 215]], "entity_1_idx_in_text_with_entity_marker": [214, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[264, 269]], "entity_2_idx_in_text_with_entity_marker": [277, 282], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d661.s0_BioInfer.d661.s0.p0", "text": "The position of the actin-binding site at the C terminal suggests that talin may work as a crosslinker between myosin and actin.", "text_with_entity_marker": "The position of the [E1]actin[/E1]-binding site at the C terminal suggests that [E2]talin[/E2] may work as a crosslinker between myosin and actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[71, 76]], "entity_2_idx_in_text_with_entity_marker": [84, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d661.s0_BioInfer.d661.s0.p1", "text": "The position of the actin-binding site at the C terminal suggests that talin may work as a crosslinker between myosin and actin.", "text_with_entity_marker": "The position of the [E1]actin[/E1]-binding site at the C terminal suggests that talin may work as a crosslinker between [E2]myosin[/E2] and actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[111, 117]], "entity_2_idx_in_text_with_entity_marker": [124, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d661.s0_BioInfer.d661.s0.p2", "text": "The position of the actin-binding site at the C terminal suggests that talin may work as a crosslinker between myosin and actin.", "text_with_entity_marker": "The position of the [E1]actin[/E1]-binding site at the C terminal suggests that talin may work as a crosslinker between myosin and [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[122, 127]], "entity_2_idx_in_text_with_entity_marker": [135, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d661.s0_BioInfer.d661.s0.p3", "text": "The position of the actin-binding site at the C terminal suggests that talin may work as a crosslinker between myosin and actin.", "text_with_entity_marker": "The position of the actin-binding site at the C terminal suggests that [E1]talin[/E1] may work as a crosslinker between [E2]myosin[/E2] and actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[71, 76]], "entity_1_idx_in_text_with_entity_marker": [75, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[111, 117]], "entity_2_idx_in_text_with_entity_marker": [124, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d661.s0_BioInfer.d661.s0.p4", "text": "The position of the actin-binding site at the C terminal suggests that talin may work as a crosslinker between myosin and actin.", "text_with_entity_marker": "The position of the actin-binding site at the C terminal suggests that [E1]talin[/E1] may work as a crosslinker between myosin and [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[71, 76]], "entity_1_idx_in_text_with_entity_marker": [75, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[122, 127]], "entity_2_idx_in_text_with_entity_marker": [135, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d661.s0_BioInfer.d661.s0.p5", "text": "The position of the actin-binding site at the C terminal suggests that talin may work as a crosslinker between myosin and actin.", "text_with_entity_marker": "The position of the actin-binding site at the C terminal suggests that talin may work as a crosslinker between [E1]myosin[/E1] and [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "myosin", "entity_1_idx": [[111, 117]], "entity_1_idx_in_text_with_entity_marker": [115, 121], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[122, 127]], "entity_2_idx_in_text_with_entity_marker": [135, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p0", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of c-Myc or [E1]cyclin D1[/E1] was sufficient to activate cyclin E-[E2]Cdk2[/E2] by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin D1", "entity_1_idx": [[23, 32]], "entity_1_idx_in_text_with_entity_marker": [27, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cdk2", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p1", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of c-Myc or [E1]cyclin D1[/E1] was sufficient to activate [E2]cyclin E[/E2]-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin D1", "entity_1_idx": [[23, 32]], "entity_1_idx_in_text_with_entity_marker": [27, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[60, 68]], "entity_2_idx_in_text_with_entity_marker": [73, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p2", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of c-Myc or [E1]cyclin D1[/E1] was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the [E2]cyclin-dependent kinase inhibitor[/E2] p21, as has been described, following estrogen treatment.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[23, 32]], "entity_1_idx_in_text_with_entity_marker": [27, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[148, 181]], "entity_2_idx_in_text_with_entity_marker": [161, 194], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p3", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of [E1]c-Myc[/E1] or [E2]cyclin D1[/E2] was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "c-Myc", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D1", "entity_2_idx": [[23, 32]], "entity_2_idx_in_text_with_entity_marker": [36, 45], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p4", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of c-Myc or [E1]cyclin D1[/E1] was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor [E2]p21[/E2], as has been described, following estrogen treatment.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[23, 32]], "entity_1_idx_in_text_with_entity_marker": [27, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[182, 185]], "entity_2_idx_in_text_with_entity_marker": [195, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p5", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of c-Myc or cyclin D1 was sufficient to activate [E1]cyclin E[/E1]-[E2]Cdk2[/E2] by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[60, 68]], "entity_1_idx_in_text_with_entity_marker": [64, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cdk2", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p6", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-[E1]Cdk2[/E1] by promoting the formation of high-molecular-weight complexes lacking the [E2]cyclin-dependent kinase inhibitor[/E2] p21, as has been described, following estrogen treatment.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Cdk2", "entity_1_idx": [[69, 73]], "entity_1_idx_in_text_with_entity_marker": [73, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[148, 181]], "entity_2_idx_in_text_with_entity_marker": [161, 194], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p7", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of [E1]c-Myc[/E1] or cyclin D1 was sufficient to activate cyclin E-[E2]Cdk2[/E2] by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "c-Myc", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cdk2", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p8", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-[E1]Cdk2[/E1] by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor [E2]p21[/E2], as has been described, following estrogen treatment.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Cdk2", "entity_1_idx": [[69, 73]], "entity_1_idx_in_text_with_entity_marker": [73, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[182, 185]], "entity_2_idx_in_text_with_entity_marker": [195, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p9", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of c-Myc or cyclin D1 was sufficient to activate [E1]cyclin E[/E1]-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the [E2]cyclin-dependent kinase inhibitor[/E2] p21, as has been described, following estrogen treatment.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[60, 68]], "entity_1_idx_in_text_with_entity_marker": [64, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[148, 181]], "entity_2_idx_in_text_with_entity_marker": [161, 194], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p10", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of [E1]c-Myc[/E1] or cyclin D1 was sufficient to activate [E2]cyclin E[/E2]-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "c-Myc", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[60, 68]], "entity_2_idx_in_text_with_entity_marker": [73, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p11", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of c-Myc or cyclin D1 was sufficient to activate [E1]cyclin E[/E1]-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor [E2]p21[/E2], as has been described, following estrogen treatment.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[60, 68]], "entity_1_idx_in_text_with_entity_marker": [64, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[182, 185]], "entity_2_idx_in_text_with_entity_marker": [195, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p12", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of [E1]c-Myc[/E1] or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the [E2]cyclin-dependent kinase inhibitor[/E2] p21, as has been described, following estrogen treatment.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "c-Myc", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[148, 181]], "entity_2_idx_in_text_with_entity_marker": [161, 194], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p13", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p21[/E2], as has been described, following estrogen treatment.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[148, 181]], "entity_1_idx_in_text_with_entity_marker": [152, 185], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p21", "entity_2_idx": [[182, 185]], "entity_2_idx_in_text_with_entity_marker": [195, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p14", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of [E1]c-Myc[/E1] or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor [E2]p21[/E2], as has been described, following estrogen treatment.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "c-Myc", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[182, 185]], "entity_2_idx_in_text_with_entity_marker": [195, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d127.s0_BioInfer.d127.s0.p0", "text": "Calpain activity in vivo was determined by observing proteolysis of actin-binding protein and talin, two known substrates of calpain.", "text_with_entity_marker": "Calpain activity in vivo was determined by observing proteolysis of [E1]actin-binding protein[/E1] and [E2]talin[/E2], two known substrates of calpain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[68, 89]], "entity_1_idx_in_text_with_entity_marker": [72, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[94, 99]], "entity_2_idx_in_text_with_entity_marker": [107, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d127.s0_BioInfer.d127.s0.p1", "text": "Calpain activity in vivo was determined by observing proteolysis of actin-binding protein and talin, two known substrates of calpain.", "text_with_entity_marker": "Calpain activity in vivo was determined by observing proteolysis of actin-binding protein and [E1]talin[/E1], two known substrates of [E2]calpain[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[94, 99]], "entity_1_idx_in_text_with_entity_marker": [98, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calpain", "entity_2_idx": [[125, 132]], "entity_2_idx_in_text_with_entity_marker": [138, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d127.s0_BioInfer.d127.s0.p2", "text": "Calpain activity in vivo was determined by observing proteolysis of actin-binding protein and talin, two known substrates of calpain.", "text_with_entity_marker": "[E1]Calpain[/E1] activity in vivo was determined by observing proteolysis of actin-binding protein and [E2]talin[/E2], two known substrates of calpain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Calpain", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[94, 99]], "entity_2_idx_in_text_with_entity_marker": [107, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d127.s0_BioInfer.d127.s0.p3", "text": "Calpain activity in vivo was determined by observing proteolysis of actin-binding protein and talin, two known substrates of calpain.", "text_with_entity_marker": "Calpain activity in vivo was determined by observing proteolysis of [E1]actin-binding protein[/E1] and talin, two known substrates of [E2]calpain[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding protein", "entity_1_idx": [[68, 89]], "entity_1_idx_in_text_with_entity_marker": [72, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calpain", "entity_2_idx": [[125, 132]], "entity_2_idx_in_text_with_entity_marker": [138, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d127.s0_BioInfer.d127.s0.p4", "text": "Calpain activity in vivo was determined by observing proteolysis of actin-binding protein and talin, two known substrates of calpain.", "text_with_entity_marker": "[E1]Calpain[/E1] activity in vivo was determined by observing proteolysis of [E2]actin-binding protein[/E2] and talin, two known substrates of calpain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Calpain", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin-binding protein", "entity_2_idx": [[68, 89]], "entity_2_idx_in_text_with_entity_marker": [81, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d127.s0_BioInfer.d127.s0.p5", "text": "Calpain activity in vivo was determined by observing proteolysis of actin-binding protein and talin, two known substrates of calpain.", "text_with_entity_marker": "[E1]Calpain[/E1] activity in vivo was determined by observing proteolysis of actin-binding protein and talin, two known substrates of [E2]calpain[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Calpain", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calpain", "entity_2_idx": [[125, 132]], "entity_2_idx_in_text_with_entity_marker": [138, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d680.s0_BioInfer.d680.s0.p0", "text": "There are only 14 non-conservative substitutions in the two myosin heavy chains, three of which are located in the secondary actin-binding loop and flanking regions and others correspond to residues so far not assigned a functional role, including two residues in the proximal S2 domain.", "text_with_entity_marker": "There are only 14 non-conservative substitutions in the two [E1]myosin heavy chains[/E1], three of which are located in the secondary [E2]actin[/E2]-binding loop and flanking regions and others correspond to residues so far not assigned a functional role, including two residues in the proximal S2 domain.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "myosin heavy chains", "entity_1_idx": [[60, 79]], "entity_1_idx_in_text_with_entity_marker": [64, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s0_BioInfer.d73.s0.p0", "text": "RAD51, RAD54, RAD55 and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "text_with_entity_marker": "[E1]RAD51[/E1], RAD54, [E2]RAD55[/E2] and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD55", "entity_2_idx": [[14, 19]], "entity_2_idx_in_text_with_entity_marker": [27, 32], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s0_BioInfer.d73.s0.p1", "text": "RAD51, RAD54, RAD55 and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "text_with_entity_marker": "[E1]RAD51[/E1], [E2]RAD54[/E2], RAD55 and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[7, 12]], "entity_2_idx_in_text_with_entity_marker": [20, 25], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s0_BioInfer.d73.s0.p2", "text": "RAD51, RAD54, RAD55 and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "text_with_entity_marker": "[E1]RAD51[/E1], RAD54, RAD55 and [E2]RAD57[/E2] are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[24, 29]], "entity_2_idx_in_text_with_entity_marker": [37, 42], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s0_BioInfer.d73.s0.p3", "text": "RAD51, RAD54, RAD55 and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "text_with_entity_marker": "RAD51, [E1]RAD54[/E1], [E2]RAD55[/E2] and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD54", "entity_1_idx": [[7, 12]], "entity_1_idx_in_text_with_entity_marker": [11, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD55", "entity_2_idx": [[14, 19]], "entity_2_idx_in_text_with_entity_marker": [27, 32], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s0_BioInfer.d73.s0.p4", "text": "RAD51, RAD54, RAD55 and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "text_with_entity_marker": "RAD51, RAD54, [E1]RAD55[/E1] and [E2]RAD57[/E2] are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD55", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[24, 29]], "entity_2_idx_in_text_with_entity_marker": [37, 42], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s0_BioInfer.d73.s0.p5", "text": "RAD51, RAD54, RAD55 and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "text_with_entity_marker": "RAD51, [E1]RAD54[/E1], RAD55 and [E2]RAD57[/E2] are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD54", "entity_1_idx": [[7, 12]], "entity_1_idx_in_text_with_entity_marker": [11, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[24, 29]], "entity_2_idx_in_text_with_entity_marker": [37, 42], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s1_BioInfer.d73.s1.p0", "text": "RAD51, RAD54, RAD55 and RAD57 are still required when the same transcribed donor is on the chromosome.", "text_with_entity_marker": "[E1]RAD51[/E1], RAD54, [E2]RAD55[/E2] and RAD57 are still required when the same transcribed donor is on the chromosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD55", "entity_2_idx": [[14, 19]], "entity_2_idx_in_text_with_entity_marker": [27, 32], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s1_BioInfer.d73.s1.p1", "text": "RAD51, RAD54, RAD55 and RAD57 are still required when the same transcribed donor is on the chromosome.", "text_with_entity_marker": "RAD51, RAD54, [E1]RAD55[/E1] and [E2]RAD57[/E2] are still required when the same transcribed donor is on the chromosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD55", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[24, 29]], "entity_2_idx_in_text_with_entity_marker": [37, 42], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s1_BioInfer.d73.s1.p2", "text": "RAD51, RAD54, RAD55 and RAD57 are still required when the same transcribed donor is on the chromosome.", "text_with_entity_marker": "RAD51, [E1]RAD54[/E1], [E2]RAD55[/E2] and RAD57 are still required when the same transcribed donor is on the chromosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD54", "entity_1_idx": [[7, 12]], "entity_1_idx_in_text_with_entity_marker": [11, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD55", "entity_2_idx": [[14, 19]], "entity_2_idx_in_text_with_entity_marker": [27, 32], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s1_BioInfer.d73.s1.p3", "text": "RAD51, RAD54, RAD55 and RAD57 are still required when the same transcribed donor is on the chromosome.", "text_with_entity_marker": "[E1]RAD51[/E1], RAD54, RAD55 and [E2]RAD57[/E2] are still required when the same transcribed donor is on the chromosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[24, 29]], "entity_2_idx_in_text_with_entity_marker": [37, 42], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s1_BioInfer.d73.s1.p4", "text": "RAD51, RAD54, RAD55 and RAD57 are still required when the same transcribed donor is on the chromosome.", "text_with_entity_marker": "[E1]RAD51[/E1], [E2]RAD54[/E2], RAD55 and RAD57 are still required when the same transcribed donor is on the chromosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[7, 12]], "entity_2_idx_in_text_with_entity_marker": [20, 25], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s1_BioInfer.d73.s1.p5", "text": "RAD51, RAD54, RAD55 and RAD57 are still required when the same transcribed donor is on the chromosome.", "text_with_entity_marker": "RAD51, [E1]RAD54[/E1], RAD55 and [E2]RAD57[/E2] are still required when the same transcribed donor is on the chromosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD54", "entity_1_idx": [[7, 12]], "entity_1_idx_in_text_with_entity_marker": [11, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[24, 29]], "entity_2_idx_in_text_with_entity_marker": [37, 42], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s2_BioInfer.d73.s2.p0", "text": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.", "text_with_entity_marker": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, [E1]RAD52[/E1], RAD54, [E2]RAD55[/E2] or RAD57.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[173, 178]], "entity_1_idx_in_text_with_entity_marker": [177, 182], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD55", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s2_BioInfer.d73.s2.p1", "text": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.", "text_with_entity_marker": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, [E1]RAD55[/E1] or [E2]RAD57[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD55", "entity_1_idx": [[187, 192]], "entity_1_idx_in_text_with_entity_marker": [191, 196], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[196, 201]], "entity_2_idx_in_text_with_entity_marker": [209, 214], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s2_BioInfer.d73.s2.p2", "text": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.", "text_with_entity_marker": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes [E1]RAD51[/E1], RAD52, RAD54, [E2]RAD55[/E2] or RAD57.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD55", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s2_BioInfer.d73.s2.p3", "text": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.", "text_with_entity_marker": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, [E1]RAD54[/E1], [E2]RAD55[/E2] or RAD57.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD54", "entity_1_idx": [[180, 185]], "entity_1_idx_in_text_with_entity_marker": [184, 189], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD55", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s2_BioInfer.d73.s2.p4", "text": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.", "text_with_entity_marker": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, [E1]RAD52[/E1], RAD54, RAD55 or [E2]RAD57[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[173, 178]], "entity_1_idx_in_text_with_entity_marker": [177, 182], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[196, 201]], "entity_2_idx_in_text_with_entity_marker": [209, 214], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s2_BioInfer.d73.s2.p5", "text": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.", "text_with_entity_marker": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes [E1]RAD51[/E1], [E2]RAD52[/E2], RAD54, RAD55 or RAD57.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s2_BioInfer.d73.s2.p6", "text": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.", "text_with_entity_marker": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, [E1]RAD52[/E1], [E2]RAD54[/E2], RAD55 or RAD57.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[173, 178]], "entity_1_idx_in_text_with_entity_marker": [177, 182], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[180, 185]], "entity_2_idx_in_text_with_entity_marker": [193, 198], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s2_BioInfer.d73.s2.p7", "text": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.", "text_with_entity_marker": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes [E1]RAD51[/E1], RAD52, RAD54, RAD55 or [E2]RAD57[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[196, 201]], "entity_2_idx_in_text_with_entity_marker": [209, 214], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s2_BioInfer.d73.s2.p8", "text": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.", "text_with_entity_marker": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, [E1]RAD54[/E1], RAD55 or [E2]RAD57[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD54", "entity_1_idx": [[180, 185]], "entity_1_idx_in_text_with_entity_marker": [184, 189], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[196, 201]], "entity_2_idx_in_text_with_entity_marker": [209, 214], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s2_BioInfer.d73.s2.p9", "text": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.", "text_with_entity_marker": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes [E1]RAD51[/E1], RAD52, [E2]RAD54[/E2], RAD55 or RAD57.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[180, 185]], "entity_2_idx_in_text_with_entity_marker": [193, 198], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d660.s0_BioInfer.d660.s0.p0", "text": "The polypeptide folds and the actin-binding surfaces of the amoeba profilins are very similar to those of bovine and human profilins.", "text_with_entity_marker": "The polypeptide folds and the [E1]actin[/E1]-binding surfaces of the amoeba [E2]profilins[/E2] are very similar to those of bovine and human profilins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[67, 76]], "entity_2_idx_in_text_with_entity_marker": [80, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d660.s0_BioInfer.d660.s0.p1", "text": "The polypeptide folds and the actin-binding surfaces of the amoeba profilins are very similar to those of bovine and human profilins.", "text_with_entity_marker": "The polypeptide folds and the actin-binding surfaces of the amoeba [E1]profilins[/E1] are very similar to those of bovine and human [E2]profilins[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilins", "entity_1_idx": [[67, 76]], "entity_1_idx_in_text_with_entity_marker": [71, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[123, 132]], "entity_2_idx_in_text_with_entity_marker": [136, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d660.s0_BioInfer.d660.s0.p2", "text": "The polypeptide folds and the actin-binding surfaces of the amoeba profilins are very similar to those of bovine and human profilins.", "text_with_entity_marker": "The polypeptide folds and the [E1]actin[/E1]-binding surfaces of the amoeba profilins are very similar to those of bovine and human [E2]profilins[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[123, 132]], "entity_2_idx_in_text_with_entity_marker": [136, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d660.s1_BioInfer.d660.s1.p0", "text": "The proximity of these sites to the actin binding site provides an explanation for the competition between actin and lipids for binding profilin.", "text_with_entity_marker": "The proximity of these sites to the [E1]actin[/E1] binding site provides an explanation for the competition between actin and lipids for binding [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[136, 144]], "entity_2_idx_in_text_with_entity_marker": [149, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d660.s1_BioInfer.d660.s1.p1", "text": "The proximity of these sites to the actin binding site provides an explanation for the competition between actin and lipids for binding profilin.", "text_with_entity_marker": "The proximity of these sites to the actin binding site provides an explanation for the competition between [E1]actin[/E1] and lipids for binding [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[107, 112]], "entity_1_idx_in_text_with_entity_marker": [111, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[136, 144]], "entity_2_idx_in_text_with_entity_marker": [149, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d660.s1_BioInfer.d660.s1.p2", "text": "The proximity of these sites to the actin binding site provides an explanation for the competition between actin and lipids for binding profilin.", "text_with_entity_marker": "The proximity of these sites to the [E1]actin[/E1] binding site provides an explanation for the competition between [E2]actin[/E2] and lipids for binding profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[107, 112]], "entity_2_idx_in_text_with_entity_marker": [120, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d660.s2_BioInfer.d660.s2.p0", "text": "X-ray structures of isoforms of the actin-binding protein profilin that differ in their affinity for phosphatidylinositol phosphates.", "text_with_entity_marker": "X-ray structures of isoforms of the [E1]actin-binding protein[/E1] [E2]profilin[/E2] that differ in their affinity for phosphatidylinositol phosphates.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding protein", "entity_1_idx": [[36, 57]], "entity_1_idx_in_text_with_entity_marker": [40, 61], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[58, 66]], "entity_2_idx_in_text_with_entity_marker": [71, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p0", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, [E1]p18[/E1], and [E2]p14[/E2] (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p18", "entity_1_idx": [[230, 233]], "entity_1_idx_in_text_with_entity_marker": [234, 237], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p14", "entity_2_idx": [[239, 242]], "entity_2_idx_in_text_with_entity_marker": [252, 255], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p1", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The [E1]Arp2[/E1]/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, [E2]p18[/E2], and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp2", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p18", "entity_2_idx": [[230, 233]], "entity_2_idx_in_text_with_entity_marker": [243, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p2", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The [E1]Arp[/E1]2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, [E2]p18[/E2], and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp", "entity_1_idx": [[4, 7], [9, 10]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p18", "entity_2_idx": [[230, 233]], "entity_2_idx_in_text_with_entity_marker": [243, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p3", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, [E1]p35[/E1], p19, [E2]p18[/E2], and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p35", "entity_1_idx": [[220, 223]], "entity_1_idx_in_text_with_entity_marker": [224, 227], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p18", "entity_2_idx": [[230, 233]], "entity_2_idx_in_text_with_entity_marker": [243, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p4", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and [E1]Arp3[/E1]; and five apparently novel proteins, p40, p35, p19, [E2]p18[/E2], and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp3", "entity_1_idx": [[173, 177]], "entity_1_idx_in_text_with_entity_marker": [177, 181], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p18", "entity_2_idx": [[230, 233]], "entity_2_idx_in_text_with_entity_marker": [243, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p5", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, [E1]p40[/E1], p35, p19, [E2]p18[/E2], and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p40", "entity_1_idx": [[215, 218]], "entity_1_idx_in_text_with_entity_marker": [219, 222], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p18", "entity_2_idx": [[230, 233]], "entity_2_idx_in_text_with_entity_marker": [243, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p6", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two [E1]actin[/E1]-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, [E2]p18[/E2], and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[140, 145]], "entity_1_idx_in_text_with_entity_marker": [144, 149], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p18", "entity_2_idx": [[230, 233]], "entity_2_idx_in_text_with_entity_marker": [243, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p7", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on [E1]profilin[/E1], consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, [E2]p18[/E2], and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[94, 102]], "entity_1_idx_in_text_with_entity_marker": [98, 106], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p18", "entity_2_idx": [[230, 233]], "entity_2_idx_in_text_with_entity_marker": [243, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p8", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, [E1]p19[/E1], [E2]p18[/E2], and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p19", "entity_1_idx": [[225, 228]], "entity_1_idx_in_text_with_entity_marker": [229, 232], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p18", "entity_2_idx": [[230, 233]], "entity_2_idx_in_text_with_entity_marker": [243, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p9", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, [E1]Arp2[/E1] and Arp3; and five apparently novel proteins, p40, p35, p19, [E2]p18[/E2], and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp2", "entity_1_idx": [[164, 168]], "entity_1_idx_in_text_with_entity_marker": [168, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p18", "entity_2_idx": [[230, 233]], "entity_2_idx_in_text_with_entity_marker": [243, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p50", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two [E1]actin[/E1]-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, [E2]p19[/E2], p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[140, 145]], "entity_1_idx_in_text_with_entity_marker": [144, 149], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p19", "entity_2_idx": [[225, 228]], "entity_2_idx_in_text_with_entity_marker": [238, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p51", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two [E1]actin[/E1]-related proteins, [E2]Arp2[/E2] and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[140, 145]], "entity_1_idx_in_text_with_entity_marker": [144, 149], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[164, 168]], "entity_2_idx_in_text_with_entity_marker": [177, 181], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p52", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on [E1]profilin[/E1], consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, [E2]p19[/E2], p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[94, 102]], "entity_1_idx_in_text_with_entity_marker": [98, 106], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p19", "entity_2_idx": [[225, 228]], "entity_2_idx_in_text_with_entity_marker": [238, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p53", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on [E1]profilin[/E1], consists of seven polypeptides; two actin-related proteins, [E2]Arp2[/E2] and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[94, 102]], "entity_1_idx_in_text_with_entity_marker": [98, 106], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Arp2", "entity_2_idx": [[164, 168]], "entity_2_idx_in_text_with_entity_marker": [177, 181], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p54", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, [E1]Arp2[/E1] and Arp3; and five apparently novel proteins, p40, p35, [E2]p19[/E2], p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp2", "entity_1_idx": [[164, 168]], "entity_1_idx_in_text_with_entity_marker": [168, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p19", "entity_2_idx": [[225, 228]], "entity_2_idx_in_text_with_entity_marker": [238, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d261.s0_BioInfer.d261.s0.p0", "text": "Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes UL5, UL8, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric [E1]helicase-primase[/E1] composed of the products of the three DNA replication-specific genes UL5, [E2]UL8[/E2], and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[61, 77]], "entity_1_idx_in_text_with_entity_marker": [65, 81], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL8", "entity_2_idx": [[152, 155]], "entity_2_idx_in_text_with_entity_marker": [165, 168], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d261.s0_BioInfer.d261.s0.p1", "text": "Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes UL5, UL8, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes [E1]UL5[/E1], [E2]UL8[/E2], and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[147, 150]], "entity_1_idx_in_text_with_entity_marker": [151, 154], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "UL8", "entity_2_idx": [[152, 155]], "entity_2_idx_in_text_with_entity_marker": [165, 168], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d261.s0_BioInfer.d261.s0.p2", "text": "Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes UL5, UL8, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes UL5, [E1]UL8[/E1], and [E2]UL52[/E2] (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[152, 155]], "entity_1_idx_in_text_with_entity_marker": [156, 159], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "UL52", "entity_2_idx": [[161, 165]], "entity_2_idx_in_text_with_entity_marker": [174, 178], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d261.s0_BioInfer.d261.s0.p3", "text": "Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes UL5, UL8, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric [E1]helicase-primase[/E1] composed of the products of the three DNA replication-specific genes [E2]UL5[/E2], UL8, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[61, 77]], "entity_1_idx_in_text_with_entity_marker": [65, 81], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL5", "entity_2_idx": [[147, 150]], "entity_2_idx_in_text_with_entity_marker": [160, 163], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d261.s0_BioInfer.d261.s0.p4", "text": "Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes UL5, UL8, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric [E1]helicase-primase[/E1] composed of the products of the three DNA replication-specific genes UL5, UL8, and [E2]UL52[/E2] (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[61, 77]], "entity_1_idx_in_text_with_entity_marker": [65, 81], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL52", "entity_2_idx": [[161, 165]], "entity_2_idx_in_text_with_entity_marker": [174, 178], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d261.s0_BioInfer.d261.s0.p5", "text": "Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes UL5, UL8, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes [E1]UL5[/E1], UL8, and [E2]UL52[/E2] (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[147, 150]], "entity_1_idx_in_text_with_entity_marker": [151, 154], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "UL52", "entity_2_idx": [[161, 165]], "entity_2_idx_in_text_with_entity_marker": [174, 178], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p40", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, [E1]embryonic beta-tubulin[/E1], hnRNP, protein L-isoaspartyl methyltransferase ([E2]PIMT[/E2]), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "embryonic beta-tubulin", "entity_1_idx": [[70, 92]], "entity_1_idx_in_text_with_entity_marker": [74, 96], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PIMT", "entity_2_idx": [[142, 146]], "entity_2_idx_in_text_with_entity_marker": [155, 159], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p41", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, [E1]embryonic beta-tubulin[/E1], hnRNP, [E2]protein L-isoaspartyl methyltransferase[/E2] (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "embryonic beta-tubulin", "entity_1_idx": [[70, 92]], "entity_1_idx_in_text_with_entity_marker": [74, 96], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "protein L-isoaspartyl methyltransferase", "entity_2_idx": [[101, 140]], "entity_2_idx_in_text_with_entity_marker": [114, 153], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p42", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase ([E1]PIMT[/E1]), ferritin heavy chain, type IV collagen, actin-binding protein [E2]cofilin[/E2], profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PIMT", "entity_1_idx": [[142, 146]], "entity_1_idx_in_text_with_entity_marker": [146, 150], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "cofilin", "entity_2_idx": [[211, 218]], "entity_2_idx_in_text_with_entity_marker": [224, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p43", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, [E1]protein L-isoaspartyl methyltransferase[/E1] (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein [E2]cofilin[/E2], profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "protein L-isoaspartyl methyltransferase", "entity_1_idx": [[101, 140]], "entity_1_idx_in_text_with_entity_marker": [105, 144], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "cofilin", "entity_2_idx": [[211, 218]], "entity_2_idx_in_text_with_entity_marker": [224, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p44", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, [E1]protein L-isoaspartyl methyltransferase[/E1] ([E2]PIMT[/E2]), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "protein L-isoaspartyl methyltransferase", "entity_1_idx": [[101, 140]], "entity_1_idx_in_text_with_entity_marker": [105, 144], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "PIMT", "entity_2_idx": [[142, 146]], "entity_2_idx_in_text_with_entity_marker": [155, 159], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p20", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion ([E1]F[/E1]), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[86, 87]], "entity_1_idx_in_text_with_entity_marker": [90, 91], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p21", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of [E1]nucleocapsid[/E1] (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[28, 40], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [32, 44], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p22", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), [E1]matrix[/E1] (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix", "entity_1_idx": [[66, 72], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [70, 76], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p23", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), [E1]phosphoprotein[/E1] (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[46, 60], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [50, 64], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p24", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and [E1]large protein[/E1] (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large protein", "entity_1_idx": [[94, 107]], "entity_1_idx_in_text_with_entity_marker": [98, 111], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p25", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix ([E1]M[/E1]), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[74, 75]], "entity_1_idx_in_text_with_entity_marker": [78, 79], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p26", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position [E1]N[/E1]: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[245, 246]], "entity_1_idx_in_text_with_entity_marker": [249, 250], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p27", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein ([E1]L[/E1]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[109, 110]], "entity_1_idx_in_text_with_entity_marker": [113, 114], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p28", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, [E1]M[/E1]: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[273, 274]], "entity_1_idx_in_text_with_entity_marker": [277, 278], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p29", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), [E1]fusion[/E1] (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[78, 84], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [82, 88], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p40", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), [E1]fusion[/E1] (F), and large protein ([E2]L[/E2]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[78, 84], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [82, 88], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[109, 110]], "entity_2_idx_in_text_with_entity_marker": [122, 123], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p41", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein ([E1]P[/E1]), matrix (M), fusion (F), and large protein ([E2]L[/E2]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[62, 63]], "entity_1_idx_in_text_with_entity_marker": [66, 67], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[109, 110]], "entity_2_idx_in_text_with_entity_marker": [122, 123], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p42", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid ([E1]N[/E1]), phosphoprotein (P), matrix (M), fusion (F), and large protein ([E2]L[/E2]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[42, 43]], "entity_1_idx_in_text_with_entity_marker": [46, 47], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[109, 110]], "entity_2_idx_in_text_with_entity_marker": [122, 123], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p43", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion ([E1]F[/E1]), and large protein ([E2]L[/E2]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[86, 87]], "entity_1_idx_in_text_with_entity_marker": [90, 91], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[109, 110]], "entity_2_idx_in_text_with_entity_marker": [122, 123], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p44", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of [E1]nucleocapsid[/E1] (N), phosphoprotein (P), matrix (M), fusion (F), and large protein ([E2]L[/E2]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[28, 40], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [32, 44], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[109, 110]], "entity_2_idx_in_text_with_entity_marker": [122, 123], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p45", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), [E1]matrix[/E1] (M), fusion (F), and large protein ([E2]L[/E2]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix", "entity_1_idx": [[66, 72], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [70, 76], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[109, 110]], "entity_2_idx_in_text_with_entity_marker": [122, 123], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p46", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), [E1]phosphoprotein[/E1] (P), matrix (M), fusion (F), and large protein ([E2]L[/E2]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[46, 60], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [50, 64], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[109, 110]], "entity_2_idx_in_text_with_entity_marker": [122, 123], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p47", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and [E1]large protein[/E1] ([E2]L[/E2]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large protein", "entity_1_idx": [[94, 107]], "entity_1_idx_in_text_with_entity_marker": [98, 111], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[109, 110]], "entity_2_idx_in_text_with_entity_marker": [122, 123], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p48", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix ([E1]M[/E1]), fusion (F), and large protein ([E2]L[/E2]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[74, 75]], "entity_1_idx_in_text_with_entity_marker": [78, 79], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[109, 110]], "entity_2_idx_in_text_with_entity_marker": [122, 123], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p49", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein ([E1]L[/E1]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position [E2]N[/E2]: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[109, 110]], "entity_1_idx_in_text_with_entity_marker": [113, 114], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "N", "entity_2_idx": [[245, 246]], "entity_2_idx_in_text_with_entity_marker": [258, 259], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p100", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), [E1]phosphoprotein[/E1] (P), matrix ([E2]M[/E2]), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[46, 60], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [50, 64], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "M", "entity_2_idx": [[74, 75]], "entity_2_idx_in_text_with_entity_marker": [87, 88], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p101", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), [E1]phosphoprotein[/E1] (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position [E2]N[/E2]: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[46, 60], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [50, 64], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "N", "entity_2_idx": [[245, 246]], "entity_2_idx_in_text_with_entity_marker": [258, 259], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p102", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix ([E1]M[/E1]), fusion (F), and [E2]large protein[/E2] (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[74, 75]], "entity_1_idx_in_text_with_entity_marker": [78, 79], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "large protein", "entity_2_idx": [[94, 107]], "entity_2_idx_in_text_with_entity_marker": [107, 120], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p103", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and [E1]large protein[/E1] (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position [E2]N[/E2]: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large protein", "entity_1_idx": [[94, 107]], "entity_1_idx_in_text_with_entity_marker": [98, 111], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "N", "entity_2_idx": [[245, 246]], "entity_2_idx_in_text_with_entity_marker": [258, 259], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p104", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix ([E1]M[/E1]), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position [E2]N[/E2]: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[74, 75]], "entity_1_idx_in_text_with_entity_marker": [78, 79], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "N", "entity_2_idx": [[245, 246]], "entity_2_idx_in_text_with_entity_marker": [258, 259], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d654.s0_BioInfer.d654.s0.p0", "text": "The observed in vivo expression patterns of alpha-catenin, beta-catenin, and plakoglobin suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.", "text_with_entity_marker": "The observed in vivo expression patterns of [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and plakoglobin suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[44, 57]], "entity_1_idx_in_text_with_entity_marker": [48, 61], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[59, 71]], "entity_2_idx_in_text_with_entity_marker": [72, 84], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d654.s0_BioInfer.d654.s0.p1", "text": "The observed in vivo expression patterns of alpha-catenin, beta-catenin, and plakoglobin suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.", "text_with_entity_marker": "The observed in vivo expression patterns of alpha-catenin, [E1]beta-catenin[/E1], and [E2]plakoglobin[/E2] suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[59, 71]], "entity_1_idx_in_text_with_entity_marker": [63, 75], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[77, 88]], "entity_2_idx_in_text_with_entity_marker": [90, 101], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d654.s0_BioInfer.d654.s0.p2", "text": "The observed in vivo expression patterns of alpha-catenin, beta-catenin, and plakoglobin suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.", "text_with_entity_marker": "The observed in vivo expression patterns of [E1]alpha-catenin[/E1], beta-catenin, and [E2]plakoglobin[/E2] suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[44, 57]], "entity_1_idx_in_text_with_entity_marker": [48, 61], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[77, 88]], "entity_2_idx_in_text_with_entity_marker": [90, 101], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d654.s1_BioInfer.d654.s1.p0", "text": "This study details the expression patterns of alpha-catenin, beta-catenin, and gamma-catenin, during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.", "text_with_entity_marker": "This study details the expression patterns of [E1]alpha-catenin[/E1], beta-catenin, and [E2]gamma-catenin[/E2], during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[46, 59]], "entity_1_idx_in_text_with_entity_marker": [50, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[79, 92]], "entity_2_idx_in_text_with_entity_marker": [92, 105], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d654.s1_BioInfer.d654.s1.p1", "text": "This study details the expression patterns of alpha-catenin, beta-catenin, and gamma-catenin, during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.", "text_with_entity_marker": "This study details the expression patterns of [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and gamma-catenin, during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[46, 59]], "entity_1_idx_in_text_with_entity_marker": [50, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[61, 73]], "entity_2_idx_in_text_with_entity_marker": [74, 86], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d654.s1_BioInfer.d654.s1.p2", "text": "This study details the expression patterns of alpha-catenin, beta-catenin, and gamma-catenin, during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.", "text_with_entity_marker": "This study details the expression patterns of alpha-catenin, [E1]beta-catenin[/E1], and [E2]gamma-catenin[/E2], during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[61, 73]], "entity_1_idx_in_text_with_entity_marker": [65, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[79, 92]], "entity_2_idx_in_text_with_entity_marker": [92, 105], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p0", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and [E1]alpha-catenin[/E1] is not affected by the differential [E2]calreticulin[/E2] expression.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[90, 103]], "entity_1_idx_in_text_with_entity_marker": [94, 107], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calreticulin", "entity_2_idx": [[140, 152]], "entity_2_idx_in_text_with_entity_marker": [153, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p1", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of [E1]actin[/E1], talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and [E2]alpha-catenin[/E2] is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[90, 103]], "entity_2_idx_in_text_with_entity_marker": [103, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p2", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, talin, [E1]alpha 5[/E1] and beta 1 integrins, pp125 focal adhesion kinase, and [E2]alpha-catenin[/E2] is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha 5", "entity_1_idx": [[27, 34], [46, 55]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[90, 103]], "entity_2_idx_in_text_with_entity_marker": [103, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p3", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, talin, alpha 5 and beta 1 integrins, [E1]pp125[/E1] focal adhesion kinase, and [E2]alpha-catenin[/E2] is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "pp125", "entity_1_idx": [[57, 62]], "entity_1_idx_in_text_with_entity_marker": [61, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[90, 103]], "entity_2_idx_in_text_with_entity_marker": [103, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p4", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, talin, alpha 5 and [E1]beta 1 integrins[/E1], pp125 focal adhesion kinase, and [E2]alpha-catenin[/E2] is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta 1 integrins", "entity_1_idx": [[39, 55]], "entity_1_idx_in_text_with_entity_marker": [43, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[90, 103]], "entity_2_idx_in_text_with_entity_marker": [103, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p5", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, [E1]talin[/E1], alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and [E2]alpha-catenin[/E2] is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[90, 103]], "entity_2_idx_in_text_with_entity_marker": [103, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p6", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 [E1]focal adhesion kinase[/E1], and [E2]alpha-catenin[/E2] is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "focal adhesion kinase", "entity_1_idx": [[63, 84]], "entity_1_idx_in_text_with_entity_marker": [67, 88], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[90, 103]], "entity_2_idx_in_text_with_entity_marker": [103, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p7", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of [E1]actin[/E1], talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential [E2]calreticulin[/E2] expression.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calreticulin", "entity_2_idx": [[140, 152]], "entity_2_idx_in_text_with_entity_marker": [153, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p8", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, talin, [E1]alpha 5[/E1] and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential [E2]calreticulin[/E2] expression.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha 5", "entity_1_idx": [[27, 34], [46, 55]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calreticulin", "entity_2_idx": [[140, 152]], "entity_2_idx_in_text_with_entity_marker": [153, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p9", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, talin, alpha 5 and beta 1 integrins, [E1]pp125[/E1] focal adhesion kinase, and alpha-catenin is not affected by the differential [E2]calreticulin[/E2] expression.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "pp125", "entity_1_idx": [[57, 62]], "entity_1_idx_in_text_with_entity_marker": [61, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calreticulin", "entity_2_idx": [[140, 152]], "entity_2_idx_in_text_with_entity_marker": [153, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p22", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and [E1]H2a[/E1] genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone [E2]H2b[/E2] genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2a", "entity_1_idx": [[21, 24]], "entity_1_idx_in_text_with_entity_marker": [25, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2b", "entity_2_idx": [[121, 124]], "entity_2_idx_in_text_with_entity_marker": [134, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p23", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone [E1]H2b[/E1] genes encode < 10% of the total [E2]H4[/E2] and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2b", "entity_1_idx": [[121, 124]], "entity_1_idx_in_text_with_entity_marker": [125, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[157, 159]], "entity_2_idx_in_text_with_entity_marker": [170, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p24", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These [E1]histone[/E1] H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone [E2]H2b[/E2] genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[6, 13]], "entity_1_idx_in_text_with_entity_marker": [10, 17], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2b", "entity_2_idx": [[121, 124]], "entity_2_idx_in_text_with_entity_marker": [134, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p25", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total [E1]H3[/E1] and H2a mRNA, whereas the histone H4 and histone [E2]H2b[/E2] genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[69, 71]], "entity_1_idx_in_text_with_entity_marker": [73, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2b", "entity_2_idx": [[121, 124]], "entity_2_idx_in_text_with_entity_marker": [134, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p26", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and [E1]histone[/E1] [E2]H2b[/E2] genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[113, 120]], "entity_1_idx_in_text_with_entity_marker": [117, 124], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2b", "entity_2_idx": [[121, 124]], "entity_2_idx_in_text_with_entity_marker": [134, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p27", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the [E1]histone[/E1] [E2]H4[/E2] and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[98, 105]], "entity_1_idx_in_text_with_entity_marker": [102, 109], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[106, 108]], "entity_2_idx_in_text_with_entity_marker": [119, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p28", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone [E1]H3[/E1] and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the [E2]histone[/E2] H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[14, 16]], "entity_1_idx_in_text_with_entity_marker": [18, 20], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[98, 105]], "entity_2_idx_in_text_with_entity_marker": [111, 118], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p29", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and [E1]H2a[/E1] genes encode approximately 40% of the total H3 and H2a mRNA, whereas the [E2]histone[/E2] H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2a", "entity_1_idx": [[21, 24]], "entity_1_idx_in_text_with_entity_marker": [25, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[98, 105]], "entity_2_idx_in_text_with_entity_marker": [111, 118], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p30", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the [E1]histone[/E1] H4 and histone H2b genes encode < 10% of the total [E2]H4[/E2] and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[98, 105]], "entity_1_idx_in_text_with_entity_marker": [102, 109], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[157, 159]], "entity_2_idx_in_text_with_entity_marker": [170, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p31", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These [E1]histone[/E1] H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the [E2]histone[/E2] H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[6, 13]], "entity_1_idx_in_text_with_entity_marker": [10, 17], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[98, 105]], "entity_2_idx_in_text_with_entity_marker": [111, 118], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p0", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, [E1]SSB[/E1], and [E2]Pol[/E2], that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SSB", "entity_1_idx": [[240, 243]], "entity_1_idx_in_text_with_entity_marker": [244, 247], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Pol", "entity_2_idx": [[249, 252]], "entity_2_idx_in_text_with_entity_marker": [262, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p1", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, [E1]UL42[/E1], UL52, [E2]SSB[/E2], and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL42", "entity_1_idx": [[228, 232]], "entity_1_idx_in_text_with_entity_marker": [232, 236], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SSB", "entity_2_idx": [[240, 243]], "entity_2_idx_in_text_with_entity_marker": [253, 256], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p2", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, [E1]UL52[/E1], [E2]SSB[/E2], and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL52", "entity_1_idx": [[234, 238]], "entity_1_idx_in_text_with_entity_marker": [238, 242], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SSB", "entity_2_idx": [[240, 243]], "entity_2_idx_in_text_with_entity_marker": [253, 256], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p3", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, [E1]UL8[/E1], UL9, UL42, UL52, [E2]SSB[/E2], and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[218, 221]], "entity_1_idx_in_text_with_entity_marker": [222, 225], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SSB", "entity_2_idx": [[240, 243]], "entity_2_idx_in_text_with_entity_marker": [253, 256], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p4", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, [E1]UL9[/E1], UL42, UL52, [E2]SSB[/E2], and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL9", "entity_1_idx": [[223, 226]], "entity_1_idx_in_text_with_entity_marker": [227, 230], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SSB", "entity_2_idx": [[240, 243]], "entity_2_idx_in_text_with_entity_marker": [253, 256], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p5", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, [E1]UL5[/E1], UL8, UL9, UL42, UL52, [E2]SSB[/E2], and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[213, 216]], "entity_1_idx_in_text_with_entity_marker": [217, 220], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SSB", "entity_2_idx": [[240, 243]], "entity_2_idx_in_text_with_entity_marker": [253, 256], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p6", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, [E1]UL42[/E1], UL52, SSB, and [E2]Pol[/E2], that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL42", "entity_1_idx": [[228, 232]], "entity_1_idx_in_text_with_entity_marker": [232, 236], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Pol", "entity_2_idx": [[249, 252]], "entity_2_idx_in_text_with_entity_marker": [262, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p7", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, [E1]UL52[/E1], SSB, and [E2]Pol[/E2], that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL52", "entity_1_idx": [[234, 238]], "entity_1_idx_in_text_with_entity_marker": [238, 242], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Pol", "entity_2_idx": [[249, 252]], "entity_2_idx_in_text_with_entity_marker": [262, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p8", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, [E1]UL8[/E1], UL9, UL42, UL52, SSB, and [E2]Pol[/E2], that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[218, 221]], "entity_1_idx_in_text_with_entity_marker": [222, 225], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Pol", "entity_2_idx": [[249, 252]], "entity_2_idx_in_text_with_entity_marker": [262, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p9", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, [E1]UL9[/E1], UL42, UL52, SSB, and [E2]Pol[/E2], that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL9", "entity_1_idx": [[223, 226]], "entity_1_idx_in_text_with_entity_marker": [227, 230], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Pol", "entity_2_idx": [[249, 252]], "entity_2_idx_in_text_with_entity_marker": [262, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p10", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, [E1]UL5[/E1], UL8, UL9, UL42, UL52, SSB, and [E2]Pol[/E2], that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[213, 216]], "entity_1_idx_in_text_with_entity_marker": [217, 220], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Pol", "entity_2_idx": [[249, 252]], "entity_2_idx_in_text_with_entity_marker": [262, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p11", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, [E1]UL42[/E1], [E2]UL52[/E2], SSB, and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL42", "entity_1_idx": [[228, 232]], "entity_1_idx_in_text_with_entity_marker": [232, 236], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[234, 238]], "entity_2_idx_in_text_with_entity_marker": [247, 251], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p12", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, [E1]UL8[/E1], UL9, [E2]UL42[/E2], UL52, SSB, and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[218, 221]], "entity_1_idx_in_text_with_entity_marker": [222, 225], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[228, 232]], "entity_2_idx_in_text_with_entity_marker": [241, 245], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p13", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, [E1]UL9[/E1], [E2]UL42[/E2], UL52, SSB, and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL9", "entity_1_idx": [[223, 226]], "entity_1_idx_in_text_with_entity_marker": [227, 230], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[228, 232]], "entity_2_idx_in_text_with_entity_marker": [241, 245], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p14", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, [E1]UL5[/E1], UL8, UL9, [E2]UL42[/E2], UL52, SSB, and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[213, 216]], "entity_1_idx_in_text_with_entity_marker": [217, 220], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[228, 232]], "entity_2_idx_in_text_with_entity_marker": [241, 245], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p15", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, [E1]UL8[/E1], UL9, UL42, [E2]UL52[/E2], SSB, and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[218, 221]], "entity_1_idx_in_text_with_entity_marker": [222, 225], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[234, 238]], "entity_2_idx_in_text_with_entity_marker": [247, 251], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p16", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, [E1]UL9[/E1], UL42, [E2]UL52[/E2], SSB, and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL9", "entity_1_idx": [[223, 226]], "entity_1_idx_in_text_with_entity_marker": [227, 230], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[234, 238]], "entity_2_idx_in_text_with_entity_marker": [247, 251], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p17", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, [E1]UL5[/E1], UL8, UL9, UL42, [E2]UL52[/E2], SSB, and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[213, 216]], "entity_1_idx_in_text_with_entity_marker": [217, 220], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[234, 238]], "entity_2_idx_in_text_with_entity_marker": [247, 251], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p18", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, [E1]UL8[/E1], [E2]UL9[/E2], UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[218, 221]], "entity_1_idx_in_text_with_entity_marker": [222, 225], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL9", "entity_2_idx": [[223, 226]], "entity_2_idx_in_text_with_entity_marker": [236, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p19", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, [E1]UL5[/E1], [E2]UL8[/E2], UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[213, 216]], "entity_1_idx_in_text_with_entity_marker": [217, 220], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL8", "entity_2_idx": [[218, 221]], "entity_2_idx_in_text_with_entity_marker": [231, 234], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p20", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, [E1]UL5[/E1], UL8, [E2]UL9[/E2], UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[213, 216]], "entity_1_idx_in_text_with_entity_marker": [217, 220], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL9", "entity_2_idx": [[223, 226]], "entity_2_idx_in_text_with_entity_marker": [236, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d629.s0_BioInfer.d629.s0.p0", "text": "The interaction between the human respiratory syncytial virus phosphoprotein (P) and nucleocapsid (N) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.", "text_with_entity_marker": "The interaction between the human respiratory syncytial virus phosphoprotein (P) and [E1]nucleocapsid[/E1] ([E2]N[/E2]) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[85, 97], [102, 109]], "entity_1_idx_in_text_with_entity_marker": [89, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[99, 100]], "entity_2_idx_in_text_with_entity_marker": [112, 113], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d629.s0_BioInfer.d629.s0.p1", "text": "The interaction between the human respiratory syncytial virus phosphoprotein (P) and nucleocapsid (N) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.", "text_with_entity_marker": "The interaction between the human respiratory syncytial virus phosphoprotein ([E1]P[/E1]) and [E2]nucleocapsid[/E2] (N) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "P", "entity_1_idx": [[78, 79]], "entity_1_idx_in_text_with_entity_marker": [82, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid", "entity_2_idx": [[85, 97], [102, 109]], "entity_2_idx_in_text_with_entity_marker": [98, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d629.s0_BioInfer.d629.s0.p2", "text": "The interaction between the human respiratory syncytial virus phosphoprotein (P) and nucleocapsid (N) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.", "text_with_entity_marker": "The interaction between the human respiratory syncytial virus [E1]phosphoprotein[/E1] (P) and [E2]nucleocapsid[/E2] (N) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phosphoprotein", "entity_1_idx": [[62, 76], [102, 109]], "entity_1_idx_in_text_with_entity_marker": [66, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid", "entity_2_idx": [[85, 97], [102, 109]], "entity_2_idx_in_text_with_entity_marker": [98, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d629.s0_BioInfer.d629.s0.p3", "text": "The interaction between the human respiratory syncytial virus phosphoprotein (P) and nucleocapsid (N) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.", "text_with_entity_marker": "The interaction between the human respiratory syncytial virus phosphoprotein ([E1]P[/E1]) and nucleocapsid ([E2]N[/E2]) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "P", "entity_1_idx": [[78, 79]], "entity_1_idx_in_text_with_entity_marker": [82, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[99, 100]], "entity_2_idx_in_text_with_entity_marker": [112, 113], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d629.s0_BioInfer.d629.s0.p4", "text": "The interaction between the human respiratory syncytial virus phosphoprotein (P) and nucleocapsid (N) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.", "text_with_entity_marker": "The interaction between the human respiratory syncytial virus [E1]phosphoprotein[/E1] (P) and nucleocapsid ([E2]N[/E2]) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phosphoprotein", "entity_1_idx": [[62, 76], [102, 109]], "entity_1_idx_in_text_with_entity_marker": [66, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[99, 100]], "entity_2_idx_in_text_with_entity_marker": [112, 113], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d629.s0_BioInfer.d629.s0.p5", "text": "The interaction between the human respiratory syncytial virus phosphoprotein (P) and nucleocapsid (N) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.", "text_with_entity_marker": "The interaction between the human respiratory syncytial virus [E1]phosphoprotein[/E1] ([E2]P[/E2]) and nucleocapsid (N) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[62, 76], [102, 109]], "entity_1_idx_in_text_with_entity_marker": [66, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[78, 79]], "entity_2_idx_in_text_with_entity_marker": [91, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p60", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, [E1]histone[/E1] H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, [E2]histone[/E2] H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[218, 225]], "entity_1_idx_in_text_with_entity_marker": [222, 229], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[287, 294]], "entity_2_idx_in_text_with_entity_marker": [300, 307], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p61", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, [E1]histone[/E1] H2A.2, oxidized histone H2A.2, histone H2A.X, [E2]histone[/E2] H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[218, 225]], "entity_1_idx_in_text_with_entity_marker": [222, 229], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[272, 279]], "entity_2_idx_in_text_with_entity_marker": [285, 292], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p62", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, [E1]histone[/E1] H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone [E2]H3[/E2] variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[218, 225]], "entity_1_idx_in_text_with_entity_marker": [222, 229], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[314, 316]], "entity_2_idx_in_text_with_entity_marker": [327, 329], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p63", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, [E1]histone[/E1] H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone [E2]H2B[/E2], three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[218, 225]], "entity_1_idx_in_text_with_entity_marker": [222, 229], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2B", "entity_2_idx": [[295, 298]], "entity_2_idx_in_text_with_entity_marker": [308, 311], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p64", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, [E1]histone[/E1] H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone [E2]H4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[218, 225]], "entity_1_idx_in_text_with_entity_marker": [222, 229], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[338, 340]], "entity_2_idx_in_text_with_entity_marker": [351, 353], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p65", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, [E1]histone[/E1] H2A.2, oxidized [E2]histone[/E2] H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[218, 225]], "entity_1_idx_in_text_with_entity_marker": [222, 229], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[242, 249]], "entity_2_idx_in_text_with_entity_marker": [255, 262], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p66", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone [E1]H2A.1[/E1], [E2]histone[/E2] H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.1", "entity_1_idx": [[211, 216]], "entity_1_idx_in_text_with_entity_marker": [215, 220], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[218, 225]], "entity_2_idx_in_text_with_entity_marker": [231, 238], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p67", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone [E1]H1[/E1] subfractions, histone H2A.1, [E2]histone[/E2] H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1", "entity_1_idx": [[186, 188]], "entity_1_idx_in_text_with_entity_marker": [190, 192], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[218, 225]], "entity_2_idx_in_text_with_entity_marker": [231, 238], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p68", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone [E1]H1(0)[/E1], four histone H1 subfractions, histone H2A.1, [E2]histone[/E2] H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1(0)", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[218, 225]], "entity_2_idx_in_text_with_entity_marker": [231, 238], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p69", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified [E1]histones[/E1] were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, [E2]histone[/E2] H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[100, 108]], "entity_1_idx_in_text_with_entity_marker": [104, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "histone", "entity_2_idx": [[218, 225]], "entity_2_idx_in_text_with_entity_marker": [231, 238], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p0", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, [E1]DDC2[/E1] MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, [E2]RAD24[/E2], BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DDC2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[189, 194]], "entity_2_idx_in_text_with_entity_marker": [202, 207], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p1", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, [E1]DDC2[/E1] MEC3, RAD53, CHK1, PDS1, and [E2]DUN1[/E2] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DDC2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DUN1", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p2", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, [E1]DDC2[/E1] MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E2]RAD9[/E2], RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DDC2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p3", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, [E1]DDC2[/E1] MEC3, RAD53, [E2]CHK1[/E2], PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DDC2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CHK1", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p4", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, [E1]DDC2[/E1] MEC3, RAD53, CHK1, [E2]PDS1[/E2], and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DDC2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PDS1", "entity_2_idx": [[81, 85]], "entity_2_idx_in_text_with_entity_marker": [94, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p5", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, [E1]DDC2[/E1] MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E2]RAD17[/E2], RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DDC2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p6", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, [E1]DDC2[/E1] MEC3, [E2]RAD53[/E2], CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DDC2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD53", "entity_2_idx": [[68, 73]], "entity_2_idx_in_text_with_entity_marker": [81, 86], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p7", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, [E1]DPB11[/E1], MEC1, [E2]DDC2[/E2] MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DPB11", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DDC2", "entity_2_idx": [[57, 61]], "entity_2_idx_in_text_with_entity_marker": [70, 74], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p8", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, [E1]MEC1[/E1], [E2]DDC2[/E2] MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC1", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DDC2", "entity_2_idx": [[57, 61]], "entity_2_idx_in_text_with_entity_marker": [70, 74], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p9", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, MEC1, [E2]DDC2[/E2] MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DDC2", "entity_2_idx": [[57, 61]], "entity_2_idx_in_text_with_entity_marker": [70, 74], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p70", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, [E1]DPB11[/E1], MEC1, DDC2 MEC3, [E2]RAD53[/E2], CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DPB11", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD53", "entity_2_idx": [[68, 73]], "entity_2_idx_in_text_with_entity_marker": [81, 86], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p71", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, [E1]MEC1[/E1], DDC2 MEC3, [E2]RAD53[/E2], CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC1", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD53", "entity_2_idx": [[68, 73]], "entity_2_idx_in_text_with_entity_marker": [81, 86], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p72", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, MEC1, DDC2 MEC3, [E2]RAD53[/E2], CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD53", "entity_2_idx": [[68, 73]], "entity_2_idx_in_text_with_entity_marker": [81, 86], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p73", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 [E1]MEC3[/E1], [E2]RAD53[/E2], CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC3", "entity_1_idx": [[62, 66]], "entity_1_idx_in_text_with_entity_marker": [66, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD53", "entity_2_idx": [[68, 73]], "entity_2_idx_in_text_with_entity_marker": [81, 86], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p74", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, [E1]RAD53[/E1], CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, [E2]BUB3[/E2], and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD53", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUB3", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p75", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, [E1]RAD53[/E1], CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD53", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p76", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, [E1]DPB11[/E1], [E2]MEC1[/E2], DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DPB11", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC1", "entity_2_idx": [[51, 55]], "entity_2_idx_in_text_with_entity_marker": [64, 68], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p77", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], [E2]DPB11[/E2], MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DPB11", "entity_2_idx": [[44, 49]], "entity_2_idx_in_text_with_entity_marker": [57, 62], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p78", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, [E1]DPB11[/E1], MEC1, DDC2 [E2]MEC3[/E2], RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DPB11", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[62, 66]], "entity_2_idx_in_text_with_entity_marker": [75, 79], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p79", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, [E1]DPB11[/E1], MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, [E2]BUB3[/E2], and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DPB11", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUB3", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d785.s0_BioInfer.d785.s0.p0", "text": "Up to now three allergens have been identified as responsible for cross-reactivity in these associations: profilin, a 14 kd protein that regulates actin; Bet v 1, the 18 kd birch pollen allergen; and a 60-69 kd allergen.", "text_with_entity_marker": "Up to now three allergens have been identified as responsible for cross-reactivity in these associations: profilin, a 14 kd protein that regulates [E1]actin[/E1]; [E2]Bet v 1[/E2], the 18 kd birch pollen allergen; and a 60-69 kd allergen.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[147, 152]], "entity_1_idx_in_text_with_entity_marker": [151, 156], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Bet v 1", "entity_2_idx": [[154, 161]], "entity_2_idx_in_text_with_entity_marker": [167, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d785.s0_BioInfer.d785.s0.p1", "text": "Up to now three allergens have been identified as responsible for cross-reactivity in these associations: profilin, a 14 kd protein that regulates actin; Bet v 1, the 18 kd birch pollen allergen; and a 60-69 kd allergen.", "text_with_entity_marker": "Up to now three allergens have been identified as responsible for cross-reactivity in these associations: [E1]profilin[/E1], a 14 kd protein that regulates [E2]actin[/E2]; Bet v 1, the 18 kd birch pollen allergen; and a 60-69 kd allergen.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[106, 114]], "entity_1_idx_in_text_with_entity_marker": [110, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d785.s0_BioInfer.d785.s0.p2", "text": "Up to now three allergens have been identified as responsible for cross-reactivity in these associations: profilin, a 14 kd protein that regulates actin; Bet v 1, the 18 kd birch pollen allergen; and a 60-69 kd allergen.", "text_with_entity_marker": "Up to now three allergens have been identified as responsible for cross-reactivity in these associations: [E1]profilin[/E1], a 14 kd protein that regulates actin; [E2]Bet v 1[/E2], the 18 kd birch pollen allergen; and a 60-69 kd allergen.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[106, 114]], "entity_1_idx_in_text_with_entity_marker": [110, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Bet v 1", "entity_2_idx": [[154, 161]], "entity_2_idx_in_text_with_entity_marker": [167, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d106.s0_BioInfer.d106.s0.p0", "text": "Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.", "text_with_entity_marker": "[E1]Neuropilin-1[/E1] is expressed by endothelial and tumor cells as an isoform-specific receptor for [E2]vascular endothelial growth factor[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Neuropilin-1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vascular endothelial growth factor", "entity_2_idx": [[93, 127]], "entity_2_idx_in_text_with_entity_marker": [106, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p10", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that [E1]histone[/E1] [E2]H4[/E2], and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[72, 79]], "entity_1_idx_in_text_with_entity_marker": [76, 83], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[80, 82]], "entity_2_idx_in_text_with_entity_marker": [93, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p11", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone [E1]H3[/E1], was acetylated from the endogenous [E2]p21[/E2]/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "H3", "entity_1_idx": [[100, 102]], "entity_1_idx_in_text_with_entity_marker": [104, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[139, 142]], "entity_2_idx_in_text_with_entity_marker": [152, 155], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p12", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous [E1]p21[/E1]/waf1 promoter in vivo, implying that [E2]CBP[/E2]/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[139, 142]], "entity_1_idx_in_text_with_entity_marker": [143, 146], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "CBP", "entity_2_idx": [[180, 183]], "entity_2_idx_in_text_with_entity_marker": [193, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p13", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous [E1]p21[/E1]/waf1 promoter in vivo, implying that CBP/p300, and not the [E2]SAGA[/E2] complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[139, 142]], "entity_1_idx_in_text_with_entity_marker": [143, 146], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SAGA", "entity_2_idx": [[202, 206]], "entity_2_idx_in_text_with_entity_marker": [215, 219], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p14", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous [E1]p21[/E1]/waf1 promoter in vivo, implying that CBP/[E2]p300[/E2], and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[139, 142]], "entity_1_idx_in_text_with_entity_marker": [143, 146], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "p300", "entity_2_idx": [[184, 188]], "entity_2_idx_in_text_with_entity_marker": [197, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p15", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous [E1]p21[/E1]/[E2]waf1[/E2] promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[139, 142]], "entity_1_idx_in_text_with_entity_marker": [143, 146], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "waf1", "entity_2_idx": [[143, 147]], "entity_2_idx_in_text_with_entity_marker": [156, 160], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p16", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous [E1]p21[/E1]/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/[E2]waf1[/E2] in HTLV-1-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[139, 142]], "entity_1_idx_in_text_with_entity_marker": [143, 146], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "waf1", "entity_2_idx": [[276, 280]], "entity_2_idx_in_text_with_entity_marker": [289, 293], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p17", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous [E1]p21[/E1]/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of [E2]p21[/E2]/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[139, 142]], "entity_1_idx_in_text_with_entity_marker": [143, 146], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "p21", "entity_2_idx": [[272, 275]], "entity_2_idx_in_text_with_entity_marker": [285, 288], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p18", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not [E1]histone[/E1] H3, was acetylated from the endogenous [E2]p21[/E2]/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[92, 99]], "entity_1_idx_in_text_with_entity_marker": [96, 103], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p21", "entity_2_idx": [[139, 142]], "entity_2_idx_in_text_with_entity_marker": [152, 155], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p19", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous [E1]p21[/E1]/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with [E2]E2A[/E2] in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[139, 142]], "entity_1_idx_in_text_with_entity_marker": [143, 146], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "E2A", "entity_2_idx": [[248, 251]], "entity_2_idx_in_text_with_entity_marker": [261, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p19", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of [E1]cofilin[/E1] to actin monomer in the filament and that cofilin increases the monomeric [E2]actin[/E2] to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[132, 139]], "entity_1_idx_in_text_with_entity_marker": [136, 143], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[214, 219]], "entity_2_idx_in_text_with_entity_marker": [227, 232], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p20", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of [E1]cofilin[/E1] to [E2]actin[/E2] monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[132, 139]], "entity_1_idx_in_text_with_entity_marker": [136, 143], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[143, 148]], "entity_2_idx_in_text_with_entity_marker": [156, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s2_BioInfer.d38.s2.p0", "text": "The gel point assay using an actin cross-linking protein and the nucleation assay also suggested that cofilin shortens the actin filaments and hence increases the filament number.", "text_with_entity_marker": "The gel point assay using an actin cross-linking protein and the nucleation assay also suggested that [E1]cofilin[/E1] shortens the [E2]actin[/E2] filaments and hence increases the filament number.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[102, 109]], "entity_1_idx_in_text_with_entity_marker": [106, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[123, 128]], "entity_2_idx_in_text_with_entity_marker": [136, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s2_BioInfer.d38.s2.p1", "text": "The gel point assay using an actin cross-linking protein and the nucleation assay also suggested that cofilin shortens the actin filaments and hence increases the filament number.", "text_with_entity_marker": "The gel point assay using an [E1]actin[/E1] cross-linking protein and the nucleation assay also suggested that cofilin shortens the [E2]actin[/E2] filaments and hence increases the filament number.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[29, 34]], "entity_1_idx_in_text_with_entity_marker": [33, 38], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[123, 128]], "entity_2_idx_in_text_with_entity_marker": [136, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s2_BioInfer.d38.s2.p2", "text": "The gel point assay using an actin cross-linking protein and the nucleation assay also suggested that cofilin shortens the actin filaments and hence increases the filament number.", "text_with_entity_marker": "The gel point assay using an [E1]actin[/E1] cross-linking protein and the nucleation assay also suggested that [E2]cofilin[/E2] shortens the actin filaments and hence increases the filament number.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[29, 34]], "entity_1_idx_in_text_with_entity_marker": [33, 38], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[102, 109]], "entity_2_idx_in_text_with_entity_marker": [115, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d341.s0_BioInfer.d341.s0.p0", "text": "Inhibition of cyclin D1 expression or induction of cyclin-dependent kinase inhibitor p21WAF1 expression was found in mimosine-treated lung cancer cells.", "text_with_entity_marker": "Inhibition of cyclin D1 expression or induction of [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p21WAF1[/E2] expression was found in mimosine-treated lung cancer cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[51, 84]], "entity_1_idx_in_text_with_entity_marker": [55, 88], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p21WAF1", "entity_2_idx": [[85, 92]], "entity_2_idx_in_text_with_entity_marker": [98, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d341.s0_BioInfer.d341.s0.p1", "text": "Inhibition of cyclin D1 expression or induction of cyclin-dependent kinase inhibitor p21WAF1 expression was found in mimosine-treated lung cancer cells.", "text_with_entity_marker": "Inhibition of [E1]cyclin D1[/E1] expression or induction of cyclin-dependent kinase inhibitor [E2]p21WAF1[/E2] expression was found in mimosine-treated lung cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[14, 23]], "entity_1_idx_in_text_with_entity_marker": [18, 27], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p21WAF1", "entity_2_idx": [[85, 92]], "entity_2_idx_in_text_with_entity_marker": [98, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d341.s0_BioInfer.d341.s0.p2", "text": "Inhibition of cyclin D1 expression or induction of cyclin-dependent kinase inhibitor p21WAF1 expression was found in mimosine-treated lung cancer cells.", "text_with_entity_marker": "Inhibition of [E1]cyclin D1[/E1] expression or induction of [E2]cyclin-dependent kinase inhibitor[/E2] p21WAF1 expression was found in mimosine-treated lung cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[14, 23]], "entity_1_idx_in_text_with_entity_marker": [18, 27], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[51, 84]], "entity_2_idx_in_text_with_entity_marker": [64, 97], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p0", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with [E1]actin-binding proteins[/E1] such as gelsolin and [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding proteins", "entity_1_idx": [[326, 348]], "entity_1_idx_in_text_with_entity_marker": [330, 352], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[370, 378]], "entity_2_idx_in_text_with_entity_marker": [383, 391], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p1", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of PKC precedes the activation of [E1]PI[/E1] and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PI", "entity_1_idx": [[72, 74], [83, 90]], "entity_1_idx_in_text_with_entity_marker": [76, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[370, 378]], "entity_2_idx_in_text_with_entity_marker": [383, 391], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p2", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of [E1]PKC[/E1] precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKC", "entity_1_idx": [[41, 44]], "entity_1_idx_in_text_with_entity_marker": [45, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[370, 378]], "entity_2_idx_in_text_with_entity_marker": [383, 391], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p3", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of PKC precedes the activation of PI and [E1]PIP kinases[/E1] and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PIP kinases", "entity_1_idx": [[79, 90]], "entity_1_idx_in_text_with_entity_marker": [83, 94], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[370, 378]], "entity_2_idx_in_text_with_entity_marker": [383, 391], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p4", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of [E1]actin[/E1] in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[239, 244]], "entity_1_idx_in_text_with_entity_marker": [243, 248], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[370, 378]], "entity_2_idx_in_text_with_entity_marker": [383, 391], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p5", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as [E1]gelsolin[/E1] and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[357, 365]], "entity_1_idx_in_text_with_entity_marker": [361, 369], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[370, 378]], "entity_2_idx_in_text_with_entity_marker": [383, 391], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p6", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of PKC precedes the activation of [E1]PI[/E1] and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with [E2]actin-binding proteins[/E2] such as gelsolin and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PI", "entity_1_idx": [[72, 74], [83, 90]], "entity_1_idx_in_text_with_entity_marker": [76, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[326, 348]], "entity_2_idx_in_text_with_entity_marker": [339, 361], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p7", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of [E1]PKC[/E1] precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with [E2]actin-binding proteins[/E2] such as gelsolin and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PKC", "entity_1_idx": [[41, 44]], "entity_1_idx_in_text_with_entity_marker": [45, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[326, 348]], "entity_2_idx_in_text_with_entity_marker": [339, 361], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p8", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of PKC precedes the activation of PI and [E1]PIP kinases[/E1] and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with [E2]actin-binding proteins[/E2] such as gelsolin and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PIP kinases", "entity_1_idx": [[79, 90]], "entity_1_idx_in_text_with_entity_marker": [83, 94], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[326, 348]], "entity_2_idx_in_text_with_entity_marker": [339, 361], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p9", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of [E1]actin[/E1] in RBL cells, possibly through the interaction of the polyphosphoinositides with [E2]actin-binding proteins[/E2] such as gelsolin and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[239, 244]], "entity_1_idx_in_text_with_entity_marker": [243, 248], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[326, 348]], "entity_2_idx_in_text_with_entity_marker": [339, 361], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p10", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with [E1]actin-binding proteins[/E1] such as [E2]gelsolin[/E2] and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding proteins", "entity_1_idx": [[326, 348]], "entity_1_idx_in_text_with_entity_marker": [330, 352], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "gelsolin", "entity_2_idx": [[357, 365]], "entity_2_idx_in_text_with_entity_marker": [370, 378], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p11", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of [E1]PKC[/E1] precedes the activation of [E2]PI[/E2] and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PKC", "entity_1_idx": [[41, 44]], "entity_1_idx_in_text_with_entity_marker": [45, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PI", "entity_2_idx": [[72, 74], [83, 90]], "entity_2_idx_in_text_with_entity_marker": [85, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p12", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of PKC precedes the activation of [E1]PI[/E1] and [E2]PIP kinases[/E2] and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PI", "entity_1_idx": [[72, 74], [83, 90]], "entity_1_idx_in_text_with_entity_marker": [76, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PIP kinases", "entity_2_idx": [[79, 90]], "entity_2_idx_in_text_with_entity_marker": [92, 103], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p13", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of PKC precedes the activation of [E1]PI[/E1] and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of [E2]actin[/E2] in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PI", "entity_1_idx": [[72, 74], [83, 90]], "entity_1_idx_in_text_with_entity_marker": [76, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[239, 244]], "entity_2_idx_in_text_with_entity_marker": [252, 257], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p14", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of PKC precedes the activation of [E1]PI[/E1] and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as [E2]gelsolin[/E2] and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PI", "entity_1_idx": [[72, 74], [83, 90]], "entity_1_idx_in_text_with_entity_marker": [76, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[357, 365]], "entity_2_idx_in_text_with_entity_marker": [370, 378], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p15", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of [E1]PKC[/E1] precedes the activation of PI and [E2]PIP kinases[/E2] and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PKC", "entity_1_idx": [[41, 44]], "entity_1_idx_in_text_with_entity_marker": [45, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PIP kinases", "entity_2_idx": [[79, 90]], "entity_2_idx_in_text_with_entity_marker": [92, 103], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p16", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of [E1]PKC[/E1] precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of [E2]actin[/E2] in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PKC", "entity_1_idx": [[41, 44]], "entity_1_idx_in_text_with_entity_marker": [45, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[239, 244]], "entity_2_idx_in_text_with_entity_marker": [252, 257], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p17", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of [E1]PKC[/E1] precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as [E2]gelsolin[/E2] and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKC", "entity_1_idx": [[41, 44]], "entity_1_idx_in_text_with_entity_marker": [45, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[357, 365]], "entity_2_idx_in_text_with_entity_marker": [370, 378], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p18", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of PKC precedes the activation of PI and [E1]PIP kinases[/E1] and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of [E2]actin[/E2] in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PIP kinases", "entity_1_idx": [[79, 90]], "entity_1_idx_in_text_with_entity_marker": [83, 94], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[239, 244]], "entity_2_idx_in_text_with_entity_marker": [252, 257], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p19", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of PKC precedes the activation of PI and [E1]PIP kinases[/E1] and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as [E2]gelsolin[/E2] and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PIP kinases", "entity_1_idx": [[79, 90]], "entity_1_idx_in_text_with_entity_marker": [83, 94], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[357, 365]], "entity_2_idx_in_text_with_entity_marker": [370, 378], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d711.s0_BioInfer.d711.s0.p20", "text": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of [E1]actin[/E1] in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as [E2]gelsolin[/E2] and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[239, 244]], "entity_1_idx_in_text_with_entity_marker": [243, 248], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[357, 365]], "entity_2_idx_in_text_with_entity_marker": [370, 378], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d585.s0_BioInfer.d585.s0.p0", "text": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "text_with_entity_marker": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [[E1]P(NJ)[/E1]] and Indiana [[E2]P(I)[/E2]] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P(NJ)", "entity_1_idx": [[81, 86]], "entity_1_idx_in_text_with_entity_marker": [85, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P(I)", "entity_2_idx": [[101, 105]], "entity_2_idx_in_text_with_entity_marker": [114, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d585.s0_BioInfer.d585.s0.p1", "text": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "text_with_entity_marker": "The phosphoprotein ([E1]P[/E1]) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [[E2]P(I)[/E2]] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "P", "entity_1_idx": [[20, 21]], "entity_1_idx_in_text_with_entity_marker": [24, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P(I)", "entity_2_idx": [[101, 105]], "entity_2_idx_in_text_with_entity_marker": [114, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d585.s0_BioInfer.d585.s0.p2", "text": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "text_with_entity_marker": "The [E1]phosphoprotein[/E1] (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [[E2]P(I)[/E2]] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phosphoprotein", "entity_1_idx": [[4, 18]], "entity_1_idx_in_text_with_entity_marker": [8, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P(I)", "entity_2_idx": [[101, 105]], "entity_2_idx_in_text_with_entity_marker": [114, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d585.s0_BioInfer.d585.s0.p3", "text": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "text_with_entity_marker": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [[E1]P(I)[/E1]] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the [E2]nucleocapsid protein[/E2] N in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P(I)", "entity_1_idx": [[101, 105]], "entity_1_idx_in_text_with_entity_marker": [105, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[265, 285]], "entity_2_idx_in_text_with_entity_marker": [278, 298], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d585.s0_BioInfer.d585.s0.p4", "text": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "text_with_entity_marker": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [[E1]P(I)[/E1]] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein [E2]N[/E2] in vivo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "P(I)", "entity_1_idx": [[101, 105]], "entity_1_idx_in_text_with_entity_marker": [105, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[286, 287]], "entity_2_idx_in_text_with_entity_marker": [299, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d585.s0_BioInfer.d585.s0.p5", "text": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "text_with_entity_marker": "The phosphoprotein ([E1]P[/E1]) of vesicular stomatitis virus (VSV) serotypes New Jersey [[E2]P(NJ)[/E2]] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "P", "entity_1_idx": [[20, 21]], "entity_1_idx_in_text_with_entity_marker": [24, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P(NJ)", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d585.s0_BioInfer.d585.s0.p6", "text": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "text_with_entity_marker": "The [E1]phosphoprotein[/E1] (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [[E2]P(NJ)[/E2]] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phosphoprotein", "entity_1_idx": [[4, 18]], "entity_1_idx_in_text_with_entity_marker": [8, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P(NJ)", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d585.s0_BioInfer.d585.s0.p7", "text": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "text_with_entity_marker": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [[E1]P(NJ)[/E1]] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the [E2]nucleocapsid protein[/E2] N in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P(NJ)", "entity_1_idx": [[81, 86]], "entity_1_idx_in_text_with_entity_marker": [85, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[265, 285]], "entity_2_idx_in_text_with_entity_marker": [278, 298], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d585.s0_BioInfer.d585.s0.p8", "text": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "text_with_entity_marker": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [[E1]P(NJ)[/E1]] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein [E2]N[/E2] in vivo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "P(NJ)", "entity_1_idx": [[81, 86]], "entity_1_idx_in_text_with_entity_marker": [85, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[286, 287]], "entity_2_idx_in_text_with_entity_marker": [299, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d585.s0_BioInfer.d585.s0.p9", "text": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "text_with_entity_marker": "The [E1]phosphoprotein[/E1] ([E2]P[/E2]) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[4, 18]], "entity_1_idx_in_text_with_entity_marker": [8, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[20, 21]], "entity_2_idx_in_text_with_entity_marker": [33, 34], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d585.s0_BioInfer.d585.s0.p10", "text": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "text_with_entity_marker": "The phosphoprotein ([E1]P[/E1]) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the [E2]nucleocapsid protein[/E2] N in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[20, 21]], "entity_1_idx_in_text_with_entity_marker": [24, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[265, 285]], "entity_2_idx_in_text_with_entity_marker": [278, 298], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d585.s0_BioInfer.d585.s0.p11", "text": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "text_with_entity_marker": "The phosphoprotein ([E1]P[/E1]) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein [E2]N[/E2] in vivo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "P", "entity_1_idx": [[20, 21]], "entity_1_idx_in_text_with_entity_marker": [24, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[286, 287]], "entity_2_idx_in_text_with_entity_marker": [299, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d585.s0_BioInfer.d585.s0.p12", "text": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "text_with_entity_marker": "The [E1]phosphoprotein[/E1] (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the [E2]nucleocapsid protein[/E2] N in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[4, 18]], "entity_1_idx_in_text_with_entity_marker": [8, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[265, 285]], "entity_2_idx_in_text_with_entity_marker": [278, 298], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d585.s0_BioInfer.d585.s0.p13", "text": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "text_with_entity_marker": "The [E1]phosphoprotein[/E1] (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein [E2]N[/E2] in vivo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phosphoprotein", "entity_1_idx": [[4, 18]], "entity_1_idx_in_text_with_entity_marker": [8, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[286, 287]], "entity_2_idx_in_text_with_entity_marker": [299, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d585.s0_BioInfer.d585.s0.p14", "text": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the nucleocapsid protein N in vivo.", "text_with_entity_marker": "The phosphoprotein (P) of vesicular stomatitis virus (VSV) serotypes New Jersey [P(NJ)] and Indiana [P(I)] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the [E1]nucleocapsid protein[/E1] [E2]N[/E2] in vivo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "nucleocapsid protein", "entity_1_idx": [[265, 285]], "entity_1_idx_in_text_with_entity_marker": [269, 289], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "N", "entity_2_idx": [[286, 287]], "entity_2_idx_in_text_with_entity_marker": [299, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d122.s0_BioInfer.d122.s0.p0", "text": "By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.", "text_with_entity_marker": "By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa ([E1]eIF3-p33[/E1]) which is part of the [E2]eIF3[/E2] complex and has an RNA binding domain.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "eIF3-p33", "entity_1_idx": [[170, 178]], "entity_1_idx_in_text_with_entity_marker": [174, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "eIF3", "entity_2_idx": [[201, 205]], "entity_2_idx_in_text_with_entity_marker": [214, 218], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d122.s0_BioInfer.d122.s0.p1", "text": "By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.", "text_with_entity_marker": "By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized [E1]eIF3[/E1] subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the [E2]eIF3[/E2] complex and has an RNA binding domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "eIF3", "entity_1_idx": [[125, 129]], "entity_1_idx_in_text_with_entity_marker": [129, 133], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "eIF3", "entity_2_idx": [[201, 205]], "entity_2_idx_in_text_with_entity_marker": [214, 218], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d122.s0_BioInfer.d122.s0.p2", "text": "By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.", "text_with_entity_marker": "By two-hybrid screening we have identified two partners that directly associate with TIF34: [E1]PRT1[/E1], a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the [E2]eIF3[/E2] complex and has an RNA binding domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PRT1", "entity_1_idx": [[92, 96]], "entity_1_idx_in_text_with_entity_marker": [96, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "eIF3", "entity_2_idx": [[201, 205]], "entity_2_idx_in_text_with_entity_marker": [214, 218], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d122.s0_BioInfer.d122.s0.p3", "text": "By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.", "text_with_entity_marker": "By two-hybrid screening we have identified two partners that directly associate with [E1]TIF34[/E1]: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the [E2]eIF3[/E2] complex and has an RNA binding domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TIF34", "entity_1_idx": [[85, 90]], "entity_1_idx_in_text_with_entity_marker": [89, 94], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "eIF3", "entity_2_idx": [[201, 205]], "entity_2_idx_in_text_with_entity_marker": [214, 218], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d122.s0_BioInfer.d122.s0.p4", "text": "By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.", "text_with_entity_marker": "By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized [E1]eIF3[/E1] subunit, and a novel protein of 33 kDa ([E2]eIF3-p33[/E2]) which is part of the eIF3 complex and has an RNA binding domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "eIF3", "entity_1_idx": [[125, 129]], "entity_1_idx_in_text_with_entity_marker": [129, 133], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "eIF3-p33", "entity_2_idx": [[170, 178]], "entity_2_idx_in_text_with_entity_marker": [183, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d122.s0_BioInfer.d122.s0.p5", "text": "By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.", "text_with_entity_marker": "By two-hybrid screening we have identified two partners that directly associate with TIF34: [E1]PRT1[/E1], a previously characterized eIF3 subunit, and a novel protein of 33 kDa ([E2]eIF3-p33[/E2]) which is part of the eIF3 complex and has an RNA binding domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PRT1", "entity_1_idx": [[92, 96]], "entity_1_idx_in_text_with_entity_marker": [96, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "eIF3-p33", "entity_2_idx": [[170, 178]], "entity_2_idx_in_text_with_entity_marker": [183, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d122.s0_BioInfer.d122.s0.p6", "text": "By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.", "text_with_entity_marker": "By two-hybrid screening we have identified two partners that directly associate with [E1]TIF34[/E1]: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa ([E2]eIF3-p33[/E2]) which is part of the eIF3 complex and has an RNA binding domain.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TIF34", "entity_1_idx": [[85, 90]], "entity_1_idx_in_text_with_entity_marker": [89, 94], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "eIF3-p33", "entity_2_idx": [[170, 178]], "entity_2_idx_in_text_with_entity_marker": [183, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d122.s0_BioInfer.d122.s0.p7", "text": "By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.", "text_with_entity_marker": "By two-hybrid screening we have identified two partners that directly associate with TIF34: [E1]PRT1[/E1], a previously characterized [E2]eIF3[/E2] subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRT1", "entity_1_idx": [[92, 96]], "entity_1_idx_in_text_with_entity_marker": [96, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "eIF3", "entity_2_idx": [[125, 129]], "entity_2_idx_in_text_with_entity_marker": [138, 142], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d122.s0_BioInfer.d122.s0.p8", "text": "By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.", "text_with_entity_marker": "By two-hybrid screening we have identified two partners that directly associate with [E1]TIF34[/E1]: PRT1, a previously characterized [E2]eIF3[/E2] subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TIF34", "entity_1_idx": [[85, 90]], "entity_1_idx_in_text_with_entity_marker": [89, 94], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "eIF3", "entity_2_idx": [[125, 129]], "entity_2_idx_in_text_with_entity_marker": [138, 142], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d122.s0_BioInfer.d122.s0.p9", "text": "By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.", "text_with_entity_marker": "By two-hybrid screening we have identified two partners that directly associate with [E1]TIF34[/E1]: [E2]PRT1[/E2], a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TIF34", "entity_1_idx": [[85, 90]], "entity_1_idx_in_text_with_entity_marker": [89, 94], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRT1", "entity_2_idx": [[92, 96]], "entity_2_idx_in_text_with_entity_marker": [105, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d122.s1_BioInfer.d122.s1.p0", "text": "Our results provide support for both physical and functional interactions between three subunits, TIF34, PRT1 and p33, in the eIF3 complex.", "text_with_entity_marker": "Our results provide support for both physical and functional interactions between three subunits, TIF34, [E1]PRT1[/E1] and [E2]p33[/E2], in the eIF3 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRT1", "entity_1_idx": [[105, 109]], "entity_1_idx_in_text_with_entity_marker": [109, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p33", "entity_2_idx": [[114, 117]], "entity_2_idx_in_text_with_entity_marker": [127, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d122.s1_BioInfer.d122.s1.p1", "text": "Our results provide support for both physical and functional interactions between three subunits, TIF34, PRT1 and p33, in the eIF3 complex.", "text_with_entity_marker": "Our results provide support for both physical and functional interactions between three subunits, TIF34, [E1]PRT1[/E1] and p33, in the [E2]eIF3[/E2] complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRT1", "entity_1_idx": [[105, 109]], "entity_1_idx_in_text_with_entity_marker": [109, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "eIF3", "entity_2_idx": [[126, 130]], "entity_2_idx_in_text_with_entity_marker": [139, 143], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d122.s1_BioInfer.d122.s1.p2", "text": "Our results provide support for both physical and functional interactions between three subunits, TIF34, PRT1 and p33, in the eIF3 complex.", "text_with_entity_marker": "Our results provide support for both physical and functional interactions between three subunits, [E1]TIF34[/E1], [E2]PRT1[/E2] and p33, in the eIF3 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TIF34", "entity_1_idx": [[98, 103]], "entity_1_idx_in_text_with_entity_marker": [102, 107], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRT1", "entity_2_idx": [[105, 109]], "entity_2_idx_in_text_with_entity_marker": [118, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d122.s1_BioInfer.d122.s1.p3", "text": "Our results provide support for both physical and functional interactions between three subunits, TIF34, PRT1 and p33, in the eIF3 complex.", "text_with_entity_marker": "Our results provide support for both physical and functional interactions between three subunits, TIF34, PRT1 and [E1]p33[/E1], in the [E2]eIF3[/E2] complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p33", "entity_1_idx": [[114, 117]], "entity_1_idx_in_text_with_entity_marker": [118, 121], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "eIF3", "entity_2_idx": [[126, 130]], "entity_2_idx_in_text_with_entity_marker": [139, 143], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d122.s1_BioInfer.d122.s1.p4", "text": "Our results provide support for both physical and functional interactions between three subunits, TIF34, PRT1 and p33, in the eIF3 complex.", "text_with_entity_marker": "Our results provide support for both physical and functional interactions between three subunits, [E1]TIF34[/E1], PRT1 and [E2]p33[/E2], in the eIF3 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TIF34", "entity_1_idx": [[98, 103]], "entity_1_idx_in_text_with_entity_marker": [102, 107], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p33", "entity_2_idx": [[114, 117]], "entity_2_idx_in_text_with_entity_marker": [127, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d122.s1_BioInfer.d122.s1.p5", "text": "Our results provide support for both physical and functional interactions between three subunits, TIF34, PRT1 and p33, in the eIF3 complex.", "text_with_entity_marker": "Our results provide support for both physical and functional interactions between three subunits, [E1]TIF34[/E1], PRT1 and p33, in the [E2]eIF3[/E2] complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TIF34", "entity_1_idx": [[98, 103]], "entity_1_idx_in_text_with_entity_marker": [102, 107], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "eIF3", "entity_2_idx": [[126, 130]], "entity_2_idx_in_text_with_entity_marker": [139, 143], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s2_BioInfer.d113.s2.p9", "text": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "Tyrosine phosphorylation of [E1]beta-catenin[/E1] was concomitantly induced with association of [E2]beta-catenin[/E2] with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[28, 40]], "entity_1_idx_in_text_with_entity_marker": [32, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[87, 99]], "entity_2_idx_in_text_with_entity_marker": [100, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s2_BioInfer.d113.s2.p10", "text": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of [E1]beta-catenin[/E1] with [E2]EGF receptor[/E2] (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[87, 99]], "entity_1_idx_in_text_with_entity_marker": [91, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "EGF receptor", "entity_2_idx": [[105, 117]], "entity_2_idx_in_text_with_entity_marker": [118, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s2_BioInfer.d113.s2.p11", "text": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of [E1]beta-catenin[/E1] with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of [E2]alpha-catenin[/E2] from E-cadherin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[87, 99]], "entity_1_idx_in_text_with_entity_marker": [91, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[254, 267]], "entity_2_idx_in_text_with_entity_marker": [267, 280], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s2_BioInfer.d113.s2.p12", "text": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "Tyrosine phosphorylation of [E1]beta-catenin[/E1] was concomitantly induced with association of beta-catenin with [E2]EGF receptor[/E2] (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[28, 40]], "entity_1_idx_in_text_with_entity_marker": [32, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "EGF receptor", "entity_2_idx": [[105, 117]], "entity_2_idx_in_text_with_entity_marker": [118, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s2_BioInfer.d113.s2.p13", "text": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "Tyrosine phosphorylation of [E1]beta-catenin[/E1] was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of [E2]alpha-catenin[/E2] from E-cadherin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[28, 40]], "entity_1_idx_in_text_with_entity_marker": [32, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[254, 267]], "entity_2_idx_in_text_with_entity_marker": [267, 280], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s2_BioInfer.d113.s2.p14", "text": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with [E1]EGF receptor[/E1] (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of [E2]alpha-catenin[/E2] from E-cadherin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGF receptor", "entity_1_idx": [[105, 117]], "entity_1_idx_in_text_with_entity_marker": [109, 121], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[254, 267]], "entity_2_idx_in_text_with_entity_marker": [267, 280], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p0", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and [E1]beta-catenin[/E1]; and the [E2]heat shock proteins[/E2] of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[305, 317]], "entity_1_idx_in_text_with_entity_marker": [309, 321], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "heat shock proteins", "entity_2_idx": [[327, 346]], "entity_2_idx_in_text_with_entity_marker": [340, 359], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p1", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and [E1]PCNA[/E1]; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the [E2]heat shock proteins[/E2] of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PCNA", "entity_1_idx": [[232, 236]], "entity_1_idx_in_text_with_entity_marker": [236, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "heat shock proteins", "entity_2_idx": [[327, 346]], "entity_2_idx_in_text_with_entity_marker": [340, 359], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p2", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, [E1]p16INK4[/E1], p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the [E2]heat shock proteins[/E2] of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p16INK4", "entity_1_idx": [[210, 217]], "entity_1_idx_in_text_with_entity_marker": [214, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "heat shock proteins", "entity_2_idx": [[327, 346]], "entity_2_idx_in_text_with_entity_marker": [340, 359], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p3", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of [E1]cyclin D1[/E1], Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the [E2]heat shock proteins[/E2] of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[195, 204]], "entity_1_idx_in_text_with_entity_marker": [199, 208], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "heat shock proteins", "entity_2_idx": [[327, 346]], "entity_2_idx_in_text_with_entity_marker": [340, 359], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p4", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the [E1]heat shock proteins[/E1] of [E2]HSP27[/E2] and HSP70.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "heat shock proteins", "entity_1_idx": [[327, 346]], "entity_1_idx_in_text_with_entity_marker": [331, 350], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "HSP27", "entity_2_idx": [[350, 355]], "entity_2_idx_in_text_with_entity_marker": [363, 368], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p5", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of [E1]E-cadherin[/E1], alpha-catenin, and beta-catenin; and the [E2]heat shock proteins[/E2] of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[274, 284]], "entity_1_idx_in_text_with_entity_marker": [278, 288], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "heat shock proteins", "entity_2_idx": [[327, 346]], "entity_2_idx_in_text_with_entity_marker": [340, 359], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p6", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, [E1]alpha-catenin[/E1], and beta-catenin; and the [E2]heat shock proteins[/E2] of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[286, 299]], "entity_1_idx_in_text_with_entity_marker": [290, 303], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "heat shock proteins", "entity_2_idx": [[327, 346]], "entity_2_idx_in_text_with_entity_marker": [340, 359], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p7", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, [E1]p27KIP1[/E1], and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the [E2]heat shock proteins[/E2] of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27KIP1", "entity_1_idx": [[219, 226]], "entity_1_idx_in_text_with_entity_marker": [223, 230], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "heat shock proteins", "entity_2_idx": [[327, 346]], "entity_2_idx_in_text_with_entity_marker": [340, 359], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p8", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, [E1]Rb[/E1], p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the [E2]heat shock proteins[/E2] of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rb", "entity_1_idx": [[206, 208]], "entity_1_idx_in_text_with_entity_marker": [210, 212], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "heat shock proteins", "entity_2_idx": [[327, 346]], "entity_2_idx_in_text_with_entity_marker": [340, 359], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p9", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the [E1]heat shock proteins[/E1] of HSP27 and [E2]HSP70[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "heat shock proteins", "entity_1_idx": [[327, 346]], "entity_1_idx_in_text_with_entity_marker": [331, 350], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "HSP70", "entity_2_idx": [[360, 365]], "entity_2_idx_in_text_with_entity_marker": [373, 378], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p0", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "[E1]Neuropilin 1[/E1] ([E2]NP-1[/E2]) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Neuropilin 1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP-1", "entity_2_idx": [[14, 18]], "entity_2_idx_in_text_with_entity_marker": [27, 31], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p1", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 ([E1]NP-1[/E1]) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 ([E2]VEGFR-2[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "NP-1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGFR-2", "entity_2_idx": [[191, 198]], "entity_2_idx_in_text_with_entity_marker": [204, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p2", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 ([E1]NP-1[/E1]) is a receptor for [E2]vascular endothelial growth factor[/E2] (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "NP-1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vascular endothelial growth factor", "entity_2_idx": [[38, 72], [80, 83]], "entity_2_idx_in_text_with_entity_marker": [51, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p3", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 ([E1]NP-1[/E1]) is a receptor for vascular endothelial growth factor (VEGF) 165 ([E2]VEGF165[/E2]) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "NP-1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF165", "entity_2_idx": [[85, 92]], "entity_2_idx_in_text_with_entity_marker": [98, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p4", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 ([E1]NP-1[/E1]) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances [E2]VEGF165[/E2] function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "NP-1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF165", "entity_2_idx": [[133, 140]], "entity_2_idx_in_text_with_entity_marker": [146, 153], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p5", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 ([E1]NP-1[/E1]) is a receptor for vascular endothelial growth factor ([E2]VEGF[/E2]) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP-1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF", "entity_2_idx": [[74, 78]], "entity_2_idx_in_text_with_entity_marker": [87, 91], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p6", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 ([E1]NP-1[/E1]) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through [E2]tyrosine kinase[/E2] VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP-1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "tyrosine kinase", "entity_2_idx": [[158, 173]], "entity_2_idx_in_text_with_entity_marker": [171, 186], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p7", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 ([E1]NP-1[/E1]) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase [E2]VEGF receptor 2[/E2] (VEGFR-2).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "NP-1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF receptor 2", "entity_2_idx": [[174, 189]], "entity_2_idx_in_text_with_entity_marker": [187, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p8", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "[E1]Neuropilin 1[/E1] (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 ([E2]VEGFR-2[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Neuropilin 1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGFR-2", "entity_2_idx": [[191, 198]], "entity_2_idx_in_text_with_entity_marker": [204, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p9", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "[E1]Neuropilin 1[/E1] (NP-1) is a receptor for [E2]vascular endothelial growth factor[/E2] (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Neuropilin 1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vascular endothelial growth factor", "entity_2_idx": [[38, 72], [80, 83]], "entity_2_idx_in_text_with_entity_marker": [51, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p10", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components ([E1]UL5[/E1], UL8, and UL52), the origin-binding protein ([E2]UL9[/E2]), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[144, 147]], "entity_1_idx_in_text_with_entity_marker": [148, 151], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL9", "entity_2_idx": [[193, 196]], "entity_2_idx_in_text_with_entity_marker": [206, 209], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p11", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, [E1]UL8[/E1], and UL52), the origin-binding protein ([E2]UL9[/E2]), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[149, 152]], "entity_1_idx_in_text_with_entity_marker": [153, 156], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL9", "entity_2_idx": [[193, 196]], "entity_2_idx_in_text_with_entity_marker": [206, 209], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p12", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the [E1]origin-binding protein[/E1] ([E2]UL9[/E2]), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "origin-binding protein", "entity_1_idx": [[169, 191]], "entity_1_idx_in_text_with_entity_marker": [173, 195], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL9", "entity_2_idx": [[193, 196]], "entity_2_idx_in_text_with_entity_marker": [206, 209], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p13", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the [E1]helicase-primase[/E1] components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein ([E2]ICP8[/E2]) assemble together to initiate the process.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "helicase-primase", "entity_1_idx": [[115, 131]], "entity_1_idx_in_text_with_entity_marker": [119, 135], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "ICP8", "entity_2_idx": [[250, 254]], "entity_2_idx_in_text_with_entity_marker": [263, 267], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p14", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral [E1]single-stranded DNA-binding protein[/E1] ([E2]ICP8[/E2]) assemble together to initiate the process.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "single-stranded DNA-binding protein", "entity_1_idx": [[213, 248]], "entity_1_idx_in_text_with_entity_marker": [217, 252], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ICP8", "entity_2_idx": [[250, 254]], "entity_2_idx_in_text_with_entity_marker": [263, 267], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p15", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components ([E1]UL5[/E1], UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein ([E2]ICP8[/E2]) assemble together to initiate the process.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[144, 147]], "entity_1_idx_in_text_with_entity_marker": [148, 151], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ICP8", "entity_2_idx": [[250, 254]], "entity_2_idx_in_text_with_entity_marker": [263, 267], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p16", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, [E1]UL8[/E1], and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein ([E2]ICP8[/E2]) assemble together to initiate the process.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[149, 152]], "entity_1_idx_in_text_with_entity_marker": [153, 156], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ICP8", "entity_2_idx": [[250, 254]], "entity_2_idx_in_text_with_entity_marker": [263, 267], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p17", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the [E1]origin-binding protein[/E1] (UL9), and the viral single-stranded DNA-binding protein ([E2]ICP8[/E2]) assemble together to initiate the process.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "origin-binding protein", "entity_1_idx": [[169, 191]], "entity_1_idx_in_text_with_entity_marker": [173, 195], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ICP8", "entity_2_idx": [[250, 254]], "entity_2_idx_in_text_with_entity_marker": [263, 267], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p18", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the [E1]helicase-primase[/E1] components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral [E2]single-stranded DNA-binding protein[/E2] (ICP8) assemble together to initiate the process.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "helicase-primase", "entity_1_idx": [[115, 131]], "entity_1_idx_in_text_with_entity_marker": [119, 135], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "single-stranded DNA-binding protein", "entity_2_idx": [[213, 248]], "entity_2_idx_in_text_with_entity_marker": [226, 261], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p19", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the [E1]helicase-primase[/E1] components ([E2]UL5[/E2], UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[115, 131]], "entity_1_idx_in_text_with_entity_marker": [119, 135], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL5", "entity_2_idx": [[144, 147]], "entity_2_idx_in_text_with_entity_marker": [157, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d320.s0_BioInfer.d320.s0.p0", "text": "In brush cells, villin and fimbrin are not only present in the actin filament core bundles of apical microvilli and their long rootlets but, in addition, both proteins are also associated with microvilli extending from the basolateral cell surface of the brush cells.", "text_with_entity_marker": "In brush cells, [E1]villin[/E1] and [E2]fimbrin[/E2] are not only present in the actin filament core bundles of apical microvilli and their long rootlets but, in addition, both proteins are also associated with microvilli extending from the basolateral cell surface of the brush cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "villin", "entity_1_idx": [[16, 22]], "entity_1_idx_in_text_with_entity_marker": [20, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[27, 34]], "entity_2_idx_in_text_with_entity_marker": [40, 47], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d320.s0_BioInfer.d320.s0.p1", "text": "In brush cells, villin and fimbrin are not only present in the actin filament core bundles of apical microvilli and their long rootlets but, in addition, both proteins are also associated with microvilli extending from the basolateral cell surface of the brush cells.", "text_with_entity_marker": "In brush cells, villin and [E1]fimbrin[/E1] are not only present in the [E2]actin[/E2] filament core bundles of apical microvilli and their long rootlets but, in addition, both proteins are also associated with microvilli extending from the basolateral cell surface of the brush cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "fimbrin", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d320.s0_BioInfer.d320.s0.p2", "text": "In brush cells, villin and fimbrin are not only present in the actin filament core bundles of apical microvilli and their long rootlets but, in addition, both proteins are also associated with microvilli extending from the basolateral cell surface of the brush cells.", "text_with_entity_marker": "In brush cells, [E1]villin[/E1] and fimbrin are not only present in the [E2]actin[/E2] filament core bundles of apical microvilli and their long rootlets but, in addition, both proteins are also associated with microvilli extending from the basolateral cell surface of the brush cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "villin", "entity_1_idx": [[16, 22]], "entity_1_idx_in_text_with_entity_marker": [20, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d320.s1_BioInfer.d320.s1.p0", "text": "In the present study we show that brush cells can be identified in tissue sections even at the light microscopic level by immunostaining with antibodies against villin and fimbrin, two proteins that crosslink actin filaments to form bundles.", "text_with_entity_marker": "In the present study we show that brush cells can be identified in tissue sections even at the light microscopic level by immunostaining with antibodies against [E1]villin[/E1] and fimbrin, two proteins that crosslink [E2]actin[/E2] filaments to form bundles.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "villin", "entity_1_idx": [[161, 167]], "entity_1_idx_in_text_with_entity_marker": [165, 171], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[209, 214]], "entity_2_idx_in_text_with_entity_marker": [222, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d320.s1_BioInfer.d320.s1.p1", "text": "In the present study we show that brush cells can be identified in tissue sections even at the light microscopic level by immunostaining with antibodies against villin and fimbrin, two proteins that crosslink actin filaments to form bundles.", "text_with_entity_marker": "In the present study we show that brush cells can be identified in tissue sections even at the light microscopic level by immunostaining with antibodies against [E1]villin[/E1] and [E2]fimbrin[/E2], two proteins that crosslink actin filaments to form bundles.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "villin", "entity_1_idx": [[161, 167]], "entity_1_idx_in_text_with_entity_marker": [165, 171], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[172, 179]], "entity_2_idx_in_text_with_entity_marker": [185, 192], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d320.s1_BioInfer.d320.s1.p2", "text": "In the present study we show that brush cells can be identified in tissue sections even at the light microscopic level by immunostaining with antibodies against villin and fimbrin, two proteins that crosslink actin filaments to form bundles.", "text_with_entity_marker": "In the present study we show that brush cells can be identified in tissue sections even at the light microscopic level by immunostaining with antibodies against villin and [E1]fimbrin[/E1], two proteins that crosslink [E2]actin[/E2] filaments to form bundles.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "fimbrin", "entity_1_idx": [[172, 179]], "entity_1_idx_in_text_with_entity_marker": [176, 183], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[209, 214]], "entity_2_idx_in_text_with_entity_marker": [222, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d290.s0_BioInfer.d290.s0.p0", "text": "Immunofluorescence studies with these antibodies showed profilin I to be distributed throughout the Acanthamoeba cytoplasm, except for lamellipodia, with the highest fluorescence intensity in cortical regions in which monomeric actin also was present, as shown by labeling with fluorescent DNase.", "text_with_entity_marker": "Immunofluorescence studies with these antibodies showed [E1]profilin I[/E1] to be distributed throughout the Acanthamoeba cytoplasm, except for lamellipodia, with the highest fluorescence intensity in cortical regions in which monomeric actin also was present, as shown by labeling with fluorescent [E2]DNase[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin I", "entity_1_idx": [[56, 66]], "entity_1_idx_in_text_with_entity_marker": [60, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DNase", "entity_2_idx": [[290, 295]], "entity_2_idx_in_text_with_entity_marker": [303, 308], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d290.s0_BioInfer.d290.s0.p1", "text": "Immunofluorescence studies with these antibodies showed profilin I to be distributed throughout the Acanthamoeba cytoplasm, except for lamellipodia, with the highest fluorescence intensity in cortical regions in which monomeric actin also was present, as shown by labeling with fluorescent DNase.", "text_with_entity_marker": "Immunofluorescence studies with these antibodies showed [E1]profilin I[/E1] to be distributed throughout the Acanthamoeba cytoplasm, except for lamellipodia, with the highest fluorescence intensity in cortical regions in which monomeric [E2]actin[/E2] also was present, as shown by labeling with fluorescent DNase.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin I", "entity_1_idx": [[56, 66]], "entity_1_idx_in_text_with_entity_marker": [60, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[228, 233]], "entity_2_idx_in_text_with_entity_marker": [241, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d290.s0_BioInfer.d290.s0.p2", "text": "Immunofluorescence studies with these antibodies showed profilin I to be distributed throughout the Acanthamoeba cytoplasm, except for lamellipodia, with the highest fluorescence intensity in cortical regions in which monomeric actin also was present, as shown by labeling with fluorescent DNase.", "text_with_entity_marker": "Immunofluorescence studies with these antibodies showed profilin I to be distributed throughout the Acanthamoeba cytoplasm, except for lamellipodia, with the highest fluorescence intensity in cortical regions in which monomeric [E1]actin[/E1] also was present, as shown by labeling with fluorescent [E2]DNase[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[228, 233]], "entity_1_idx_in_text_with_entity_marker": [232, 237], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DNase", "entity_2_idx": [[290, 295]], "entity_2_idx_in_text_with_entity_marker": [303, 308], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d290.s1_BioInfer.d290.s1.p0", "text": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an actin monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "text_with_entity_marker": "The differential localization of the three [E1]actin[/E1] monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an [E2]actin[/E2] monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[43, 48]], "entity_1_idx_in_text_with_entity_marker": [47, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[231, 236]], "entity_2_idx_in_text_with_entity_marker": [244, 249], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d290.s1_BioInfer.d290.s1.p1", "text": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an actin monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "text_with_entity_marker": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) [E1]profilin I[/E1] functions predominantly as an [E2]actin[/E2] monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin I", "entity_1_idx": [[190, 200]], "entity_1_idx_in_text_with_entity_marker": [194, 204], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[231, 236]], "entity_2_idx_in_text_with_entity_marker": [244, 249], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d290.s1_BioInfer.d290.s1.p2", "text": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an actin monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "text_with_entity_marker": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an [E1]actin[/E1] monomer-binding protein; (2) [E2]profilin II[/E2] regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[231, 236]], "entity_1_idx_in_text_with_entity_marker": [235, 240], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin II", "entity_2_idx": [[266, 277]], "entity_2_idx_in_text_with_entity_marker": [279, 290], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d290.s1_BioInfer.d290.s1.p3", "text": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an actin monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "text_with_entity_marker": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an [E1]actin[/E1] monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) [E2]actobindin[/E2] inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[231, 236]], "entity_1_idx_in_text_with_entity_marker": [235, 240], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actobindin", "entity_2_idx": [[323, 333]], "entity_2_idx_in_text_with_entity_marker": [336, 346], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d290.s1_BioInfer.d290.s1.p4", "text": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an actin monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "text_with_entity_marker": "The differential localization of the three [E1]actin[/E1] monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) [E2]profilin I[/E2] functions predominantly as an actin monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[43, 48]], "entity_1_idx_in_text_with_entity_marker": [47, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin I", "entity_2_idx": [[190, 200]], "entity_2_idx_in_text_with_entity_marker": [203, 213], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d290.s1_BioInfer.d290.s1.p5", "text": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an actin monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "text_with_entity_marker": "The differential localization of the three [E1]actin[/E1] monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an actin monomer-binding protein; (2) [E2]profilin II[/E2] regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[43, 48]], "entity_1_idx_in_text_with_entity_marker": [47, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin II", "entity_2_idx": [[266, 277]], "entity_2_idx_in_text_with_entity_marker": [279, 290], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d290.s1_BioInfer.d290.s1.p6", "text": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an actin monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "text_with_entity_marker": "The differential localization of the three [E1]actin[/E1] monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an actin monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) [E2]actobindin[/E2] inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[43, 48]], "entity_1_idx_in_text_with_entity_marker": [47, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actobindin", "entity_2_idx": [[323, 333]], "entity_2_idx_in_text_with_entity_marker": [336, 346], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d290.s1_BioInfer.d290.s1.p7", "text": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an actin monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "text_with_entity_marker": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) [E1]profilin I[/E1] functions predominantly as an actin monomer-binding protein; (2) [E2]profilin II[/E2] regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin I", "entity_1_idx": [[190, 200]], "entity_1_idx_in_text_with_entity_marker": [194, 204], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin II", "entity_2_idx": [[266, 277]], "entity_2_idx_in_text_with_entity_marker": [279, 290], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d290.s1_BioInfer.d290.s1.p8", "text": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an actin monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "text_with_entity_marker": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) [E1]profilin I[/E1] functions predominantly as an actin monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) [E2]actobindin[/E2] inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin I", "entity_1_idx": [[190, 200]], "entity_1_idx_in_text_with_entity_marker": [194, 204], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actobindin", "entity_2_idx": [[323, 333]], "entity_2_idx_in_text_with_entity_marker": [336, 346], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d290.s1_BioInfer.d290.s1.p9", "text": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an actin monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "text_with_entity_marker": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an actin monomer-binding protein; (2) [E1]profilin II[/E1] regulates, or is regulated by, PIP2; and (3) [E2]actobindin[/E2] inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin II", "entity_1_idx": [[266, 277]], "entity_1_idx_in_text_with_entity_marker": [270, 281], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actobindin", "entity_2_idx": [[323, 333]], "entity_2_idx_in_text_with_entity_marker": [336, 346], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s0_BioInfer.d109.s0.p0", "text": "Neuropilin-1 (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "text_with_entity_marker": "[E1]Neuropilin-1[/E1] ([E2]NRP1[/E2]) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Neuropilin-1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NRP1", "entity_2_idx": [[14, 18]], "entity_2_idx_in_text_with_entity_marker": [27, 31], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s0_BioInfer.d109.s0.p1", "text": "Neuropilin-1 (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "text_with_entity_marker": "[E1]Neuropilin-1[/E1] (NRP1) is a 130-kDa transmembrane receptor for [E2]semaphorins[/E2], mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Neuropilin-1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "semaphorins", "entity_2_idx": [[60, 71]], "entity_2_idx_in_text_with_entity_marker": [73, 84], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s0_BioInfer.d109.s0.p2", "text": "Neuropilin-1 (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "text_with_entity_marker": "[E1]Neuropilin-1[/E1] (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for [E2]vascular endothelial growth factor 165[/E2] (VEGF(165)), an angiogenesis factor.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Neuropilin-1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vascular endothelial growth factor 165", "entity_2_idx": [[113, 151]], "entity_2_idx_in_text_with_entity_marker": [126, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s0_BioInfer.d109.s0.p3", "text": "Neuropilin-1 (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "text_with_entity_marker": "[E1]Neuropilin-1[/E1] (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 ([E2]VEGF(165)[/E2]), an angiogenesis factor.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Neuropilin-1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF(165)", "entity_2_idx": [[153, 162]], "entity_2_idx_in_text_with_entity_marker": [166, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s0_BioInfer.d109.s0.p4", "text": "Neuropilin-1 (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "text_with_entity_marker": "Neuropilin-1 ([E1]NRP1[/E1]) is a 130-kDa transmembrane receptor for [E2]semaphorins[/E2], mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "NRP1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "semaphorins", "entity_2_idx": [[60, 71]], "entity_2_idx_in_text_with_entity_marker": [73, 84], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s0_BioInfer.d109.s0.p5", "text": "Neuropilin-1 (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "text_with_entity_marker": "Neuropilin-1 ([E1]NRP1[/E1]) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for [E2]vascular endothelial growth factor 165[/E2] (VEGF(165)), an angiogenesis factor.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "NRP1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vascular endothelial growth factor 165", "entity_2_idx": [[113, 151]], "entity_2_idx_in_text_with_entity_marker": [126, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s0_BioInfer.d109.s0.p6", "text": "Neuropilin-1 (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "text_with_entity_marker": "Neuropilin-1 ([E1]NRP1[/E1]) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 ([E2]VEGF(165)[/E2]), an angiogenesis factor.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "NRP1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF(165)", "entity_2_idx": [[153, 162]], "entity_2_idx_in_text_with_entity_marker": [166, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s0_BioInfer.d109.s0.p7", "text": "Neuropilin-1 (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "text_with_entity_marker": "Neuropilin-1 (NRP1) is a 130-kDa transmembrane receptor for [E1]semaphorins[/E1], mediators of neuronal guidance, and for [E2]vascular endothelial growth factor 165[/E2] (VEGF(165)), an angiogenesis factor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "semaphorins", "entity_1_idx": [[60, 71]], "entity_1_idx_in_text_with_entity_marker": [64, 75], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "vascular endothelial growth factor 165", "entity_2_idx": [[113, 151]], "entity_2_idx_in_text_with_entity_marker": [126, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s0_BioInfer.d109.s0.p8", "text": "Neuropilin-1 (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "text_with_entity_marker": "Neuropilin-1 (NRP1) is a 130-kDa transmembrane receptor for [E1]semaphorins[/E1], mediators of neuronal guidance, and for vascular endothelial growth factor 165 ([E2]VEGF(165)[/E2]), an angiogenesis factor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "semaphorins", "entity_1_idx": [[60, 71]], "entity_1_idx_in_text_with_entity_marker": [64, 75], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "VEGF(165)", "entity_2_idx": [[153, 162]], "entity_2_idx_in_text_with_entity_marker": [166, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s0_BioInfer.d109.s0.p9", "text": "Neuropilin-1 (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "text_with_entity_marker": "Neuropilin-1 (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for [E1]vascular endothelial growth factor 165[/E1] ([E2]VEGF(165)[/E2]), an angiogenesis factor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vascular endothelial growth factor 165", "entity_1_idx": [[113, 151]], "entity_1_idx_in_text_with_entity_marker": [117, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF(165)", "entity_2_idx": [[153, 162]], "entity_2_idx_in_text_with_entity_marker": [166, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d572.s0_BioInfer.d572.s0.p0", "text": "The amino acid composition of the 15-kDa protein was similar to that of mammalian profilin and it inhibited the salt-induced polymerization of rabbit skeletal muscle actin.", "text_with_entity_marker": "The amino acid composition of the 15-kDa protein was similar to that of mammalian [E1]profilin[/E1] and it inhibited the salt-induced polymerization of rabbit [E2]skeletal muscle actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[82, 90]], "entity_1_idx_in_text_with_entity_marker": [86, 94], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "skeletal muscle actin", "entity_2_idx": [[150, 171]], "entity_2_idx_in_text_with_entity_marker": [163, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d265.s0_BioInfer.d265.s0.p0", "text": "How profilin/barbed-end synergy controls actin polymerization: a kinetic model of the ATP hydrolysis circuit.", "text_with_entity_marker": "How [E1]profilin[/E1]/barbed-end synergy controls [E2]actin[/E2] polymerization: a kinetic model of the ATP hydrolysis circuit.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[4, 12]], "entity_1_idx_in_text_with_entity_marker": [8, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[41, 46]], "entity_2_idx_in_text_with_entity_marker": [54, 59], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d265.s1_BioInfer.d265.s1.p0", "text": "In particular, both profilin and free filament barbed ends have been shown to play major roles in the processing of ATP by actin.", "text_with_entity_marker": "In particular, both [E1]profilin[/E1] and free filament barbed ends have been shown to play major roles in the processing of ATP by [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[123, 128]], "entity_2_idx_in_text_with_entity_marker": [136, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d265.s2_BioInfer.d265.s2.p0", "text": "We have developed a new integrated kinetic model to examine how the maintenance of the pool of unpolymerized actin and the flux of actin subunits through filaments are controlled by profilin and free filament barbed ends through their interaction with ATP.", "text_with_entity_marker": "We have developed a new integrated kinetic model to examine how the maintenance of the pool of unpolymerized actin and the flux of [E1]actin[/E1] subunits through filaments are controlled by [E2]profilin[/E2] and free filament barbed ends through their interaction with ATP.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[131, 136]], "entity_1_idx_in_text_with_entity_marker": [135, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[182, 190]], "entity_2_idx_in_text_with_entity_marker": [195, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d265.s2_BioInfer.d265.s2.p1", "text": "We have developed a new integrated kinetic model to examine how the maintenance of the pool of unpolymerized actin and the flux of actin subunits through filaments are controlled by profilin and free filament barbed ends through their interaction with ATP.", "text_with_entity_marker": "We have developed a new integrated kinetic model to examine how the maintenance of the pool of unpolymerized [E1]actin[/E1] and the flux of actin subunits through filaments are controlled by [E2]profilin[/E2] and free filament barbed ends through their interaction with ATP.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[109, 114]], "entity_1_idx_in_text_with_entity_marker": [113, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[182, 190]], "entity_2_idx_in_text_with_entity_marker": [195, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d265.s2_BioInfer.d265.s2.p2", "text": "We have developed a new integrated kinetic model to examine how the maintenance of the pool of unpolymerized actin and the flux of actin subunits through filaments are controlled by profilin and free filament barbed ends through their interaction with ATP.", "text_with_entity_marker": "We have developed a new integrated kinetic model to examine how the maintenance of the pool of unpolymerized [E1]actin[/E1] and the flux of [E2]actin[/E2] subunits through filaments are controlled by profilin and free filament barbed ends through their interaction with ATP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[109, 114]], "entity_1_idx_in_text_with_entity_marker": [113, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d686.s0_BioInfer.d686.s0.p0", "text": "The results clearly showed that the mutated cofilin possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant cofilin with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with actin.", "text_with_entity_marker": "The results clearly showed that the mutated [E1]cofilin[/E1] possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant [E2]cofilin[/E2] with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[44, 51]], "entity_1_idx_in_text_with_entity_marker": [48, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[170, 177]], "entity_2_idx_in_text_with_entity_marker": [183, 190], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d686.s0_BioInfer.d686.s0.p1", "text": "The results clearly showed that the mutated cofilin possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant cofilin with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with actin.", "text_with_entity_marker": "The results clearly showed that the mutated cofilin possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant [E1]cofilin[/E1] with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[170, 177]], "entity_1_idx_in_text_with_entity_marker": [174, 181], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[282, 287]], "entity_2_idx_in_text_with_entity_marker": [295, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d686.s0_BioInfer.d686.s0.p2", "text": "The results clearly showed that the mutated cofilin possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant cofilin with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with actin.", "text_with_entity_marker": "The results clearly showed that the mutated [E1]cofilin[/E1] possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant cofilin with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[44, 51]], "entity_1_idx_in_text_with_entity_marker": [48, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[282, 287]], "entity_2_idx_in_text_with_entity_marker": [295, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p5", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, [E1]TRAIL[/E1], FADD, TRADD, RIP, FAF, FAP, and [E2]caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAIL", "entity_1_idx": [[160, 165]], "entity_1_idx_in_text_with_entity_marker": [164, 169], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p6", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, [E1]TRAIL[/E1], [E2]FADD[/E2], TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAIL", "entity_1_idx": [[160, 165]], "entity_1_idx_in_text_with_entity_marker": [164, 169], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p7", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, [E1]Fas ligand[/E1], TNFR-1, [E2]TRAIL[/E2], FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas ligand", "entity_1_idx": [[140, 150]], "entity_1_idx_in_text_with_entity_marker": [144, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAIL", "entity_2_idx": [[160, 165]], "entity_2_idx_in_text_with_entity_marker": [173, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p8", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, [E1]TNFR-1[/E1], [E2]TRAIL[/E2], FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNFR-1", "entity_1_idx": [[152, 158]], "entity_1_idx_in_text_with_entity_marker": [156, 162], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAIL", "entity_2_idx": [[160, 165]], "entity_2_idx_in_text_with_entity_marker": [173, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p9", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for [E1]Fas[/E1], Fas ligand, TNFR-1, [E2]TRAIL[/E2], FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAIL", "entity_2_idx": [[160, 165]], "entity_2_idx_in_text_with_entity_marker": [173, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p10", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, [E1]ribonuclease[/E1] protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, [E2]FAF[/E2], FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonuclease", "entity_1_idx": [[57, 69]], "entity_1_idx_in_text_with_entity_marker": [61, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[185, 188]], "entity_2_idx_in_text_with_entity_marker": [198, 201], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p11", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, [E1]ribonuclease[/E1] protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, [E2]FAP[/E2], and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonuclease", "entity_1_idx": [[57, 69]], "entity_1_idx_in_text_with_entity_marker": [61, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p12", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, [E1]ribonuclease[/E1] protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, [E2]TRADD[/E2], RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonuclease", "entity_1_idx": [[57, 69]], "entity_1_idx_in_text_with_entity_marker": [61, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRADD", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p13", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, [E1]ribonuclease[/E1] protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, [E2]RIP[/E2], FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonuclease", "entity_1_idx": [[57, 69]], "entity_1_idx_in_text_with_entity_marker": [61, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[180, 183]], "entity_2_idx_in_text_with_entity_marker": [193, 196], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p14", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, [E1]ribonuclease[/E1] protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and [E2]caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonuclease", "entity_1_idx": [[57, 69]], "entity_1_idx_in_text_with_entity_marker": [61, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d754.s0_BioInfer.d754.s0.p0", "text": "Thus, it is likely that the both cofilin isoforms are involved in the regulation of actin assembly during myofibrillogenesis.", "text_with_entity_marker": "Thus, it is likely that the both [E1]cofilin[/E1] isoforms are involved in the regulation of [E2]actin[/E2] assembly during myofibrillogenesis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[33, 40]], "entity_1_idx_in_text_with_entity_marker": [37, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[84, 89]], "entity_2_idx_in_text_with_entity_marker": [97, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d213.s0_BioInfer.d213.s0.p0", "text": "Fluorescent actin analogs with a high affinity for profilin in vitro exhibit an enhanced gradient of assembly in living cells.", "text_with_entity_marker": "Fluorescent [E1]actin[/E1] analogs with a high affinity for [E2]profilin[/E2] in vitro exhibit an enhanced gradient of assembly in living cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[12, 17]], "entity_1_idx_in_text_with_entity_marker": [16, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[51, 59]], "entity_2_idx_in_text_with_entity_marker": [64, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d213.s1_BioInfer.d213.s1.p0", "text": "Three-dimensional fluorescence microscopy of the fluorescent analog of actin with a high affinity for profilin revealed that it incorporated into cortical cytoplasmic fibers and was also distributed diffusely in the non-cortical cytoplasm consistent with a bias of actin assembly near the surface of the cell.", "text_with_entity_marker": "Three-dimensional fluorescence microscopy of the fluorescent analog of [E1]actin[/E1] with a high affinity for [E2]profilin[/E2] revealed that it incorporated into cortical cytoplasmic fibers and was also distributed diffusely in the non-cortical cytoplasm consistent with a bias of actin assembly near the surface of the cell.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[71, 76]], "entity_1_idx_in_text_with_entity_marker": [75, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[102, 110]], "entity_2_idx_in_text_with_entity_marker": [115, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d213.s1_BioInfer.d213.s1.p1", "text": "Three-dimensional fluorescence microscopy of the fluorescent analog of actin with a high affinity for profilin revealed that it incorporated into cortical cytoplasmic fibers and was also distributed diffusely in the non-cortical cytoplasm consistent with a bias of actin assembly near the surface of the cell.", "text_with_entity_marker": "Three-dimensional fluorescence microscopy of the fluorescent analog of [E1]actin[/E1] with a high affinity for profilin revealed that it incorporated into cortical cytoplasmic fibers and was also distributed diffusely in the non-cortical cytoplasm consistent with a bias of [E2]actin[/E2] assembly near the surface of the cell.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[71, 76]], "entity_1_idx_in_text_with_entity_marker": [75, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[265, 270]], "entity_2_idx_in_text_with_entity_marker": [278, 283], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d213.s1_BioInfer.d213.s1.p2", "text": "Three-dimensional fluorescence microscopy of the fluorescent analog of actin with a high affinity for profilin revealed that it incorporated into cortical cytoplasmic fibers and was also distributed diffusely in the non-cortical cytoplasm consistent with a bias of actin assembly near the surface of the cell.", "text_with_entity_marker": "Three-dimensional fluorescence microscopy of the fluorescent analog of actin with a high affinity for [E1]profilin[/E1] revealed that it incorporated into cortical cytoplasmic fibers and was also distributed diffusely in the non-cortical cytoplasm consistent with a bias of [E2]actin[/E2] assembly near the surface of the cell.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[102, 110]], "entity_1_idx_in_text_with_entity_marker": [106, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[265, 270]], "entity_2_idx_in_text_with_entity_marker": [278, 283], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d213.s2_BioInfer.d213.s2.p0", "text": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "text_with_entity_marker": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of [E1]actin[/E1] that bound profilin, a protein that interacts with phosphoinositides and [E2]actin[/E2]-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[103, 108]], "entity_1_idx_in_text_with_entity_marker": [107, 112], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d213.s2_BioInfer.d213.s2.p1", "text": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "text_with_entity_marker": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of [E1]actin[/E1] that bound [E2]profilin[/E2], a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[103, 108]], "entity_1_idx_in_text_with_entity_marker": [107, 112], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[120, 128]], "entity_2_idx_in_text_with_entity_marker": [133, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d213.s2_BioInfer.d213.s2.p2", "text": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "text_with_entity_marker": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of [E1]actin[/E1] that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit [E2]DNase I[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[103, 108]], "entity_1_idx_in_text_with_entity_marker": [107, 112], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DNase I", "entity_2_idx": [[372, 379]], "entity_2_idx_in_text_with_entity_marker": [385, 392], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d213.s2_BioInfer.d213.s2.p3", "text": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "text_with_entity_marker": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of [E1]actin[/E1] that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled [E2]actin[/E2] (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[103, 108]], "entity_1_idx_in_text_with_entity_marker": [107, 112], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[312, 317]], "entity_2_idx_in_text_with_entity_marker": [325, 330], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d213.s2_BioInfer.d213.s2.p4", "text": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "text_with_entity_marker": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound [E1]profilin[/E1], a protein that interacts with phosphoinositides and [E2]actin[/E2]-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[120, 128]], "entity_1_idx_in_text_with_entity_marker": [124, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d213.s2_BioInfer.d213.s2.p5", "text": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "text_with_entity_marker": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and [E1]actin[/E1]-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit [E2]DNase I[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[182, 187]], "entity_1_idx_in_text_with_entity_marker": [186, 191], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DNase I", "entity_2_idx": [[372, 379]], "entity_2_idx_in_text_with_entity_marker": [385, 392], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d213.s2_BioInfer.d213.s2.p6", "text": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "text_with_entity_marker": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and [E1]actin[/E1]-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled [E2]actin[/E2] (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[182, 187]], "entity_1_idx_in_text_with_entity_marker": [186, 191], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[312, 317]], "entity_2_idx_in_text_with_entity_marker": [325, 330], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d213.s2_BioInfer.d213.s2.p7", "text": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "text_with_entity_marker": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound [E1]profilin[/E1], a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit [E2]DNase I[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[120, 128]], "entity_1_idx_in_text_with_entity_marker": [124, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DNase I", "entity_2_idx": [[372, 379]], "entity_2_idx_in_text_with_entity_marker": [385, 392], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d213.s2_BioInfer.d213.s2.p8", "text": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "text_with_entity_marker": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound [E1]profilin[/E1], a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled [E2]actin[/E2] (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[120, 128]], "entity_1_idx_in_text_with_entity_marker": [124, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[312, 317]], "entity_2_idx_in_text_with_entity_marker": [325, 330], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d213.s2_BioInfer.d213.s2.p9", "text": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "text_with_entity_marker": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled [E1]actin[/E1] (Kd > 30 microM), yet retained the ability to inhibit [E2]DNase I[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[312, 317]], "entity_1_idx_in_text_with_entity_marker": [316, 321], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DNase I", "entity_2_idx": [[372, 379]], "entity_2_idx_in_text_with_entity_marker": [385, 392], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p120", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone [E1]H3[/E1] has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone [E2]H3[/E2]; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[253, 255]], "entity_1_idx_in_text_with_entity_marker": [257, 259], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[383, 385]], "entity_2_idx_in_text_with_entity_marker": [396, 398], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p121", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones [E1]H2A[/E1], H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone [E2]H4[/E2] (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A", "entity_1_idx": [[42, 45]], "entity_1_idx_in_text_with_entity_marker": [46, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[180, 182]], "entity_2_idx_in_text_with_entity_marker": [193, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p122", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, [E1]H3[/E1], and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone [E2]H4[/E2] (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[52, 54]], "entity_1_idx_in_text_with_entity_marker": [56, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[180, 182]], "entity_2_idx_in_text_with_entity_marker": [193, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p123", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, [E1]H2B[/E1], H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone [E2]H4[/E2] (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2B", "entity_1_idx": [[47, 50]], "entity_1_idx_in_text_with_entity_marker": [51, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[180, 182]], "entity_2_idx_in_text_with_entity_marker": [193, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p124", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone [E1]H4[/E1] (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones [E2]H2A[/E2] and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[180, 182]], "entity_1_idx_in_text_with_entity_marker": [184, 186], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A", "entity_2_idx": [[396, 399]], "entity_2_idx_in_text_with_entity_marker": [409, 412], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p125", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone [E1]H4[/E1] (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone [E2]H3[/E2]; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[180, 182]], "entity_1_idx_in_text_with_entity_marker": [184, 186], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[383, 385]], "entity_2_idx_in_text_with_entity_marker": [396, 398], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p126", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones [E1]H2A[/E1], H2B, [E2]H3[/E2], and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A", "entity_1_idx": [[42, 45]], "entity_1_idx_in_text_with_entity_marker": [46, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[52, 54]], "entity_2_idx_in_text_with_entity_marker": [65, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p127", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones [E1]H2A[/E1], [E2]H2B[/E2], H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A", "entity_1_idx": [[42, 45]], "entity_1_idx_in_text_with_entity_marker": [46, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2B", "entity_2_idx": [[47, 50]], "entity_2_idx_in_text_with_entity_marker": [60, 63], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p128", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones [E1]H2A[/E1], H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones [E2]H2A[/E2] and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A", "entity_1_idx": [[42, 45]], "entity_1_idx_in_text_with_entity_marker": [46, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A", "entity_2_idx": [[396, 399]], "entity_2_idx_in_text_with_entity_marker": [409, 412], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p129", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones [E1]H2A[/E1], H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone [E2]H3[/E2]; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A", "entity_1_idx": [[42, 45]], "entity_1_idx_in_text_with_entity_marker": [46, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[383, 385]], "entity_2_idx_in_text_with_entity_marker": [396, 398], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d800.s0_BioInfer.d800.s0.p0", "text": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "text_with_entity_marker": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"[E1]pancadherin[/E1]\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the [E2]actin[/E2] microfilaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "pancadherin", "entity_1_idx": [[137, 148]], "entity_1_idx_in_text_with_entity_marker": [141, 152], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[252, 257]], "entity_2_idx_in_text_with_entity_marker": [265, 270], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d800.s0_BioInfer.d800.s0.p1", "text": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "text_with_entity_marker": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, [E1]p120[/E1], and vinculin, and the association of these complexes with the [E2]actin[/E2] microfilaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p120", "entity_1_idx": [[184, 188]], "entity_1_idx_in_text_with_entity_marker": [188, 192], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[252, 257]], "entity_2_idx_in_text_with_entity_marker": [265, 270], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d800.s0_BioInfer.d800.s0.p2", "text": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "text_with_entity_marker": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with [E1]alpha-catenin[/E1], beta-catenin, p120, and vinculin, and the association of these complexes with the [E2]actin[/E2] microfilaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[155, 168]], "entity_1_idx_in_text_with_entity_marker": [159, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[252, 257]], "entity_2_idx_in_text_with_entity_marker": [265, 270], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d800.s0_BioInfer.d800.s0.p3", "text": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "text_with_entity_marker": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and [E1]vinculin[/E1], and the association of these complexes with the [E2]actin[/E2] microfilaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[194, 202]], "entity_1_idx_in_text_with_entity_marker": [198, 206], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[252, 257]], "entity_2_idx_in_text_with_entity_marker": [265, 270], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d800.s0_BioInfer.d800.s0.p4", "text": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "text_with_entity_marker": "We describe the localization of cadherin-11 and [E1]N-cadherin[/E1] along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the [E2]actin[/E2] microfilaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[48, 58]], "entity_1_idx_in_text_with_entity_marker": [52, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[252, 257]], "entity_2_idx_in_text_with_entity_marker": [265, 270], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d800.s0_BioInfer.d800.s0.p5", "text": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "text_with_entity_marker": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, [E1]beta-catenin[/E1], p120, and vinculin, and the association of these complexes with the [E2]actin[/E2] microfilaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[170, 182]], "entity_1_idx_in_text_with_entity_marker": [174, 186], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[252, 257]], "entity_2_idx_in_text_with_entity_marker": [265, 270], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d800.s0_BioInfer.d800.s0.p6", "text": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "text_with_entity_marker": "We describe the localization of [E1]cadherin-11[/E1] and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the [E2]actin[/E2] microfilaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cadherin-11", "entity_1_idx": [[32, 43]], "entity_1_idx_in_text_with_entity_marker": [36, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[252, 257]], "entity_2_idx_in_text_with_entity_marker": [265, 270], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d800.s0_BioInfer.d800.s0.p7", "text": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "text_with_entity_marker": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"[E1]pancadherin[/E1]\" with alpha-catenin, beta-catenin, [E2]p120[/E2], and vinculin, and the association of these complexes with the actin microfilaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "pancadherin", "entity_1_idx": [[137, 148]], "entity_1_idx_in_text_with_entity_marker": [141, 152], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p120", "entity_2_idx": [[184, 188]], "entity_2_idx_in_text_with_entity_marker": [197, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d800.s0_BioInfer.d800.s0.p8", "text": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "text_with_entity_marker": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"[E1]pancadherin[/E1]\" with [E2]alpha-catenin[/E2], beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "pancadherin", "entity_1_idx": [[137, 148]], "entity_1_idx_in_text_with_entity_marker": [141, 152], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[155, 168]], "entity_2_idx_in_text_with_entity_marker": [168, 181], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d800.s0_BioInfer.d800.s0.p9", "text": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"pancadherin\" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.", "text_with_entity_marker": "We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of \"[E1]pancadherin[/E1]\" with alpha-catenin, beta-catenin, p120, and [E2]vinculin[/E2], and the association of these complexes with the actin microfilaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "pancadherin", "entity_1_idx": [[137, 148]], "entity_1_idx_in_text_with_entity_marker": [141, 152], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[194, 202]], "entity_2_idx_in_text_with_entity_marker": [207, 215], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p0", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by [E1]GBD[/E1]-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, [E2]SIR4[/E2], and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GBD", "entity_1_idx": [[22, 25]], "entity_1_idx_in_text_with_entity_marker": [26, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SIR4", "entity_2_idx": [[126, 130]], "entity_2_idx_in_text_with_entity_marker": [139, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p1", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by GBD-[E1]SIR1[/E1] requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, [E2]SIR4[/E2], and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR1", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SIR4", "entity_2_idx": [[126, 130]], "entity_2_idx_in_text_with_entity_marker": [139, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p2", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, [E1]SIR3[/E1], [E2]SIR4[/E2], and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR3", "entity_1_idx": [[120, 124]], "entity_1_idx_in_text_with_entity_marker": [124, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SIR4", "entity_2_idx": [[126, 130]], "entity_2_idx_in_text_with_entity_marker": [139, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p3", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, [E1]SIR4[/E1], and histone [E2]H4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR4", "entity_1_idx": [[126, 130]], "entity_1_idx_in_text_with_entity_marker": [130, 134], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[144, 146]], "entity_2_idx_in_text_with_entity_marker": [157, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p4", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, [E1]SIR2[/E1], SIR3, [E2]SIR4[/E2], and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR2", "entity_1_idx": [[114, 118]], "entity_1_idx_in_text_with_entity_marker": [118, 122], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SIR4", "entity_2_idx": [[126, 130]], "entity_2_idx_in_text_with_entity_marker": [139, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p5", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, [E1]SIR4[/E1], and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR4", "entity_1_idx": [[126, 130]], "entity_1_idx_in_text_with_entity_marker": [130, 134], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[136, 143]], "entity_2_idx_in_text_with_entity_marker": [149, 156], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p6", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by [E1]GBD[/E1]-[E2]SIR1[/E2] requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "GBD", "entity_1_idx": [[22, 25]], "entity_1_idx_in_text_with_entity_marker": [26, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SIR1", "entity_2_idx": [[26, 30]], "entity_2_idx_in_text_with_entity_marker": [39, 43], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p7", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by [E1]GBD[/E1]-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, [E2]SIR3[/E2], SIR4, and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GBD", "entity_1_idx": [[22, 25]], "entity_1_idx_in_text_with_entity_marker": [26, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SIR3", "entity_2_idx": [[120, 124]], "entity_2_idx_in_text_with_entity_marker": [133, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p8", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by [E1]GBD[/E1]-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone [E2]H4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GBD", "entity_1_idx": [[22, 25]], "entity_1_idx_in_text_with_entity_marker": [26, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[144, 146]], "entity_2_idx_in_text_with_entity_marker": [157, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p9", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by [E1]GBD[/E1]-SIR1 requires the trans-acting factors that normally participate in repression, namely, [E2]SIR2[/E2], SIR3, SIR4, and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GBD", "entity_1_idx": [[22, 25]], "entity_1_idx_in_text_with_entity_marker": [26, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SIR2", "entity_2_idx": [[114, 118]], "entity_2_idx_in_text_with_entity_marker": [127, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p10", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by [E1]GBD[/E1]-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GBD", "entity_1_idx": [[22, 25]], "entity_1_idx_in_text_with_entity_marker": [26, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[136, 143]], "entity_2_idx_in_text_with_entity_marker": [149, 156], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p11", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by GBD-[E1]SIR1[/E1] requires the trans-acting factors that normally participate in repression, namely, SIR2, [E2]SIR3[/E2], SIR4, and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR1", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SIR3", "entity_2_idx": [[120, 124]], "entity_2_idx_in_text_with_entity_marker": [133, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p12", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by GBD-[E1]SIR1[/E1] requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone [E2]H4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR1", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[144, 146]], "entity_2_idx_in_text_with_entity_marker": [157, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p13", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by GBD-[E1]SIR1[/E1] requires the trans-acting factors that normally participate in repression, namely, [E2]SIR2[/E2], SIR3, SIR4, and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR1", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SIR2", "entity_2_idx": [[114, 118]], "entity_2_idx_in_text_with_entity_marker": [127, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p14", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by GBD-[E1]SIR1[/E1] requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR1", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[136, 143]], "entity_2_idx_in_text_with_entity_marker": [149, 156], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p15", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, [E1]SIR3[/E1], SIR4, and histone [E2]H4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR3", "entity_1_idx": [[120, 124]], "entity_1_idx_in_text_with_entity_marker": [124, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[144, 146]], "entity_2_idx_in_text_with_entity_marker": [157, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p16", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, [E1]SIR2[/E1], [E2]SIR3[/E2], SIR4, and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR2", "entity_1_idx": [[114, 118]], "entity_1_idx_in_text_with_entity_marker": [118, 122], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SIR3", "entity_2_idx": [[120, 124]], "entity_2_idx_in_text_with_entity_marker": [133, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p17", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, [E1]SIR3[/E1], SIR4, and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR3", "entity_1_idx": [[120, 124]], "entity_1_idx_in_text_with_entity_marker": [124, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[136, 143]], "entity_2_idx_in_text_with_entity_marker": [149, 156], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p18", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, [E1]SIR2[/E1], SIR3, SIR4, and histone [E2]H4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR2", "entity_1_idx": [[114, 118]], "entity_1_idx_in_text_with_entity_marker": [118, 122], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[144, 146]], "entity_2_idx_in_text_with_entity_marker": [157, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p19", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and [E1]histone[/E1] [E2]H4[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[136, 143]], "entity_1_idx_in_text_with_entity_marker": [140, 147], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[144, 146]], "entity_2_idx_in_text_with_entity_marker": [157, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p20", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, [E1]SIR2[/E1], SIR3, SIR4, and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR2", "entity_1_idx": [[114, 118]], "entity_1_idx_in_text_with_entity_marker": [118, 122], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[136, 143]], "entity_2_idx_in_text_with_entity_marker": [149, 156], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d702.s0_BioInfer.d702.s0.p0", "text": "These phenotypes are similar to those of the mutant of PFY1, which encodes profilin, an actin-binding protein.", "text_with_entity_marker": "These phenotypes are similar to those of the mutant of [E1]PFY1[/E1], which encodes profilin, an [E2]actin-binding protein[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PFY1", "entity_1_idx": [[55, 59]], "entity_1_idx_in_text_with_entity_marker": [59, 63], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "actin-binding protein", "entity_2_idx": [[88, 109]], "entity_2_idx_in_text_with_entity_marker": [101, 122], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d702.s0_BioInfer.d702.s0.p1", "text": "These phenotypes are similar to those of the mutant of PFY1, which encodes profilin, an actin-binding protein.", "text_with_entity_marker": "These phenotypes are similar to those of the mutant of [E1]PFY1[/E1], which encodes [E2]profilin[/E2], an actin-binding protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PFY1", "entity_1_idx": [[55, 59]], "entity_1_idx_in_text_with_entity_marker": [59, 63], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "profilin", "entity_2_idx": [[75, 83]], "entity_2_idx_in_text_with_entity_marker": [88, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d702.s0_BioInfer.d702.s0.p2", "text": "These phenotypes are similar to those of the mutant of PFY1, which encodes profilin, an actin-binding protein.", "text_with_entity_marker": "These phenotypes are similar to those of the mutant of PFY1, which encodes [E1]profilin[/E1], an [E2]actin-binding protein[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[75, 83]], "entity_1_idx_in_text_with_entity_marker": [79, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[88, 109]], "entity_2_idx_in_text_with_entity_marker": [101, 122], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s0_BioInfer.d35.s0.p0", "text": "Aip1p interacts with cofilin to disassemble actin filaments.", "text_with_entity_marker": "[E1]Aip1p[/E1] interacts with cofilin to disassemble [E2]actin[/E2] filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Aip1p", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[44, 49]], "entity_2_idx_in_text_with_entity_marker": [57, 62], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s0_BioInfer.d35.s0.p1", "text": "Aip1p interacts with cofilin to disassemble actin filaments.", "text_with_entity_marker": "[E1]Aip1p[/E1] interacts with [E2]cofilin[/E2] to disassemble actin filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Aip1p", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[21, 28]], "entity_2_idx_in_text_with_entity_marker": [34, 41], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s0_BioInfer.d35.s0.p2", "text": "Aip1p interacts with cofilin to disassemble actin filaments.", "text_with_entity_marker": "Aip1p interacts with [E1]cofilin[/E1] to disassemble [E2]actin[/E2] filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[21, 28]], "entity_1_idx_in_text_with_entity_marker": [25, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[44, 49]], "entity_2_idx_in_text_with_entity_marker": [57, 62], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s1_BioInfer.d35.s1.p0", "text": "Aip1p localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific actin and cofilin mutations.", "text_with_entity_marker": "Aip1p localizes to cortical [E1]actin[/E1] patches in yeast cells, and this localization is disrupted by specific [E2]actin[/E2] and cofilin mutations.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[28, 33]], "entity_1_idx_in_text_with_entity_marker": [32, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s1_BioInfer.d35.s1.p1", "text": "Aip1p localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific actin and cofilin mutations.", "text_with_entity_marker": "[E1]Aip1p[/E1] localizes to cortical [E2]actin[/E2] patches in yeast cells, and this localization is disrupted by specific actin and cofilin mutations.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Aip1p", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[28, 33]], "entity_2_idx_in_text_with_entity_marker": [41, 46], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s1_BioInfer.d35.s1.p2", "text": "Aip1p localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific actin and cofilin mutations.", "text_with_entity_marker": "Aip1p localizes to cortical [E1]actin[/E1] patches in yeast cells, and this localization is disrupted by specific actin and [E2]cofilin[/E2] mutations.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[28, 33]], "entity_1_idx_in_text_with_entity_marker": [32, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[115, 122]], "entity_2_idx_in_text_with_entity_marker": [128, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s1_BioInfer.d35.s1.p3", "text": "Aip1p localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific actin and cofilin mutations.", "text_with_entity_marker": "[E1]Aip1p[/E1] localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific [E2]actin[/E2] and cofilin mutations.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Aip1p", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s1_BioInfer.d35.s1.p4", "text": "Aip1p localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific actin and cofilin mutations.", "text_with_entity_marker": "Aip1p localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific [E1]actin[/E1] and [E2]cofilin[/E2] mutations.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[105, 110]], "entity_1_idx_in_text_with_entity_marker": [109, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[115, 122]], "entity_2_idx_in_text_with_entity_marker": [128, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s1_BioInfer.d35.s1.p5", "text": "Aip1p localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific actin and cofilin mutations.", "text_with_entity_marker": "[E1]Aip1p[/E1] localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific actin and [E2]cofilin[/E2] mutations.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Aip1p", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[115, 122]], "entity_2_idx_in_text_with_entity_marker": [128, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s2_BioInfer.d35.s2.p0", "text": "A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.", "text_with_entity_marker": "A two-hybrid-based approach using [E1]cofilin[/E1] and [E2]actin[/E2] mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[34, 41]], "entity_1_idx_in_text_with_entity_marker": [38, 45], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[46, 51]], "entity_2_idx_in_text_with_entity_marker": [59, 64], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d595.s0_BioInfer.d595.s0.p0", "text": "The common denominator is impaired beta-catenin association with either E-cadherin (PaTuII) or alpha-catenin (BxPc3 and T3M4).", "text_with_entity_marker": "The common denominator is impaired [E1]beta-catenin[/E1] association with either [E2]E-cadherin[/E2] (PaTuII) or alpha-catenin (BxPc3 and T3M4).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[35, 47]], "entity_1_idx_in_text_with_entity_marker": [39, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[72, 82]], "entity_2_idx_in_text_with_entity_marker": [85, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d595.s0_BioInfer.d595.s0.p1", "text": "The common denominator is impaired beta-catenin association with either E-cadherin (PaTuII) or alpha-catenin (BxPc3 and T3M4).", "text_with_entity_marker": "The common denominator is impaired [E1]beta-catenin[/E1] association with either E-cadherin (PaTuII) or [E2]alpha-catenin[/E2] (BxPc3 and T3M4).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[35, 47]], "entity_1_idx_in_text_with_entity_marker": [39, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[95, 108]], "entity_2_idx_in_text_with_entity_marker": [108, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d595.s0_BioInfer.d595.s0.p2", "text": "The common denominator is impaired beta-catenin association with either E-cadherin (PaTuII) or alpha-catenin (BxPc3 and T3M4).", "text_with_entity_marker": "The common denominator is impaired beta-catenin association with either [E1]E-cadherin[/E1] (PaTuII) or [E2]alpha-catenin[/E2] (BxPc3 and T3M4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[72, 82]], "entity_1_idx_in_text_with_entity_marker": [76, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[95, 108]], "entity_2_idx_in_text_with_entity_marker": [108, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d524.s0_BioInfer.d524.s0.p10", "text": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "text_with_entity_marker": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of [E1]alpha-catenin[/E1], although [E2]alpha-catenin[/E2] expression did prevent accumulation of beta-catenin in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[155, 168]], "entity_1_idx_in_text_with_entity_marker": [159, 172], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[179, 192]], "entity_2_idx_in_text_with_entity_marker": [192, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d524.s0_BioInfer.d524.s0.p11", "text": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "text_with_entity_marker": "Rod formation was prevented by coexpression of [E1]N-cadherin[/E1], APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although [E2]alpha-catenin[/E2] expression did prevent accumulation of beta-catenin in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[47, 57]], "entity_1_idx_in_text_with_entity_marker": [51, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[179, 192]], "entity_2_idx_in_text_with_entity_marker": [192, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d524.s0_BioInfer.d524.s0.p12", "text": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "text_with_entity_marker": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of [E1]beta-catenin[/E1], but not by coexpression of alpha-catenin, although [E2]alpha-catenin[/E2] expression did prevent accumulation of beta-catenin in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[114, 126]], "entity_1_idx_in_text_with_entity_marker": [118, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[179, 192]], "entity_2_idx_in_text_with_entity_marker": [192, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d524.s0_BioInfer.d524.s0.p13", "text": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "text_with_entity_marker": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the [E1]armadillo[/E1] repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of [E2]beta-catenin[/E2] in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "armadillo", "entity_1_idx": [[93, 102]], "entity_1_idx_in_text_with_entity_marker": [97, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[232, 244]], "entity_2_idx_in_text_with_entity_marker": [245, 257], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d524.s0_BioInfer.d524.s0.p14", "text": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "text_with_entity_marker": "Rod formation was prevented by coexpression of N-cadherin, APC, and [E1]Tcf-4[/E1], which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of [E2]beta-catenin[/E2] in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Tcf-4", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[232, 244]], "entity_2_idx_in_text_with_entity_marker": [245, 257], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d524.s0_BioInfer.d524.s0.p15", "text": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "text_with_entity_marker": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of [E1]alpha-catenin[/E1], although alpha-catenin expression did prevent accumulation of [E2]beta-catenin[/E2] in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[155, 168]], "entity_1_idx_in_text_with_entity_marker": [159, 172], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[232, 244]], "entity_2_idx_in_text_with_entity_marker": [245, 257], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d524.s0_BioInfer.d524.s0.p16", "text": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "text_with_entity_marker": "Rod formation was prevented by coexpression of [E1]N-cadherin[/E1], APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of [E2]beta-catenin[/E2] in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[47, 57]], "entity_1_idx_in_text_with_entity_marker": [51, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[232, 244]], "entity_2_idx_in_text_with_entity_marker": [245, 257], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d524.s0_BioInfer.d524.s0.p17", "text": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "text_with_entity_marker": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of [E1]beta-catenin[/E1], but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of [E2]beta-catenin[/E2] in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[114, 126]], "entity_1_idx_in_text_with_entity_marker": [118, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[232, 244]], "entity_2_idx_in_text_with_entity_marker": [245, 257], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d524.s0_BioInfer.d524.s0.p18", "text": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "text_with_entity_marker": "Rod formation was prevented by coexpression of N-cadherin, APC, and [E1]Tcf-4[/E1], which bind to the [E2]armadillo[/E2] repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Tcf-4", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "armadillo", "entity_2_idx": [[93, 102]], "entity_2_idx_in_text_with_entity_marker": [106, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d524.s0_BioInfer.d524.s0.p19", "text": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "text_with_entity_marker": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the [E1]armadillo[/E1] repeats of beta-catenin, but not by coexpression of [E2]alpha-catenin[/E2], although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "armadillo", "entity_1_idx": [[93, 102]], "entity_1_idx_in_text_with_entity_marker": [97, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[155, 168]], "entity_2_idx_in_text_with_entity_marker": [168, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d750.s0_BioInfer.d750.s0.p0", "text": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.", "text_with_entity_marker": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: [E1]Armadillo[/E1] (homolog of beta-catenin), Drosophila [E2]E-cadherin[/E2] (DE-cadherin), and alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Armadillo", "entity_1_idx": [[108, 117]], "entity_1_idx_in_text_with_entity_marker": [112, 121], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[156, 166]], "entity_2_idx_in_text_with_entity_marker": [169, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d750.s0_BioInfer.d750.s0.p1", "text": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.", "text_with_entity_marker": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila [E1]E-cadherin[/E1] (DE-cadherin), and [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[156, 166]], "entity_1_idx_in_text_with_entity_marker": [160, 170], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[186, 199]], "entity_2_idx_in_text_with_entity_marker": [199, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d750.s0_BioInfer.d750.s0.p2", "text": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.", "text_with_entity_marker": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of [E1]beta-catenin[/E1]), Drosophila [E2]E-cadherin[/E2] (DE-cadherin), and alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[130, 142]], "entity_1_idx_in_text_with_entity_marker": [134, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[156, 166]], "entity_2_idx_in_text_with_entity_marker": [169, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d750.s0_BioInfer.d750.s0.p3", "text": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.", "text_with_entity_marker": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila [E1]E-cadherin[/E1] ([E2]DE-cadherin[/E2]), and alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[156, 166]], "entity_1_idx_in_text_with_entity_marker": [160, 170], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DE-cadherin", "entity_2_idx": [[168, 179]], "entity_2_idx_in_text_with_entity_marker": [181, 192], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d750.s0_BioInfer.d750.s0.p4", "text": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.", "text_with_entity_marker": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: [E1]Armadillo[/E1] (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Armadillo", "entity_1_idx": [[108, 117]], "entity_1_idx_in_text_with_entity_marker": [112, 121], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[186, 199]], "entity_2_idx_in_text_with_entity_marker": [199, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d750.s0_BioInfer.d750.s0.p5", "text": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.", "text_with_entity_marker": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: [E1]Armadillo[/E1] (homolog of [E2]beta-catenin[/E2]), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Armadillo", "entity_1_idx": [[108, 117]], "entity_1_idx_in_text_with_entity_marker": [112, 121], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[130, 142]], "entity_2_idx_in_text_with_entity_marker": [143, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d750.s0_BioInfer.d750.s0.p6", "text": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.", "text_with_entity_marker": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: [E1]Armadillo[/E1] (homolog of beta-catenin), Drosophila E-cadherin ([E2]DE-cadherin[/E2]), and alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Armadillo", "entity_1_idx": [[108, 117]], "entity_1_idx_in_text_with_entity_marker": [112, 121], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DE-cadherin", "entity_2_idx": [[168, 179]], "entity_2_idx_in_text_with_entity_marker": [181, 192], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d750.s0_BioInfer.d750.s0.p7", "text": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.", "text_with_entity_marker": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of [E1]beta-catenin[/E1]), Drosophila E-cadherin (DE-cadherin), and [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[130, 142]], "entity_1_idx_in_text_with_entity_marker": [134, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[186, 199]], "entity_2_idx_in_text_with_entity_marker": [199, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d750.s0_BioInfer.d750.s0.p8", "text": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.", "text_with_entity_marker": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin ([E1]DE-cadherin[/E1]), and [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DE-cadherin", "entity_1_idx": [[168, 179]], "entity_1_idx_in_text_with_entity_marker": [172, 183], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[186, 199]], "entity_2_idx_in_text_with_entity_marker": [199, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d750.s0_BioInfer.d750.s0.p9", "text": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.", "text_with_entity_marker": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of [E1]beta-catenin[/E1]), Drosophila E-cadherin ([E2]DE-cadherin[/E2]), and alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[130, 142]], "entity_1_idx_in_text_with_entity_marker": [134, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DE-cadherin", "entity_2_idx": [[168, 179]], "entity_2_idx_in_text_with_entity_marker": [181, 192], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d89.s0_BioInfer.d89.s0.p0", "text": "BACKGROUND: Although profilin is believed to be an essential regulator of the actin cytoskeleton in most cells, its precise role in mammalian cells remains unknown.", "text_with_entity_marker": "BACKGROUND: Although [E1]profilin[/E1] is believed to be an essential regulator of the [E2]actin[/E2] cytoskeleton in most cells, its precise role in mammalian cells remains unknown.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[21, 29]], "entity_1_idx_in_text_with_entity_marker": [25, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[78, 83]], "entity_2_idx_in_text_with_entity_marker": [91, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d48.s0_BioInfer.d48.s0.p0", "text": "A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of talin and vinculin on the structure, chain dynamics, elasticity and viscoelasticity of actin filaments with time.", "text_with_entity_marker": "A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of talin and [E1]vinculin[/E1] on the structure, chain dynamics, elasticity and viscoelasticity of [E2]actin[/E2] filaments with time.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "vinculin", "entity_1_idx": [[158, 166]], "entity_1_idx_in_text_with_entity_marker": [162, 170], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[235, 240]], "entity_2_idx_in_text_with_entity_marker": [248, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d48.s0_BioInfer.d48.s0.p1", "text": "A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of talin and vinculin on the structure, chain dynamics, elasticity and viscoelasticity of actin filaments with time.", "text_with_entity_marker": "A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of [E1]talin[/E1] and [E2]vinculin[/E2] on the structure, chain dynamics, elasticity and viscoelasticity of actin filaments with time.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[148, 153]], "entity_1_idx_in_text_with_entity_marker": [152, 157], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d48.s0_BioInfer.d48.s0.p2", "text": "A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of talin and vinculin on the structure, chain dynamics, elasticity and viscoelasticity of actin filaments with time.", "text_with_entity_marker": "A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of [E1]talin[/E1] and vinculin on the structure, chain dynamics, elasticity and viscoelasticity of [E2]actin[/E2] filaments with time.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[148, 153]], "entity_1_idx_in_text_with_entity_marker": [152, 157], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[235, 240]], "entity_2_idx_in_text_with_entity_marker": [248, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d48.s1_BioInfer.d48.s1.p0", "text": "The viscoelasticity of entangled actin networks: the influence of defects and modulation by talin and vinculin.", "text_with_entity_marker": "The viscoelasticity of entangled [E1]actin[/E1] networks: the influence of defects and modulation by [E2]talin[/E2] and vinculin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[33, 38]], "entity_1_idx_in_text_with_entity_marker": [37, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d48.s1_BioInfer.d48.s1.p1", "text": "The viscoelasticity of entangled actin networks: the influence of defects and modulation by talin and vinculin.", "text_with_entity_marker": "The viscoelasticity of entangled [E1]actin[/E1] networks: the influence of defects and modulation by talin and [E2]vinculin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[33, 38]], "entity_1_idx_in_text_with_entity_marker": [37, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[102, 110]], "entity_2_idx_in_text_with_entity_marker": [115, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d48.s1_BioInfer.d48.s1.p2", "text": "The viscoelasticity of entangled actin networks: the influence of defects and modulation by talin and vinculin.", "text_with_entity_marker": "The viscoelasticity of entangled actin networks: the influence of defects and modulation by [E1]talin[/E1] and [E2]vinculin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[92, 97]], "entity_1_idx_in_text_with_entity_marker": [96, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[102, 110]], "entity_2_idx_in_text_with_entity_marker": [115, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d309.s0_BioInfer.d309.s0.p0", "text": "Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of cyclin D1.", "text_with_entity_marker": "Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16([E1]INK4A[/E1]) and/or up-regulation of [E2]cyclin D1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "INK4A", "entity_1_idx": [[152, 157]], "entity_1_idx_in_text_with_entity_marker": [156, 161], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D1", "entity_2_idx": [[183, 192]], "entity_2_idx_in_text_with_entity_marker": [196, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d309.s0_BioInfer.d309.s0.p1", "text": "Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of cyclin D1.", "text_with_entity_marker": "Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the [E1]cyclin-dependent kinase inhibitor[/E1] p16([E2]INK4A[/E2]) and/or up-regulation of cyclin D1.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[114, 147]], "entity_1_idx_in_text_with_entity_marker": [118, 151], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "INK4A", "entity_2_idx": [[152, 157]], "entity_2_idx_in_text_with_entity_marker": [165, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d309.s0_BioInfer.d309.s0.p2", "text": "Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of cyclin D1.", "text_with_entity_marker": "Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor [E1]p16[/E1]([E2]INK4A[/E2]) and/or up-regulation of cyclin D1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p16", "entity_1_idx": [[148, 151]], "entity_1_idx_in_text_with_entity_marker": [152, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "INK4A", "entity_2_idx": [[152, 157]], "entity_2_idx_in_text_with_entity_marker": [165, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d309.s0_BioInfer.d309.s0.p3", "text": "Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of cyclin D1.", "text_with_entity_marker": "Inactivation of the [E1]Rb[/E1] pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16([E2]INK4A[/E2]) and/or up-regulation of cyclin D1.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Rb", "entity_1_idx": [[20, 22]], "entity_1_idx_in_text_with_entity_marker": [24, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "INK4A", "entity_2_idx": [[152, 157]], "entity_2_idx_in_text_with_entity_marker": [165, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d309.s0_BioInfer.d309.s0.p4", "text": "Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of cyclin D1.", "text_with_entity_marker": "Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the [E1]cyclin-dependent kinase inhibitor[/E1] p16(INK4A) and/or up-regulation of [E2]cyclin D1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[114, 147]], "entity_1_idx_in_text_with_entity_marker": [118, 151], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin D1", "entity_2_idx": [[183, 192]], "entity_2_idx_in_text_with_entity_marker": [196, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d309.s0_BioInfer.d309.s0.p5", "text": "Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of cyclin D1.", "text_with_entity_marker": "Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor [E1]p16[/E1](INK4A) and/or up-regulation of [E2]cyclin D1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p16", "entity_1_idx": [[148, 151]], "entity_1_idx_in_text_with_entity_marker": [152, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D1", "entity_2_idx": [[183, 192]], "entity_2_idx_in_text_with_entity_marker": [196, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d309.s0_BioInfer.d309.s0.p6", "text": "Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of cyclin D1.", "text_with_entity_marker": "Inactivation of the [E1]Rb[/E1] pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of [E2]cyclin D1[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Rb", "entity_1_idx": [[20, 22]], "entity_1_idx_in_text_with_entity_marker": [24, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D1", "entity_2_idx": [[183, 192]], "entity_2_idx_in_text_with_entity_marker": [196, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d309.s0_BioInfer.d309.s0.p7", "text": "Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of cyclin D1.", "text_with_entity_marker": "Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p16[/E2](INK4A) and/or up-regulation of cyclin D1.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[114, 147]], "entity_1_idx_in_text_with_entity_marker": [118, 151], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p16", "entity_2_idx": [[148, 151]], "entity_2_idx_in_text_with_entity_marker": [161, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d309.s0_BioInfer.d309.s0.p8", "text": "Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of cyclin D1.", "text_with_entity_marker": "Inactivation of the [E1]Rb[/E1] pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the [E2]cyclin-dependent kinase inhibitor[/E2] p16(INK4A) and/or up-regulation of cyclin D1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rb", "entity_1_idx": [[20, 22]], "entity_1_idx_in_text_with_entity_marker": [24, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[114, 147]], "entity_2_idx_in_text_with_entity_marker": [127, 160], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d309.s0_BioInfer.d309.s0.p9", "text": "Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of cyclin D1.", "text_with_entity_marker": "Inactivation of the [E1]Rb[/E1] pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor [E2]p16[/E2](INK4A) and/or up-regulation of cyclin D1.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Rb", "entity_1_idx": [[20, 22]], "entity_1_idx_in_text_with_entity_marker": [24, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p16", "entity_2_idx": [[148, 151]], "entity_2_idx_in_text_with_entity_marker": [161, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d194.s0_BioInfer.d194.s0.p0", "text": "Even though rates of total protein and actin synthesis resembled values measured in vivo, myosin heavy chain fractional rate of synthesis was only 22% of in vivo levels.", "text_with_entity_marker": "Even though rates of total protein and [E1]actin[/E1] synthesis resembled values measured in vivo, [E2]myosin heavy chain[/E2] fractional rate of synthesis was only 22% of in vivo levels.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[90, 108]], "entity_2_idx_in_text_with_entity_marker": [103, 121], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d65.s0_BioInfer.d65.s0.p0", "text": "An oligomeric form of simian virus 40 large T-antigen is immunologically related to the cellular tumor antigen p53.", "text_with_entity_marker": "An oligomeric form of simian virus 40 [E1]large T-antigen[/E1] is immunologically related to the cellular tumor antigen [E2]p53[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "large T-antigen", "entity_1_idx": [[38, 53]], "entity_1_idx_in_text_with_entity_marker": [42, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[111, 114]], "entity_2_idx_in_text_with_entity_marker": [124, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d65.s1_BioInfer.d65.s1.p0", "text": "The cellular tumor antigen p53 is bound to the simian virus 40 (SV40) large T-antigen in SV40-infected and -transformed cells.", "text_with_entity_marker": "The cellular tumor antigen [E1]p53[/E1] is bound to the simian virus 40 (SV40) [E2]large T-antigen[/E2] in SV40-infected and -transformed cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p53", "entity_1_idx": [[27, 30]], "entity_1_idx_in_text_with_entity_marker": [31, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large T-antigen", "entity_2_idx": [[70, 85]], "entity_2_idx_in_text_with_entity_marker": [83, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d362.s0_BioInfer.d362.s0.p0", "text": "Interestingly, the regions that show the most structural diversity are located at or near the actin-binding site of profilin.", "text_with_entity_marker": "Interestingly, the regions that show the most structural diversity are located at or near the [E1]actin[/E1]-binding site of [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[94, 99]], "entity_1_idx_in_text_with_entity_marker": [98, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[116, 124]], "entity_2_idx_in_text_with_entity_marker": [129, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d743.s0_BioInfer.d743.s0.p0", "text": "This paper describes the structural and biochemical characterization of talin, a protein localized to various cellular sites where bundles of actin filaments attach to the plasma membrane.", "text_with_entity_marker": "This paper describes the structural and biochemical characterization of [E1]talin[/E1], a protein localized to various cellular sites where bundles of [E2]actin[/E2] filaments attach to the plasma membrane.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[142, 147]], "entity_2_idx_in_text_with_entity_marker": [155, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p40", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P) and [E2]matrix[/E2] (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[96, 110], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [100, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[119, 125], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p41", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and [E1]matrix[/E1] (M) proteins of MV and the H, [E2]F[/E2], NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix", "entity_1_idx": [[119, 125], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [123, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[156, 157], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [169, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p42", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and [E2]matrix[/E2] (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[119, 125], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p43", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]) and [E2]matrix[/E2] (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[112, 113]], "entity_1_idx_in_text_with_entity_marker": [116, 117], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[119, 125], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p44", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P) and [E2]matrix[/E2] (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[91, 93]], "entity_1_idx_in_text_with_entity_marker": [95, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[119, 125], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p45", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and [E1]matrix[/E1] ([E2]M[/E2]) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix", "entity_1_idx": [[119, 125], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [123, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[127, 128]], "entity_2_idx_in_text_with_entity_marker": [140, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p46", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] (H), fusion (F), [E2]nucleocapsid protein[/E2] (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[69, 89], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [82, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p47", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the [E2]H[/E2], F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[153, 154], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [166, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p48", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and [E2]P proteins[/E2] of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P proteins", "entity_2_idx": [[166, 176]], "entity_2_idx_in_text_with_entity_marker": [179, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p49", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] (H), fusion (F), nucleocapsid protein (NP), [E2]phosphoprotein[/E2] (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[96, 110], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [109, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p50", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, [E2]F[/E2], NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[156, 157], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [169, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p51", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] ([E2]H[/E2]), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[53, 54]], "entity_2_idx_in_text_with_entity_marker": [66, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p52", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] (H), fusion (F), nucleocapsid protein (NP), phosphoprotein ([E2]P[/E2]) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[112, 113]], "entity_2_idx_in_text_with_entity_marker": [125, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p53", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] (H), fusion (F), nucleocapsid protein ([E2]NP[/E2]), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[91, 93]], "entity_2_idx_in_text_with_entity_marker": [104, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p54", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix ([E2]M[/E2]) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[127, 128]], "entity_2_idx_in_text_with_entity_marker": [140, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p55", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P) and matrix (M) proteins of MV and the [E2]H[/E2], F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[153, 154], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [166, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p56", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and [E2]P proteins[/E2] of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P proteins", "entity_2_idx": [[166, 176]], "entity_2_idx_in_text_with_entity_marker": [179, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p57", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), [E1]nucleocapsid protein[/E1] (NP), [E2]phosphoprotein[/E2] (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[96, 110], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [109, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p58", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, [E2]F[/E2], NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[156, 157], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [169, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p59", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), fusion (F), [E2]nucleocapsid protein[/E2] (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[69, 89], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [82, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d452.s0_BioInfer.d452.s0.p0", "text": "N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the actin-binding proteins, profilin, and gelsolin.", "text_with_entity_marker": "N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the [E1]actin-binding proteins[/E1], [E2]profilin[/E2], and gelsolin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding proteins", "entity_1_idx": [[230, 252]], "entity_1_idx_in_text_with_entity_marker": [234, 256], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[254, 262]], "entity_2_idx_in_text_with_entity_marker": [267, 275], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d452.s0_BioInfer.d452.s0.p1", "text": "N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the actin-binding proteins, profilin, and gelsolin.", "text_with_entity_marker": "N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of [E1]actin[/E1] assembly through its association with the [E2]actin-binding proteins[/E2], profilin, and gelsolin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[182, 187]], "entity_1_idx_in_text_with_entity_marker": [186, 191], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[230, 252]], "entity_2_idx_in_text_with_entity_marker": [243, 265], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d452.s0_BioInfer.d452.s0.p2", "text": "N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the actin-binding proteins, profilin, and gelsolin.", "text_with_entity_marker": "N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the [E1]actin-binding proteins[/E1], profilin, and [E2]gelsolin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding proteins", "entity_1_idx": [[230, 252]], "entity_1_idx_in_text_with_entity_marker": [234, 256], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "gelsolin", "entity_2_idx": [[268, 276]], "entity_2_idx_in_text_with_entity_marker": [281, 289], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d452.s0_BioInfer.d452.s0.p3", "text": "N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the actin-binding proteins, profilin, and gelsolin.", "text_with_entity_marker": "N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of [E1]actin[/E1] assembly through its association with the actin-binding proteins, [E2]profilin[/E2], and gelsolin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[182, 187]], "entity_1_idx_in_text_with_entity_marker": [186, 191], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[254, 262]], "entity_2_idx_in_text_with_entity_marker": [267, 275], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d452.s0_BioInfer.d452.s0.p4", "text": "N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the actin-binding proteins, profilin, and gelsolin.", "text_with_entity_marker": "N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the actin-binding proteins, [E1]profilin[/E1], and [E2]gelsolin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[254, 262]], "entity_1_idx_in_text_with_entity_marker": [258, 266], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[268, 276]], "entity_2_idx_in_text_with_entity_marker": [281, 289], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d452.s0_BioInfer.d452.s0.p5", "text": "N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the actin-binding proteins, profilin, and gelsolin.", "text_with_entity_marker": "N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of [E1]actin[/E1] assembly through its association with the actin-binding proteins, profilin, and [E2]gelsolin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[182, 187]], "entity_1_idx_in_text_with_entity_marker": [186, 191], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[268, 276]], "entity_2_idx_in_text_with_entity_marker": [281, 289], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d79.s0_BioInfer.d79.s0.p0", "text": "A series of truncations was carried out at the C terminus of profilin, a region that has been implicated in actin binding.", "text_with_entity_marker": "A series of truncations was carried out at the C terminus of [E1]profilin[/E1], a region that has been implicated in [E2]actin[/E2] binding.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[61, 69]], "entity_1_idx_in_text_with_entity_marker": [65, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[108, 113]], "entity_2_idx_in_text_with_entity_marker": [121, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d79.s1_BioInfer.d79.s1.p0", "text": "Since our earlier studies of Acanthamoeba profilins suggested the importance of PIP2 binding for suppression, we conclude that both activities are implicated and that an interplay between PIP2 binding and actin binding may be important for profilin function.", "text_with_entity_marker": "Since our earlier studies of Acanthamoeba profilins suggested the importance of PIP2 binding for suppression, we conclude that both activities are implicated and that an interplay between PIP2 binding and [E1]actin[/E1] binding may be important for [E2]profilin[/E2] function.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[240, 248]], "entity_2_idx_in_text_with_entity_marker": [253, 261], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d79.s1_BioInfer.d79.s1.p1", "text": "Since our earlier studies of Acanthamoeba profilins suggested the importance of PIP2 binding for suppression, we conclude that both activities are implicated and that an interplay between PIP2 binding and actin binding may be important for profilin function.", "text_with_entity_marker": "Since our earlier studies of Acanthamoeba [E1]profilins[/E1] suggested the importance of PIP2 binding for suppression, we conclude that both activities are implicated and that an interplay between PIP2 binding and actin binding may be important for [E2]profilin[/E2] function.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[240, 248]], "entity_2_idx_in_text_with_entity_marker": [253, 261], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d79.s1_BioInfer.d79.s1.p2", "text": "Since our earlier studies of Acanthamoeba profilins suggested the importance of PIP2 binding for suppression, we conclude that both activities are implicated and that an interplay between PIP2 binding and actin binding may be important for profilin function.", "text_with_entity_marker": "Since our earlier studies of Acanthamoeba [E1]profilins[/E1] suggested the importance of PIP2 binding for suppression, we conclude that both activities are implicated and that an interplay between PIP2 binding and [E2]actin[/E2] binding may be important for profilin function.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d457.s0_BioInfer.d457.s0.p0", "text": "Of the five major structural proteins of MV, only nucleocapsid (N) protein and phosphoprotein (P protein) were consistently detected in diseased brain areas.", "text_with_entity_marker": "Of the five major structural proteins of MV, only [E1]nucleocapsid[/E1] ([E2]N[/E2]) protein and phosphoprotein (P protein) were consistently detected in diseased brain areas.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[50, 62], [67, 74]], "entity_1_idx_in_text_with_entity_marker": [54, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[64, 65]], "entity_2_idx_in_text_with_entity_marker": [77, 78], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d457.s0_BioInfer.d457.s0.p1", "text": "Of the five major structural proteins of MV, only nucleocapsid (N) protein and phosphoprotein (P protein) were consistently detected in diseased brain areas.", "text_with_entity_marker": "Of the five major structural proteins of MV, only [E1]nucleocapsid[/E1] (N) protein and [E2]phosphoprotein[/E2] (P protein) were consistently detected in diseased brain areas.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[50, 62], [67, 74]], "entity_1_idx_in_text_with_entity_marker": [54, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[79, 93]], "entity_2_idx_in_text_with_entity_marker": [92, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d457.s0_BioInfer.d457.s0.p2", "text": "Of the five major structural proteins of MV, only nucleocapsid (N) protein and phosphoprotein (P protein) were consistently detected in diseased brain areas.", "text_with_entity_marker": "Of the five major structural proteins of MV, only [E1]nucleocapsid[/E1] (N) protein and phosphoprotein ([E2]P protein[/E2]) were consistently detected in diseased brain areas.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[50, 62], [67, 74]], "entity_1_idx_in_text_with_entity_marker": [54, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P protein", "entity_2_idx": [[95, 104]], "entity_2_idx_in_text_with_entity_marker": [108, 117], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d457.s0_BioInfer.d457.s0.p3", "text": "Of the five major structural proteins of MV, only nucleocapsid (N) protein and phosphoprotein (P protein) were consistently detected in diseased brain areas.", "text_with_entity_marker": "Of the five major structural proteins of MV, only nucleocapsid ([E1]N[/E1]) protein and [E2]phosphoprotein[/E2] (P protein) were consistently detected in diseased brain areas.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[64, 65]], "entity_1_idx_in_text_with_entity_marker": [68, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[79, 93]], "entity_2_idx_in_text_with_entity_marker": [92, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d457.s0_BioInfer.d457.s0.p4", "text": "Of the five major structural proteins of MV, only nucleocapsid (N) protein and phosphoprotein (P protein) were consistently detected in diseased brain areas.", "text_with_entity_marker": "Of the five major structural proteins of MV, only nucleocapsid ([E1]N[/E1]) protein and phosphoprotein ([E2]P protein[/E2]) were consistently detected in diseased brain areas.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[64, 65]], "entity_1_idx_in_text_with_entity_marker": [68, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P protein", "entity_2_idx": [[95, 104]], "entity_2_idx_in_text_with_entity_marker": [108, 117], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d457.s0_BioInfer.d457.s0.p5", "text": "Of the five major structural proteins of MV, only nucleocapsid (N) protein and phosphoprotein (P protein) were consistently detected in diseased brain areas.", "text_with_entity_marker": "Of the five major structural proteins of MV, only nucleocapsid (N) protein and [E1]phosphoprotein[/E1] ([E2]P protein[/E2]) were consistently detected in diseased brain areas.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[79, 93]], "entity_1_idx_in_text_with_entity_marker": [83, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P protein", "entity_2_idx": [[95, 104]], "entity_2_idx_in_text_with_entity_marker": [108, 117], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p0", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the [E1]skeletal muscle actin[/E1], or the [E2]myosin heavy chain[/E2] genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "skeletal muscle actin", "entity_1_idx": [[223, 244]], "entity_1_idx_in_text_with_entity_marker": [227, 248], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[253, 271]], "entity_2_idx_in_text_with_entity_marker": [266, 284], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p1", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, [E1]Myf5[/E1], the skeletal muscle actin, or the [E2]myosin heavy chain[/E2] genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Myf5", "entity_1_idx": [[213, 217]], "entity_1_idx_in_text_with_entity_marker": [217, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[253, 271]], "entity_2_idx_in_text_with_entity_marker": [266, 284], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p2", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, [E1]MRF4[/E1], Myf5, the skeletal muscle actin, or the [E2]myosin heavy chain[/E2] genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MRF4", "entity_1_idx": [[207, 211]], "entity_1_idx_in_text_with_entity_marker": [211, 215], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[253, 271]], "entity_2_idx_in_text_with_entity_marker": [266, 284], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p3", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous [E1]MyoD1[/E1], MRF4, Myf5, the skeletal muscle actin, or the [E2]myosin heavy chain[/E2] genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MyoD1", "entity_1_idx": [[200, 205]], "entity_1_idx_in_text_with_entity_marker": [204, 209], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[253, 271]], "entity_2_idx_in_text_with_entity_marker": [266, 284], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p4", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and [E1]myosin light chain 2[/E1] gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the [E2]myosin heavy chain[/E2] genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin light chain 2", "entity_1_idx": [[151, 171]], "entity_1_idx_in_text_with_entity_marker": [155, 175], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[253, 271]], "entity_2_idx_in_text_with_entity_marker": [266, 284], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p5", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous [E1]myogenin[/E1] and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the [E2]myosin heavy chain[/E2] genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myogenin", "entity_1_idx": [[138, 146]], "entity_1_idx_in_text_with_entity_marker": [142, 150], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[253, 271]], "entity_2_idx_in_text_with_entity_marker": [266, 284], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p6", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, [E1]Myf5[/E1], the [E2]skeletal muscle actin[/E2], or the myosin heavy chain genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Myf5", "entity_1_idx": [[213, 217]], "entity_1_idx_in_text_with_entity_marker": [217, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "skeletal muscle actin", "entity_2_idx": [[223, 244]], "entity_2_idx_in_text_with_entity_marker": [236, 257], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p7", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, [E1]MRF4[/E1], Myf5, the [E2]skeletal muscle actin[/E2], or the myosin heavy chain genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MRF4", "entity_1_idx": [[207, 211]], "entity_1_idx_in_text_with_entity_marker": [211, 215], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "skeletal muscle actin", "entity_2_idx": [[223, 244]], "entity_2_idx_in_text_with_entity_marker": [236, 257], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p8", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous [E1]MyoD1[/E1], MRF4, Myf5, the [E2]skeletal muscle actin[/E2], or the myosin heavy chain genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MyoD1", "entity_1_idx": [[200, 205]], "entity_1_idx_in_text_with_entity_marker": [204, 209], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "skeletal muscle actin", "entity_2_idx": [[223, 244]], "entity_2_idx_in_text_with_entity_marker": [236, 257], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p9", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and [E1]myosin light chain 2[/E1] gene but not the endogenous MyoD1, MRF4, Myf5, the [E2]skeletal muscle actin[/E2], or the myosin heavy chain genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin light chain 2", "entity_1_idx": [[151, 171]], "entity_1_idx_in_text_with_entity_marker": [155, 175], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "skeletal muscle actin", "entity_2_idx": [[223, 244]], "entity_2_idx_in_text_with_entity_marker": [236, 257], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p10", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous [E1]myogenin[/E1] and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the [E2]skeletal muscle actin[/E2], or the myosin heavy chain genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myogenin", "entity_1_idx": [[138, 146]], "entity_1_idx_in_text_with_entity_marker": [142, 150], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "skeletal muscle actin", "entity_2_idx": [[223, 244]], "entity_2_idx_in_text_with_entity_marker": [236, 257], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p11", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, [E1]MRF4[/E1], [E2]Myf5[/E2], the skeletal muscle actin, or the myosin heavy chain genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MRF4", "entity_1_idx": [[207, 211]], "entity_1_idx_in_text_with_entity_marker": [211, 215], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Myf5", "entity_2_idx": [[213, 217]], "entity_2_idx_in_text_with_entity_marker": [226, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p12", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous [E1]MyoD1[/E1], MRF4, [E2]Myf5[/E2], the skeletal muscle actin, or the myosin heavy chain genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MyoD1", "entity_1_idx": [[200, 205]], "entity_1_idx_in_text_with_entity_marker": [204, 209], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Myf5", "entity_2_idx": [[213, 217]], "entity_2_idx_in_text_with_entity_marker": [226, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p13", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and [E1]myosin light chain 2[/E1] gene but not the endogenous MyoD1, MRF4, [E2]Myf5[/E2], the skeletal muscle actin, or the myosin heavy chain genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin light chain 2", "entity_1_idx": [[151, 171]], "entity_1_idx_in_text_with_entity_marker": [155, 175], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Myf5", "entity_2_idx": [[213, 217]], "entity_2_idx_in_text_with_entity_marker": [226, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p14", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous [E1]myogenin[/E1] and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, [E2]Myf5[/E2], the skeletal muscle actin, or the myosin heavy chain genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myogenin", "entity_1_idx": [[138, 146]], "entity_1_idx_in_text_with_entity_marker": [142, 150], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Myf5", "entity_2_idx": [[213, 217]], "entity_2_idx_in_text_with_entity_marker": [226, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p15", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous [E1]MyoD1[/E1], [E2]MRF4[/E2], Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MyoD1", "entity_1_idx": [[200, 205]], "entity_1_idx_in_text_with_entity_marker": [204, 209], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MRF4", "entity_2_idx": [[207, 211]], "entity_2_idx_in_text_with_entity_marker": [220, 224], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p16", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and [E1]myosin light chain 2[/E1] gene but not the endogenous MyoD1, [E2]MRF4[/E2], Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin light chain 2", "entity_1_idx": [[151, 171]], "entity_1_idx_in_text_with_entity_marker": [155, 175], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MRF4", "entity_2_idx": [[207, 211]], "entity_2_idx_in_text_with_entity_marker": [220, 224], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p17", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous [E1]myogenin[/E1] and myosin light chain 2 gene but not the endogenous MyoD1, [E2]MRF4[/E2], Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myogenin", "entity_1_idx": [[138, 146]], "entity_1_idx_in_text_with_entity_marker": [142, 150], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MRF4", "entity_2_idx": [[207, 211]], "entity_2_idx_in_text_with_entity_marker": [220, 224], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p18", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and [E1]myosin light chain 2[/E1] gene but not the endogenous [E2]MyoD1[/E2], MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin light chain 2", "entity_1_idx": [[151, 171]], "entity_1_idx_in_text_with_entity_marker": [155, 175], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MyoD1", "entity_2_idx": [[200, 205]], "entity_2_idx_in_text_with_entity_marker": [213, 218], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p19", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous [E1]myogenin[/E1] and myosin light chain 2 gene but not the endogenous [E2]MyoD1[/E2], MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myogenin", "entity_1_idx": [[138, 146]], "entity_1_idx_in_text_with_entity_marker": [142, 150], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MyoD1", "entity_2_idx": [[200, 205]], "entity_2_idx_in_text_with_entity_marker": [213, 218], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p20", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous [E1]myogenin[/E1] and [E2]myosin light chain 2[/E2] gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myogenin", "entity_1_idx": [[138, 146]], "entity_1_idx_in_text_with_entity_marker": [142, 150], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin light chain 2", "entity_2_idx": [[151, 171]], "entity_2_idx_in_text_with_entity_marker": [164, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d771.s0_BioInfer.d771.s0.p0", "text": "Total protein, myosin heavy chain (MHC), and actin appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.", "text_with_entity_marker": "Total protein, myosin heavy chain ([E1]MHC[/E1]), and [E2]actin[/E2] appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHC", "entity_1_idx": [[35, 38]], "entity_1_idx_in_text_with_entity_marker": [39, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[45, 50]], "entity_2_idx_in_text_with_entity_marker": [58, 63], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d771.s0_BioInfer.d771.s0.p1", "text": "Total protein, myosin heavy chain (MHC), and actin appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.", "text_with_entity_marker": "Total protein, [E1]myosin heavy chain[/E1] (MHC), and [E2]actin[/E2] appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[15, 33]], "entity_1_idx_in_text_with_entity_marker": [19, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[45, 50]], "entity_2_idx_in_text_with_entity_marker": [58, 63], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d771.s0_BioInfer.d771.s0.p2", "text": "Total protein, myosin heavy chain (MHC), and actin appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.", "text_with_entity_marker": "Total protein, [E1]myosin heavy chain[/E1] ([E2]MHC[/E2]), and actin appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[15, 33]], "entity_1_idx_in_text_with_entity_marker": [19, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[35, 38]], "entity_2_idx_in_text_with_entity_marker": [48, 51], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d496.s0_BioInfer.d496.s0.p0", "text": "Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.", "text_with_entity_marker": "[E1]Profilin II[/E1] binds actin with a similar affinity to that of [E2]profilin I[/E2], although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Profilin II", "entity_1_idx": [[0, 11]], "entity_1_idx_in_text_with_entity_marker": [4, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin I", "entity_2_idx": [[59, 69]], "entity_2_idx_in_text_with_entity_marker": [72, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d496.s0_BioInfer.d496.s0.p1", "text": "Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.", "text_with_entity_marker": "Profilin II binds actin with a similar affinity to that of [E1]profilin I[/E1], although it inhibits actin polymerization more strongly than [E2]profilin I[/E2] under non-equilibrium conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin I", "entity_1_idx": [[59, 69]], "entity_1_idx_in_text_with_entity_marker": [63, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin I", "entity_2_idx": [[132, 142]], "entity_2_idx_in_text_with_entity_marker": [145, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d496.s0_BioInfer.d496.s0.p2", "text": "Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.", "text_with_entity_marker": "Profilin II binds [E1]actin[/E1] with a similar affinity to that of [E2]profilin I[/E2], although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin I", "entity_2_idx": [[59, 69]], "entity_2_idx_in_text_with_entity_marker": [72, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d496.s0_BioInfer.d496.s0.p3", "text": "Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.", "text_with_entity_marker": "Profilin II binds actin with a similar affinity to that of [E1]profilin I[/E1], although it inhibits [E2]actin[/E2] polymerization more strongly than profilin I under non-equilibrium conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin I", "entity_1_idx": [[59, 69]], "entity_1_idx_in_text_with_entity_marker": [63, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d496.s0_BioInfer.d496.s0.p4", "text": "Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.", "text_with_entity_marker": "[E1]Profilin II[/E1] binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than [E2]profilin I[/E2] under non-equilibrium conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Profilin II", "entity_1_idx": [[0, 11]], "entity_1_idx_in_text_with_entity_marker": [4, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin I", "entity_2_idx": [[132, 142]], "entity_2_idx_in_text_with_entity_marker": [145, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d496.s0_BioInfer.d496.s0.p5", "text": "Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.", "text_with_entity_marker": "[E1]Profilin II[/E1] binds [E2]actin[/E2] with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Profilin II", "entity_1_idx": [[0, 11]], "entity_1_idx_in_text_with_entity_marker": [4, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[18, 23]], "entity_2_idx_in_text_with_entity_marker": [31, 36], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d496.s0_BioInfer.d496.s0.p6", "text": "Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.", "text_with_entity_marker": "[E1]Profilin II[/E1] binds actin with a similar affinity to that of profilin I, although it inhibits [E2]actin[/E2] polymerization more strongly than profilin I under non-equilibrium conditions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Profilin II", "entity_1_idx": [[0, 11]], "entity_1_idx_in_text_with_entity_marker": [4, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d496.s0_BioInfer.d496.s0.p7", "text": "Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.", "text_with_entity_marker": "Profilin II binds [E1]actin[/E1] with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than [E2]profilin I[/E2] under non-equilibrium conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin I", "entity_2_idx": [[132, 142]], "entity_2_idx_in_text_with_entity_marker": [145, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d496.s0_BioInfer.d496.s0.p8", "text": "Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.", "text_with_entity_marker": "Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits [E1]actin[/E1] polymerization more strongly than [E2]profilin I[/E2] under non-equilibrium conditions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[92, 97]], "entity_1_idx_in_text_with_entity_marker": [96, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin I", "entity_2_idx": [[132, 142]], "entity_2_idx_in_text_with_entity_marker": [145, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d496.s0_BioInfer.d496.s0.p9", "text": "Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.", "text_with_entity_marker": "Profilin II binds [E1]actin[/E1] with a similar affinity to that of profilin I, although it inhibits [E2]actin[/E2] polymerization more strongly than profilin I under non-equilibrium conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d496.s1_BioInfer.d496.s1.p0", "text": "Since functional characteristics for profilin II are lacking, we assayed the actin, the phosphatidylinositol 4,5-bisphosphate and the poly(L-proline) binding properties of this isoform.", "text_with_entity_marker": "Since functional characteristics for [E1]profilin II[/E1] are lacking, we assayed the [E2]actin[/E2], the phosphatidylinositol 4,5-bisphosphate and the poly(L-proline) binding properties of this isoform.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin II", "entity_1_idx": [[37, 48]], "entity_1_idx_in_text_with_entity_marker": [41, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[77, 82]], "entity_2_idx_in_text_with_entity_marker": [90, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d453.s0_BioInfer.d453.s0.p0", "text": "No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.", "text_with_entity_marker": "No evidence for the surface expression of the phosphoprotein ([E1]P[/E1]), matrix (M) or nucleocapsid ([E2]N[/E2]) proteins was found.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[62, 63]], "entity_1_idx_in_text_with_entity_marker": [66, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[94, 95]], "entity_2_idx_in_text_with_entity_marker": [107, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d453.s0_BioInfer.d453.s0.p1", "text": "No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.", "text_with_entity_marker": "No evidence for the surface expression of the phosphoprotein ([E1]P[/E1]), matrix (M) or [E2]nucleocapsid[/E2] (N) proteins was found.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[62, 63]], "entity_1_idx_in_text_with_entity_marker": [66, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid", "entity_2_idx": [[80, 92], [97, 105]], "entity_2_idx_in_text_with_entity_marker": [93, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d453.s0_BioInfer.d453.s0.p2", "text": "No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.", "text_with_entity_marker": "No evidence for the surface expression of the [E1]phosphoprotein[/E1] ([E2]P[/E2]), matrix (M) or nucleocapsid (N) proteins was found.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[46, 60], [97, 105]], "entity_1_idx_in_text_with_entity_marker": [50, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[62, 63]], "entity_2_idx_in_text_with_entity_marker": [75, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d453.s0_BioInfer.d453.s0.p3", "text": "No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.", "text_with_entity_marker": "No evidence for the surface expression of the phosphoprotein ([E1]P[/E1]), matrix ([E2]M[/E2]) or nucleocapsid (N) proteins was found.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[62, 63]], "entity_1_idx_in_text_with_entity_marker": [66, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[74, 75]], "entity_2_idx_in_text_with_entity_marker": [87, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d453.s0_BioInfer.d453.s0.p4", "text": "No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.", "text_with_entity_marker": "No evidence for the surface expression of the phosphoprotein ([E1]P[/E1]), [E2]matrix[/E2] (M) or nucleocapsid (N) proteins was found.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[62, 63]], "entity_1_idx_in_text_with_entity_marker": [66, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[66, 72], [97, 105]], "entity_2_idx_in_text_with_entity_marker": [79, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d453.s0_BioInfer.d453.s0.p5", "text": "No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.", "text_with_entity_marker": "No evidence for the surface expression of the phosphoprotein (P), matrix (M) or [E1]nucleocapsid[/E1] ([E2]N[/E2]) proteins was found.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[80, 92], [97, 105]], "entity_1_idx_in_text_with_entity_marker": [84, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[94, 95]], "entity_2_idx_in_text_with_entity_marker": [107, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d453.s0_BioInfer.d453.s0.p6", "text": "No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.", "text_with_entity_marker": "No evidence for the surface expression of the [E1]phosphoprotein[/E1] (P), matrix (M) or nucleocapsid ([E2]N[/E2]) proteins was found.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[46, 60], [97, 105]], "entity_1_idx_in_text_with_entity_marker": [50, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[94, 95]], "entity_2_idx_in_text_with_entity_marker": [107, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d453.s0_BioInfer.d453.s0.p7", "text": "No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.", "text_with_entity_marker": "No evidence for the surface expression of the phosphoprotein (P), matrix ([E1]M[/E1]) or nucleocapsid ([E2]N[/E2]) proteins was found.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[74, 75]], "entity_1_idx_in_text_with_entity_marker": [78, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[94, 95]], "entity_2_idx_in_text_with_entity_marker": [107, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d453.s0_BioInfer.d453.s0.p8", "text": "No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.", "text_with_entity_marker": "No evidence for the surface expression of the phosphoprotein (P), [E1]matrix[/E1] (M) or nucleocapsid ([E2]N[/E2]) proteins was found.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix", "entity_1_idx": [[66, 72], [97, 105]], "entity_1_idx_in_text_with_entity_marker": [70, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[94, 95]], "entity_2_idx_in_text_with_entity_marker": [107, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d453.s0_BioInfer.d453.s0.p9", "text": "No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.", "text_with_entity_marker": "No evidence for the surface expression of the [E1]phosphoprotein[/E1] (P), matrix (M) or [E2]nucleocapsid[/E2] (N) proteins was found.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[46, 60], [97, 105]], "entity_1_idx_in_text_with_entity_marker": [50, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid", "entity_2_idx": [[80, 92], [97, 105]], "entity_2_idx_in_text_with_entity_marker": [93, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d453.s0_BioInfer.d453.s0.p10", "text": "No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.", "text_with_entity_marker": "No evidence for the surface expression of the phosphoprotein (P), matrix ([E1]M[/E1]) or [E2]nucleocapsid[/E2] (N) proteins was found.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[74, 75]], "entity_1_idx_in_text_with_entity_marker": [78, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid", "entity_2_idx": [[80, 92], [97, 105]], "entity_2_idx_in_text_with_entity_marker": [93, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d453.s0_BioInfer.d453.s0.p11", "text": "No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.", "text_with_entity_marker": "No evidence for the surface expression of the phosphoprotein (P), [E1]matrix[/E1] (M) or [E2]nucleocapsid[/E2] (N) proteins was found.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix", "entity_1_idx": [[66, 72], [97, 105]], "entity_1_idx_in_text_with_entity_marker": [70, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid", "entity_2_idx": [[80, 92], [97, 105]], "entity_2_idx_in_text_with_entity_marker": [93, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d453.s0_BioInfer.d453.s0.p12", "text": "No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.", "text_with_entity_marker": "No evidence for the surface expression of the [E1]phosphoprotein[/E1] (P), matrix ([E2]M[/E2]) or nucleocapsid (N) proteins was found.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[46, 60], [97, 105]], "entity_1_idx_in_text_with_entity_marker": [50, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[74, 75]], "entity_2_idx_in_text_with_entity_marker": [87, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d453.s0_BioInfer.d453.s0.p13", "text": "No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.", "text_with_entity_marker": "No evidence for the surface expression of the [E1]phosphoprotein[/E1] (P), [E2]matrix[/E2] (M) or nucleocapsid (N) proteins was found.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[46, 60], [97, 105]], "entity_1_idx_in_text_with_entity_marker": [50, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[66, 72], [97, 105]], "entity_2_idx_in_text_with_entity_marker": [79, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d453.s0_BioInfer.d453.s0.p14", "text": "No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.", "text_with_entity_marker": "No evidence for the surface expression of the phosphoprotein (P), [E1]matrix[/E1] ([E2]M[/E2]) or nucleocapsid (N) proteins was found.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix", "entity_1_idx": [[66, 72], [97, 105]], "entity_1_idx_in_text_with_entity_marker": [70, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[74, 75]], "entity_2_idx_in_text_with_entity_marker": [87, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p30", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed [E1]profilins[/E1] form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native [E2]profilin-I[/E2]; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[303, 312]], "entity_1_idx_in_text_with_entity_marker": [307, 316], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin-I", "entity_2_idx": [[464, 474]], "entity_2_idx_in_text_with_entity_marker": [477, 487], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p31", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed [E1]profilins[/E1] form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba [E2]profilins[/E2] inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[303, 312]], "entity_1_idx_in_text_with_entity_marker": [307, 316], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[515, 524]], "entity_2_idx_in_text_with_entity_marker": [528, 537], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p32", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed [E1]profilins[/E1] form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba [E2]profilin-I[/E2] has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[303, 312]], "entity_1_idx_in_text_with_entity_marker": [307, 316], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin-I", "entity_2_idx": [[403, 413]], "entity_2_idx_in_text_with_entity_marker": [416, 426], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p33", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human [E1]profilins[/E1] rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed [E2]profilins[/E2] form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[139, 148]], "entity_1_idx_in_text_with_entity_marker": [143, 152], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[303, 312]], "entity_2_idx_in_text_with_entity_marker": [316, 325], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p34", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed [E1]profilins[/E1] form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[303, 312]], "entity_1_idx_in_text_with_entity_marker": [307, 316], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[533, 538]], "entity_2_idx_in_text_with_entity_marker": [546, 551], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p35", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native [E1]profilin-I[/E1]; and 4) dialyzed human and Acanthamoeba [E2]profilins[/E2] inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin-I", "entity_1_idx": [[464, 474]], "entity_1_idx_in_text_with_entity_marker": [468, 478], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[515, 524]], "entity_2_idx_in_text_with_entity_marker": [528, 537], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p36", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba [E1]profilin-I[/E1] has an NMR spectrum identical with that of native [E2]profilin-I[/E2]; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin-I", "entity_1_idx": [[403, 413]], "entity_1_idx_in_text_with_entity_marker": [407, 417], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin-I", "entity_2_idx": [[464, 474]], "entity_2_idx_in_text_with_entity_marker": [477, 487], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p37", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human [E1]profilins[/E1] rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native [E2]profilin-I[/E2]; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[139, 148]], "entity_1_idx_in_text_with_entity_marker": [143, 152], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin-I", "entity_2_idx": [[464, 474]], "entity_2_idx_in_text_with_entity_marker": [477, 487], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p38", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native [E1]profilin-I[/E1]; and 4) dialyzed human and Acanthamoeba profilins inhibit [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin-I", "entity_1_idx": [[464, 474]], "entity_1_idx_in_text_with_entity_marker": [468, 478], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[533, 538]], "entity_2_idx_in_text_with_entity_marker": [546, 551], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p39", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba [E1]profilin-I[/E1] has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba [E2]profilins[/E2] inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin-I", "entity_1_idx": [[403, 413]], "entity_1_idx_in_text_with_entity_marker": [407, 417], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[515, 524]], "entity_2_idx_in_text_with_entity_marker": [528, 537], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d733.s0_BioInfer.d733.s0.p0", "text": "They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, RAD51, and RAD52 for viability.", "text_with_entity_marker": "They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes [E1]RAD50[/E1], RAD51, and [E2]RAD52[/E2] for viability.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD50", "entity_1_idx": [[188, 193]], "entity_1_idx_in_text_with_entity_marker": [192, 197], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[206, 211]], "entity_2_idx_in_text_with_entity_marker": [219, 224], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d733.s0_BioInfer.d733.s0.p1", "text": "They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, RAD51, and RAD52 for viability.", "text_with_entity_marker": "They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, [E1]RAD51[/E1], and [E2]RAD52[/E2] for viability.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[195, 200]], "entity_1_idx_in_text_with_entity_marker": [199, 204], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[206, 211]], "entity_2_idx_in_text_with_entity_marker": [219, 224], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d733.s0_BioInfer.d733.s0.p2", "text": "They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, RAD51, and RAD52 for viability.", "text_with_entity_marker": "They exhibited strong synergistic increases in [E1]CAN1[/E1] duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, RAD51, and [E2]RAD52[/E2] for viability.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CAN1", "entity_1_idx": [[47, 51]], "entity_1_idx_in_text_with_entity_marker": [51, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[206, 211]], "entity_2_idx_in_text_with_entity_marker": [219, 224], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d733.s0_BioInfer.d733.s0.p3", "text": "They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, RAD51, and RAD52 for viability.", "text_with_entity_marker": "They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes [E1]RAD50[/E1], [E2]RAD51[/E2], and RAD52 for viability.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD50", "entity_1_idx": [[188, 193]], "entity_1_idx_in_text_with_entity_marker": [192, 197], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[195, 200]], "entity_2_idx_in_text_with_entity_marker": [208, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d733.s0_BioInfer.d733.s0.p4", "text": "They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, RAD51, and RAD52 for viability.", "text_with_entity_marker": "They exhibited strong synergistic increases in [E1]CAN1[/E1] duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes [E2]RAD50[/E2], RAD51, and RAD52 for viability.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CAN1", "entity_1_idx": [[47, 51]], "entity_1_idx_in_text_with_entity_marker": [51, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD50", "entity_2_idx": [[188, 193]], "entity_2_idx_in_text_with_entity_marker": [201, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d733.s0_BioInfer.d733.s0.p5", "text": "They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, RAD51, and RAD52 for viability.", "text_with_entity_marker": "They exhibited strong synergistic increases in [E1]CAN1[/E1] duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, [E2]RAD51[/E2], and RAD52 for viability.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CAN1", "entity_1_idx": [[47, 51]], "entity_1_idx_in_text_with_entity_marker": [51, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[195, 200]], "entity_2_idx_in_text_with_entity_marker": [208, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d349.s0_BioInfer.d349.s0.p0", "text": "In order to determine possible changes in the cytoskeleton organization and function during these processes, we have studied the in situ distribution of two major cytoskeleton-associated elements involved in the membrane anchorage of actin microfilaments, i.e. vinculin and talin, during the ontogeny of the neural crest and its derivatives in the avian embryo.", "text_with_entity_marker": "In order to determine possible changes in the cytoskeleton organization and function during these processes, we have studied the in situ distribution of two major cytoskeleton-associated elements involved in the membrane anchorage of actin microfilaments, i.e. [E1]vinculin[/E1] and [E2]talin[/E2], during the ontogeny of the neural crest and its derivatives in the avian embryo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[261, 269]], "entity_1_idx_in_text_with_entity_marker": [265, 273], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[274, 279]], "entity_2_idx_in_text_with_entity_marker": [287, 292], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d349.s0_BioInfer.d349.s0.p1", "text": "In order to determine possible changes in the cytoskeleton organization and function during these processes, we have studied the in situ distribution of two major cytoskeleton-associated elements involved in the membrane anchorage of actin microfilaments, i.e. vinculin and talin, during the ontogeny of the neural crest and its derivatives in the avian embryo.", "text_with_entity_marker": "In order to determine possible changes in the cytoskeleton organization and function during these processes, we have studied the in situ distribution of two major cytoskeleton-associated elements involved in the membrane anchorage of [E1]actin[/E1] microfilaments, i.e. [E2]vinculin[/E2] and talin, during the ontogeny of the neural crest and its derivatives in the avian embryo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[234, 239]], "entity_1_idx_in_text_with_entity_marker": [238, 243], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[261, 269]], "entity_2_idx_in_text_with_entity_marker": [274, 282], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d349.s0_BioInfer.d349.s0.p2", "text": "In order to determine possible changes in the cytoskeleton organization and function during these processes, we have studied the in situ distribution of two major cytoskeleton-associated elements involved in the membrane anchorage of actin microfilaments, i.e. vinculin and talin, during the ontogeny of the neural crest and its derivatives in the avian embryo.", "text_with_entity_marker": "In order to determine possible changes in the cytoskeleton organization and function during these processes, we have studied the in situ distribution of two major cytoskeleton-associated elements involved in the membrane anchorage of [E1]actin[/E1] microfilaments, i.e. vinculin and [E2]talin[/E2], during the ontogeny of the neural crest and its derivatives in the avian embryo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[234, 239]], "entity_1_idx_in_text_with_entity_marker": [238, 243], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[274, 279]], "entity_2_idx_in_text_with_entity_marker": [287, 292], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p0", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[82, 95]], "entity_1_idx_in_text_with_entity_marker": [86, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[97, 109]], "entity_2_idx_in_text_with_entity_marker": [110, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p1", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, [E1]beta-catenin[/E1], plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, [E2]paxillin[/E2] and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[97, 109]], "entity_1_idx_in_text_with_entity_marker": [101, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[232, 240]], "entity_2_idx_in_text_with_entity_marker": [245, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p2", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, [E1]beta-catenin[/E1], plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and [E2]talin[/E2], did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[97, 109]], "entity_1_idx_in_text_with_entity_marker": [101, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[245, 250]], "entity_2_idx_in_text_with_entity_marker": [258, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p3", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, [E1]beta-catenin[/E1], [E2]plakoglobin[/E2], vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[97, 109]], "entity_1_idx_in_text_with_entity_marker": [101, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[111, 122]], "entity_2_idx_in_text_with_entity_marker": [124, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p4", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, [E1]beta-catenin[/E1], plakoglobin, vinculin and [E2]alpha-actinin[/E2] appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[97, 109]], "entity_1_idx_in_text_with_entity_marker": [101, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-actinin", "entity_2_idx": [[137, 150]], "entity_2_idx_in_text_with_entity_marker": [150, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p5", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, [E1]beta-catenin[/E1], plakoglobin, [E2]vinculin[/E2] and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[97, 109]], "entity_1_idx_in_text_with_entity_marker": [101, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[124, 132]], "entity_2_idx_in_text_with_entity_marker": [137, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p6", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, [E1]cadherins[/E1], alpha-catenin, [E2]beta-catenin[/E2], plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cadherins", "entity_1_idx": [[71, 80]], "entity_1_idx_in_text_with_entity_marker": [75, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[97, 109]], "entity_2_idx_in_text_with_entity_marker": [110, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p7", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, [E1]integrins[/E1], cadherins, alpha-catenin, [E2]beta-catenin[/E2], plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "integrins", "entity_1_idx": [[60, 69]], "entity_1_idx_in_text_with_entity_marker": [64, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[97, 109]], "entity_2_idx_in_text_with_entity_marker": [110, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p8", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, [E1]alpha-catenin[/E1], beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, [E2]paxillin[/E2] and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[82, 95]], "entity_1_idx_in_text_with_entity_marker": [86, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[232, 240]], "entity_2_idx_in_text_with_entity_marker": [245, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p9", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, [E1]alpha-catenin[/E1], beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and [E2]talin[/E2], did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[82, 95]], "entity_1_idx_in_text_with_entity_marker": [86, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[245, 250]], "entity_2_idx_in_text_with_entity_marker": [258, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d314.s0_BioInfer.d314.s0.p0", "text": "In addition, we demonstrate that cofilin and its actin binding peptide compete with gelsolin segments 2-3 for binding to actin filaments.", "text_with_entity_marker": "In addition, we demonstrate that [E1]cofilin[/E1] and its [E2]actin[/E2] binding peptide compete with gelsolin segments 2-3 for binding to actin filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[33, 40]], "entity_1_idx_in_text_with_entity_marker": [37, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[49, 54]], "entity_2_idx_in_text_with_entity_marker": [62, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d314.s0_BioInfer.d314.s0.p1", "text": "In addition, we demonstrate that cofilin and its actin binding peptide compete with gelsolin segments 2-3 for binding to actin filaments.", "text_with_entity_marker": "In addition, we demonstrate that cofilin and its [E1]actin[/E1] binding peptide compete with gelsolin segments 2-3 for binding to [E2]actin[/E2] filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[121, 126]], "entity_2_idx_in_text_with_entity_marker": [134, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d314.s0_BioInfer.d314.s0.p2", "text": "In addition, we demonstrate that cofilin and its actin binding peptide compete with gelsolin segments 2-3 for binding to actin filaments.", "text_with_entity_marker": "In addition, we demonstrate that cofilin and its [E1]actin[/E1] binding peptide compete with [E2]gelsolin[/E2] segments 2-3 for binding to actin filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[84, 92]], "entity_2_idx_in_text_with_entity_marker": [97, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d314.s0_BioInfer.d314.s0.p3", "text": "In addition, we demonstrate that cofilin and its actin binding peptide compete with gelsolin segments 2-3 for binding to actin filaments.", "text_with_entity_marker": "In addition, we demonstrate that [E1]cofilin[/E1] and its actin binding peptide compete with gelsolin segments 2-3 for binding to [E2]actin[/E2] filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[33, 40]], "entity_1_idx_in_text_with_entity_marker": [37, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[121, 126]], "entity_2_idx_in_text_with_entity_marker": [134, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d314.s0_BioInfer.d314.s0.p4", "text": "In addition, we demonstrate that cofilin and its actin binding peptide compete with gelsolin segments 2-3 for binding to actin filaments.", "text_with_entity_marker": "In addition, we demonstrate that [E1]cofilin[/E1] and its actin binding peptide compete with [E2]gelsolin[/E2] segments 2-3 for binding to actin filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[33, 40]], "entity_1_idx_in_text_with_entity_marker": [37, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[84, 92]], "entity_2_idx_in_text_with_entity_marker": [97, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d314.s0_BioInfer.d314.s0.p5", "text": "In addition, we demonstrate that cofilin and its actin binding peptide compete with gelsolin segments 2-3 for binding to actin filaments.", "text_with_entity_marker": "In addition, we demonstrate that cofilin and its actin binding peptide compete with [E1]gelsolin[/E1] segments 2-3 for binding to [E2]actin[/E2] filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gelsolin", "entity_1_idx": [[84, 92]], "entity_1_idx_in_text_with_entity_marker": [88, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[121, 126]], "entity_2_idx_in_text_with_entity_marker": [134, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s2_BioInfer.d214.s2.p0", "text": "We examined the axonal transport of actin and its monomer binding proteins, actin depolymerizing factor, cofilin, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.", "text_with_entity_marker": "We examined the axonal transport of [E1]actin[/E1] and its monomer binding proteins, actin depolymerizing factor, cofilin, and [E2]profilin[/E2], in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[118, 126]], "entity_2_idx_in_text_with_entity_marker": [131, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s2_BioInfer.d214.s2.p1", "text": "We examined the axonal transport of actin and its monomer binding proteins, actin depolymerizing factor, cofilin, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.", "text_with_entity_marker": "We examined the axonal transport of actin and its monomer binding proteins, [E1]actin depolymerizing factor[/E1], cofilin, and [E2]profilin[/E2], in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin depolymerizing factor", "entity_1_idx": [[76, 103]], "entity_1_idx_in_text_with_entity_marker": [80, 107], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[118, 126]], "entity_2_idx_in_text_with_entity_marker": [131, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s2_BioInfer.d214.s2.p2", "text": "We examined the axonal transport of actin and its monomer binding proteins, actin depolymerizing factor, cofilin, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.", "text_with_entity_marker": "We examined the axonal transport of actin and its monomer binding proteins, actin depolymerizing factor, [E1]cofilin[/E1], and [E2]profilin[/E2], in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[105, 112]], "entity_1_idx_in_text_with_entity_marker": [109, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[118, 126]], "entity_2_idx_in_text_with_entity_marker": [131, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s2_BioInfer.d214.s2.p3", "text": "We examined the axonal transport of actin and its monomer binding proteins, actin depolymerizing factor, cofilin, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.", "text_with_entity_marker": "We examined the axonal transport of [E1]actin[/E1] and its monomer binding proteins, [E2]actin depolymerizing factor[/E2], cofilin, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[76, 103]], "entity_2_idx_in_text_with_entity_marker": [89, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s2_BioInfer.d214.s2.p4", "text": "We examined the axonal transport of actin and its monomer binding proteins, actin depolymerizing factor, cofilin, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.", "text_with_entity_marker": "We examined the axonal transport of [E1]actin[/E1] and its monomer binding proteins, actin depolymerizing factor, [E2]cofilin[/E2], and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[105, 112]], "entity_2_idx_in_text_with_entity_marker": [118, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s2_BioInfer.d214.s2.p5", "text": "We examined the axonal transport of actin and its monomer binding proteins, actin depolymerizing factor, cofilin, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.", "text_with_entity_marker": "We examined the axonal transport of actin and its monomer binding proteins, [E1]actin depolymerizing factor[/E1], [E2]cofilin[/E2], and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin depolymerizing factor", "entity_1_idx": [[76, 103]], "entity_1_idx_in_text_with_entity_marker": [80, 107], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[105, 112]], "entity_2_idx_in_text_with_entity_marker": [118, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d277.s0_BioInfer.d277.s0.p0", "text": "However, there were no changes in the expression of E-cadherin, alpha-catenin, and beta-catenin.", "text_with_entity_marker": "However, there were no changes in the expression of [E1]E-cadherin[/E1], alpha-catenin, and [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[52, 62]], "entity_1_idx_in_text_with_entity_marker": [56, 66], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[83, 95]], "entity_2_idx_in_text_with_entity_marker": [96, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d277.s0_BioInfer.d277.s0.p1", "text": "However, there were no changes in the expression of E-cadherin, alpha-catenin, and beta-catenin.", "text_with_entity_marker": "However, there were no changes in the expression of [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], and beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[52, 62]], "entity_1_idx_in_text_with_entity_marker": [56, 66], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[64, 77]], "entity_2_idx_in_text_with_entity_marker": [77, 90], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d277.s0_BioInfer.d277.s0.p2", "text": "However, there were no changes in the expression of E-cadherin, alpha-catenin, and beta-catenin.", "text_with_entity_marker": "However, there were no changes in the expression of E-cadherin, [E1]alpha-catenin[/E1], and [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[64, 77]], "entity_1_idx_in_text_with_entity_marker": [68, 81], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[83, 95]], "entity_2_idx_in_text_with_entity_marker": [96, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d698.s0_BioInfer.d698.s0.p10", "text": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These findings suggest that this novel [E1]RhoGAP[/E1] is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of [E2]PLC-delta[/E2], which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RhoGAP", "entity_1_idx": [[39, 45]], "entity_1_idx_in_text_with_entity_marker": [43, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PLC-delta", "entity_2_idx": [[160, 169]], "entity_2_idx_in_text_with_entity_marker": [173, 182], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d698.s0_BioInfer.d698.s0.p11", "text": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These findings suggest that this novel [E1]RhoGAP[/E1] is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RhoGAP", "entity_1_idx": [[39, 45]], "entity_1_idx_in_text_with_entity_marker": [43, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[312, 320]], "entity_2_idx_in_text_with_entity_marker": [325, 333], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d698.s0_BioInfer.d698.s0.p12", "text": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These findings suggest that this novel [E1]RhoGAP[/E1] is involved in the [E2]Rho[/E2] signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RhoGAP", "entity_1_idx": [[39, 45]], "entity_1_idx_in_text_with_entity_marker": [43, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Rho", "entity_2_idx": [[65, 68]], "entity_2_idx_in_text_with_entity_marker": [78, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d698.s0_BioInfer.d698.s0.p13", "text": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of [E1]Rho[/E1] activation, and mediates the stimulation of PLC-delta, which leads to [E2]actin[/E2]-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rho", "entity_1_idx": [[112, 115]], "entity_1_idx_in_text_with_entity_marker": [116, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[186, 191]], "entity_2_idx_in_text_with_entity_marker": [199, 204], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d698.s0_BioInfer.d698.s0.p14", "text": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of [E1]Rho[/E1] activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to [E2]actin binding proteins[/E2] such as gelsolin and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rho", "entity_1_idx": [[112, 115]], "entity_1_idx_in_text_with_entity_marker": [116, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin binding proteins", "entity_2_idx": [[268, 290]], "entity_2_idx_in_text_with_entity_marker": [281, 303], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d698.s0_BioInfer.d698.s0.p15", "text": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of [E1]Rho[/E1] activation, and mediates the stimulation of [E2]PLC-delta[/E2], which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rho", "entity_1_idx": [[112, 115]], "entity_1_idx_in_text_with_entity_marker": [116, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PLC-delta", "entity_2_idx": [[160, 169]], "entity_2_idx_in_text_with_entity_marker": [173, 182], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d698.s0_BioInfer.d698.s0.p16", "text": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of [E1]Rho[/E1] activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rho", "entity_1_idx": [[112, 115]], "entity_1_idx_in_text_with_entity_marker": [116, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[312, 320]], "entity_2_idx_in_text_with_entity_marker": [325, 333], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d698.s0_BioInfer.d698.s0.p17", "text": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These findings suggest that this novel RhoGAP is involved in the [E1]Rho[/E1] signalling pathway, probably downstream of [E2]Rho[/E2] activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Rho", "entity_1_idx": [[65, 68]], "entity_1_idx_in_text_with_entity_marker": [69, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Rho", "entity_2_idx": [[112, 115]], "entity_2_idx_in_text_with_entity_marker": [125, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d698.s0_BioInfer.d698.s0.p18", "text": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to [E1]actin[/E1]-related cytoskeletal changes through the hydrolysis of PIP2, which binds to [E2]actin binding proteins[/E2] such as gelsolin and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[186, 191]], "entity_1_idx_in_text_with_entity_marker": [190, 195], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin binding proteins", "entity_2_idx": [[268, 290]], "entity_2_idx_in_text_with_entity_marker": [281, 303], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d698.s0_BioInfer.d698.s0.p19", "text": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of [E1]PLC-delta[/E1], which leads to [E2]actin[/E2]-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC-delta", "entity_1_idx": [[160, 169]], "entity_1_idx_in_text_with_entity_marker": [164, 173], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[186, 191]], "entity_2_idx_in_text_with_entity_marker": [199, 204], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d45.s2_BioInfer.d45.s2.p3", "text": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "text_with_entity_marker": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; [E1]profilin[/E1] inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of [E2]actin[/E2] with profilin cannot account for the strong inhibition of spontaneous polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[207, 215]], "entity_1_idx_in_text_with_entity_marker": [211, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[337, 342]], "entity_2_idx_in_text_with_entity_marker": [350, 355], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d45.s2_BioInfer.d45.s2.p4", "text": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "text_with_entity_marker": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; [E1]profilin[/E1] inhibits the elongation of platelet actin much more strongly than [E2]muscle actin[/E2]; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[207, 215]], "entity_1_idx_in_text_with_entity_marker": [211, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "muscle actin", "entity_2_idx": [[282, 294]], "entity_2_idx_in_text_with_entity_marker": [295, 307], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d45.s2_BioInfer.d45.s2.p5", "text": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "text_with_entity_marker": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; [E1]profilin[/E1] inhibits the elongation of [E2]platelet actin[/E2] much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[207, 215]], "entity_1_idx_in_text_with_entity_marker": [211, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "platelet actin", "entity_2_idx": [[243, 257]], "entity_2_idx_in_text_with_entity_marker": [256, 270], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d45.s2_BioInfer.d45.s2.p6", "text": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "text_with_entity_marker": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: [E1]profilin[/E1] has different effects on elongation at the two ends of [E2]actin[/E2] filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[126, 134]], "entity_1_idx_in_text_with_entity_marker": [130, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[190, 195]], "entity_2_idx_in_text_with_entity_marker": [203, 208], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d45.s2_BioInfer.d45.s2.p7", "text": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "text_with_entity_marker": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: [E1]profilin[/E1] has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with [E2]profilin[/E2] cannot account for the strong inhibition of spontaneous polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[126, 134]], "entity_1_idx_in_text_with_entity_marker": [130, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[348, 356]], "entity_2_idx_in_text_with_entity_marker": [361, 369], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d45.s2_BioInfer.d45.s2.p8", "text": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "text_with_entity_marker": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: [E1]profilin[/E1] has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of [E2]actin[/E2] with profilin cannot account for the strong inhibition of spontaneous polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[126, 134]], "entity_1_idx_in_text_with_entity_marker": [130, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[337, 342]], "entity_2_idx_in_text_with_entity_marker": [350, 355], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d45.s2_BioInfer.d45.s2.p9", "text": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "text_with_entity_marker": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: [E1]profilin[/E1] has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than [E2]muscle actin[/E2]; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[126, 134]], "entity_1_idx_in_text_with_entity_marker": [130, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "muscle actin", "entity_2_idx": [[282, 294]], "entity_2_idx_in_text_with_entity_marker": [295, 307], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d45.s2_BioInfer.d45.s2.p10", "text": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "text_with_entity_marker": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: [E1]profilin[/E1] has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of [E2]platelet actin[/E2] much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[126, 134]], "entity_1_idx_in_text_with_entity_marker": [130, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "platelet actin", "entity_2_idx": [[243, 257]], "entity_2_idx_in_text_with_entity_marker": [256, 270], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d45.s2_BioInfer.d45.s2.p11", "text": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "text_with_entity_marker": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of [E1]actin[/E1] filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with [E2]profilin[/E2] cannot account for the strong inhibition of spontaneous polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[190, 195]], "entity_1_idx_in_text_with_entity_marker": [194, 199], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[348, 356]], "entity_2_idx_in_text_with_entity_marker": [361, 369], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d45.s2_BioInfer.d45.s2.p12", "text": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "text_with_entity_marker": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of [E1]actin[/E1] filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of [E2]actin[/E2] with profilin cannot account for the strong inhibition of spontaneous polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[190, 195]], "entity_1_idx_in_text_with_entity_marker": [194, 199], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[337, 342]], "entity_2_idx_in_text_with_entity_marker": [350, 355], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p30", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/[E1]CDK2[/E1] complexes and suppression of kinase activity associated to [E2]cyclin E[/E2]/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDK2", "entity_1_idx": [[208, 212]], "entity_1_idx_in_text_with_entity_marker": [212, 216], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[272, 280]], "entity_2_idx_in_text_with_entity_marker": [285, 293], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p31", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to [E1]cyclin E[/E1]/CDK2 (but not to [E2]cyclin D3[/E2]/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[272, 280]], "entity_1_idx_in_text_with_entity_marker": [276, 284], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D3", "entity_2_idx": [[298, 307]], "entity_2_idx_in_text_with_entity_marker": [311, 320], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p32", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with [E1]cyclin E[/E1]/CDK2 complexes and suppression of kinase activity associated to [E2]cyclin E[/E2]/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[199, 207]], "entity_1_idx_in_text_with_entity_marker": [203, 211], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[272, 280]], "entity_2_idx_in_text_with_entity_marker": [285, 293], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p33", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of [E1]p27[/E1] with cyclin E/CDK2 complexes and suppression of kinase activity associated to [E2]cyclin E[/E2]/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27", "entity_1_idx": [[190, 193]], "entity_1_idx_in_text_with_entity_marker": [194, 197], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[272, 280]], "entity_2_idx_in_text_with_entity_marker": [285, 293], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p34", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of [E1]kinase[/E1] activity associated to [E2]cyclin E[/E2]/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "kinase", "entity_1_idx": [[242, 248]], "entity_1_idx_in_text_with_entity_marker": [246, 252], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin E", "entity_2_idx": [[272, 280]], "entity_2_idx_in_text_with_entity_marker": [285, 293], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p35", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/[E1]CDK2[/E1] complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to [E2]cyclin D3[/E2]/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDK2", "entity_1_idx": [[208, 212]], "entity_1_idx_in_text_with_entity_marker": [212, 216], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D3", "entity_2_idx": [[298, 307]], "entity_2_idx_in_text_with_entity_marker": [311, 320], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p36", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with [E1]cyclin E[/E1]/[E2]CDK2[/E2] complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[199, 207]], "entity_1_idx_in_text_with_entity_marker": [203, 211], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK2", "entity_2_idx": [[208, 212]], "entity_2_idx_in_text_with_entity_marker": [221, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p37", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of [E1]p27[/E1] with cyclin E/[E2]CDK2[/E2] complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[190, 193]], "entity_1_idx_in_text_with_entity_marker": [194, 197], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK2", "entity_2_idx": [[208, 212]], "entity_2_idx_in_text_with_entity_marker": [221, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p38", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/[E1]CDK2[/E1] complexes and suppression of [E2]kinase[/E2] activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDK2", "entity_1_idx": [[208, 212]], "entity_1_idx_in_text_with_entity_marker": [212, 216], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "kinase", "entity_2_idx": [[242, 248]], "entity_2_idx_in_text_with_entity_marker": [255, 261], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p39", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with [E1]cyclin E[/E1]/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to [E2]cyclin D3[/E2]/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[199, 207]], "entity_1_idx_in_text_with_entity_marker": [203, 211], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D3", "entity_2_idx": [[298, 307]], "entity_2_idx_in_text_with_entity_marker": [311, 320], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p40", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of [E1]p27[/E1] with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to [E2]cyclin D3[/E2]/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27", "entity_1_idx": [[190, 193]], "entity_1_idx_in_text_with_entity_marker": [194, 197], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D3", "entity_2_idx": [[298, 307]], "entity_2_idx_in_text_with_entity_marker": [311, 320], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p41", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of [E1]kinase[/E1] activity associated to cyclin E/CDK2 (but not to [E2]cyclin D3[/E2]/CDK4).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "kinase", "entity_1_idx": [[242, 248]], "entity_1_idx_in_text_with_entity_marker": [246, 252], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin D3", "entity_2_idx": [[298, 307]], "entity_2_idx_in_text_with_entity_marker": [311, 320], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p42", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of [E1]p27[/E1] with [E2]cyclin E[/E2]/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[190, 193]], "entity_1_idx_in_text_with_entity_marker": [194, 197], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[199, 207]], "entity_2_idx_in_text_with_entity_marker": [212, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p43", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with [E1]cyclin E[/E1]/CDK2 complexes and suppression of [E2]kinase[/E2] activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[199, 207]], "entity_1_idx_in_text_with_entity_marker": [203, 211], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "kinase", "entity_2_idx": [[242, 248]], "entity_2_idx_in_text_with_entity_marker": [255, 261], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p44", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of [E1]p27[/E1] with cyclin E/CDK2 complexes and suppression of [E2]kinase[/E2] activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27", "entity_1_idx": [[190, 193]], "entity_1_idx_in_text_with_entity_marker": [194, 197], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "kinase", "entity_2_idx": [[242, 248]], "entity_2_idx_in_text_with_entity_marker": [255, 261], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d807.s0_BioInfer.d807.s0.p0", "text": "We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.", "text_with_entity_marker": "We have analyzed the expression levels of the genes encoding [E1]alpha-catenin[/E1], beta-catenin and [E2]plakoglobin[/E2] in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[61, 74]], "entity_1_idx_in_text_with_entity_marker": [65, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[93, 104]], "entity_2_idx_in_text_with_entity_marker": [106, 117], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d807.s0_BioInfer.d807.s0.p1", "text": "We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.", "text_with_entity_marker": "We have analyzed the expression levels of the genes encoding [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2] and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[61, 74]], "entity_1_idx_in_text_with_entity_marker": [65, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[76, 88]], "entity_2_idx_in_text_with_entity_marker": [89, 101], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d807.s0_BioInfer.d807.s0.p2", "text": "We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.", "text_with_entity_marker": "We have analyzed the expression levels of the genes encoding [E1]alpha-catenin[/E1], beta-catenin and plakoglobin in correlation to the [E2]E-cadherin[/E2] expression levels in cell lines derived from human cervical carcinomas.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[61, 74]], "entity_1_idx_in_text_with_entity_marker": [65, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[127, 137]], "entity_2_idx_in_text_with_entity_marker": [140, 150], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d807.s0_BioInfer.d807.s0.p3", "text": "We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.", "text_with_entity_marker": "We have analyzed the expression levels of the genes encoding alpha-catenin, [E1]beta-catenin[/E1] and [E2]plakoglobin[/E2] in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[76, 88]], "entity_1_idx_in_text_with_entity_marker": [80, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[93, 104]], "entity_2_idx_in_text_with_entity_marker": [106, 117], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d807.s0_BioInfer.d807.s0.p4", "text": "We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.", "text_with_entity_marker": "We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and [E1]plakoglobin[/E1] in correlation to the [E2]E-cadherin[/E2] expression levels in cell lines derived from human cervical carcinomas.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[93, 104]], "entity_1_idx_in_text_with_entity_marker": [97, 108], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[127, 137]], "entity_2_idx_in_text_with_entity_marker": [140, 150], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d807.s0_BioInfer.d807.s0.p5", "text": "We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.", "text_with_entity_marker": "We have analyzed the expression levels of the genes encoding alpha-catenin, [E1]beta-catenin[/E1] and plakoglobin in correlation to the [E2]E-cadherin[/E2] expression levels in cell lines derived from human cervical carcinomas.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[76, 88]], "entity_1_idx_in_text_with_entity_marker": [80, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[127, 137]], "entity_2_idx_in_text_with_entity_marker": [140, 150], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d0.s0_BioInfer.d0.s0.p0", "text": "alpha-catenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.", "text_with_entity_marker": "[E1]alpha-catenin[/E1] inhibits beta-catenin signaling by preventing formation of a beta-catenin*[E2]T-cell factor[/E2]*DNA complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[0, 13]], "entity_1_idx_in_text_with_entity_marker": [4, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "T-cell factor", "entity_2_idx": [[88, 101]], "entity_2_idx_in_text_with_entity_marker": [101, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d0.s0_BioInfer.d0.s0.p1", "text": "alpha-catenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.", "text_with_entity_marker": "alpha-catenin inhibits [E1]beta-catenin[/E1] signaling by preventing formation of a beta-catenin*[E2]T-cell factor[/E2]*DNA complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[23, 35]], "entity_1_idx_in_text_with_entity_marker": [27, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "T-cell factor", "entity_2_idx": [[88, 101]], "entity_2_idx_in_text_with_entity_marker": [101, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d0.s0_BioInfer.d0.s0.p2", "text": "alpha-catenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.", "text_with_entity_marker": "alpha-catenin inhibits beta-catenin signaling by preventing formation of a [E1]beta-catenin[/E1]*[E2]T-cell factor[/E2]*DNA complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[75, 87]], "entity_1_idx_in_text_with_entity_marker": [79, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "T-cell factor", "entity_2_idx": [[88, 101]], "entity_2_idx_in_text_with_entity_marker": [101, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d0.s0_BioInfer.d0.s0.p3", "text": "alpha-catenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.", "text_with_entity_marker": "[E1]alpha-catenin[/E1] inhibits [E2]beta-catenin[/E2] signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[0, 13]], "entity_1_idx_in_text_with_entity_marker": [4, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[23, 35]], "entity_2_idx_in_text_with_entity_marker": [36, 48], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d0.s0_BioInfer.d0.s0.p4", "text": "alpha-catenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.", "text_with_entity_marker": "[E1]alpha-catenin[/E1] inhibits beta-catenin signaling by preventing formation of a [E2]beta-catenin[/E2]*T-cell factor*DNA complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[0, 13]], "entity_1_idx_in_text_with_entity_marker": [4, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[75, 87]], "entity_2_idx_in_text_with_entity_marker": [88, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d0.s0_BioInfer.d0.s0.p5", "text": "alpha-catenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.", "text_with_entity_marker": "alpha-catenin inhibits [E1]beta-catenin[/E1] signaling by preventing formation of a [E2]beta-catenin[/E2]*T-cell factor*DNA complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[23, 35]], "entity_1_idx_in_text_with_entity_marker": [27, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[75, 87]], "entity_2_idx_in_text_with_entity_marker": [88, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d748.s0_BioInfer.d748.s0.p0", "text": "Those observations were extended to include a spatiotemporal immunohistochemical analyses of beta-catenin and alpha-catenin, as well as a more detailed study of N-cadherin, during segmentation, compaction, and compartmentalization of the somite.", "text_with_entity_marker": "Those observations were extended to include a spatiotemporal immunohistochemical analyses of [E1]beta-catenin[/E1] and alpha-catenin, as well as a more detailed study of [E2]N-cadherin[/E2], during segmentation, compaction, and compartmentalization of the somite.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[93, 105]], "entity_1_idx_in_text_with_entity_marker": [97, 109], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "N-cadherin", "entity_2_idx": [[161, 171]], "entity_2_idx_in_text_with_entity_marker": [174, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d748.s0_BioInfer.d748.s0.p1", "text": "Those observations were extended to include a spatiotemporal immunohistochemical analyses of beta-catenin and alpha-catenin, as well as a more detailed study of N-cadherin, during segmentation, compaction, and compartmentalization of the somite.", "text_with_entity_marker": "Those observations were extended to include a spatiotemporal immunohistochemical analyses of beta-catenin and [E1]alpha-catenin[/E1], as well as a more detailed study of [E2]N-cadherin[/E2], during segmentation, compaction, and compartmentalization of the somite.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[110, 123]], "entity_1_idx_in_text_with_entity_marker": [114, 127], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "N-cadherin", "entity_2_idx": [[161, 171]], "entity_2_idx_in_text_with_entity_marker": [174, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d748.s0_BioInfer.d748.s0.p2", "text": "Those observations were extended to include a spatiotemporal immunohistochemical analyses of beta-catenin and alpha-catenin, as well as a more detailed study of N-cadherin, during segmentation, compaction, and compartmentalization of the somite.", "text_with_entity_marker": "Those observations were extended to include a spatiotemporal immunohistochemical analyses of [E1]beta-catenin[/E1] and [E2]alpha-catenin[/E2], as well as a more detailed study of N-cadherin, during segmentation, compaction, and compartmentalization of the somite.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[93, 105]], "entity_1_idx_in_text_with_entity_marker": [97, 109], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[110, 123]], "entity_2_idx_in_text_with_entity_marker": [123, 136], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d551.s0_BioInfer.d551.s0.p0", "text": "Structural studies on the ribbon-to-helix transition in profilin: actin crystals.", "text_with_entity_marker": "Structural studies on the ribbon-to-helix transition in [E1]profilin[/E1]: [E2]actin[/E2] crystals.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[56, 64]], "entity_1_idx_in_text_with_entity_marker": [60, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[66, 71]], "entity_2_idx_in_text_with_entity_marker": [79, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d708.s0_BioInfer.d708.s0.p0", "text": "These results indicate that (i) cotranslational assembly of myosin heavy chains is developmentally regulated, (ii) structures containing actin and not microtubules may mediate initial association of the heavy chains with the cytoskeleton, and (iii) the site of translation dictates where a significant fraction of the heavy chains will be inserted into the cytoskeleton.", "text_with_entity_marker": "These results indicate that (i) cotranslational assembly of [E1]myosin heavy chains[/E1] is developmentally regulated, (ii) structures containing [E2]actin[/E2] and not microtubules may mediate initial association of the heavy chains with the cytoskeleton, and (iii) the site of translation dictates where a significant fraction of the heavy chains will be inserted into the cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "myosin heavy chains", "entity_1_idx": [[60, 79]], "entity_1_idx_in_text_with_entity_marker": [64, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[137, 142]], "entity_2_idx_in_text_with_entity_marker": [150, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p80", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase ([E2]HN[/E2]) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[87, 88]], "entity_1_idx_in_text_with_entity_marker": [91, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[204, 206]], "entity_2_idx_in_text_with_entity_marker": [217, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p81", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic ([E1]SH[/E1]) protein, haemagglutinin-neuraminidase ([E2]HN[/E2]) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SH", "entity_1_idx": [[161, 163]], "entity_1_idx_in_text_with_entity_marker": [165, 167], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[204, 206]], "entity_2_idx_in_text_with_entity_marker": [217, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p82", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein ([E1]F[/E1]), small hydrophobic (SH) protein, haemagglutinin-neuraminidase ([E2]HN[/E2]) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[138, 139]], "entity_1_idx_in_text_with_entity_marker": [142, 143], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[204, 206]], "entity_2_idx_in_text_with_entity_marker": [217, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p83", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase ([E1]HN[/E1]) protein and large ([E2]L[/E2]) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HN", "entity_1_idx": [[204, 206]], "entity_1_idx_in_text_with_entity_marker": [208, 210], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[227, 228]], "entity_2_idx_in_text_with_entity_marker": [240, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p84", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P), V protein, [E2]matrix protein[/E2] (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[66, 68]], "entity_1_idx_in_text_with_entity_marker": [70, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix protein", "entity_2_idx": [[102, 116]], "entity_2_idx_in_text_with_entity_marker": [115, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p85", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, [E2]haemagglutinin-neuraminidase[/E2] (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[66, 68]], "entity_1_idx_in_text_with_entity_marker": [70, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "haemagglutinin-neuraminidase", "entity_2_idx": [[174, 202], [208, 215]], "entity_2_idx_in_text_with_entity_marker": [187, 215], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p86", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein ([E1]NP[/E1]), phosphoprotein ([E2]P[/E2]), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[66, 68]], "entity_1_idx_in_text_with_entity_marker": [70, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[87, 88]], "entity_2_idx_in_text_with_entity_marker": [100, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p87", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic ([E2]SH[/E2]) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[66, 68]], "entity_1_idx_in_text_with_entity_marker": [70, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SH", "entity_2_idx": [[161, 163]], "entity_2_idx_in_text_with_entity_marker": [174, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p88", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P), V protein, matrix protein (M), fusion protein ([E2]F[/E2]), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[66, 68]], "entity_1_idx_in_text_with_entity_marker": [70, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[138, 139]], "entity_2_idx_in_text_with_entity_marker": [151, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p89", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large ([E2]L[/E2]) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[66, 68]], "entity_1_idx_in_text_with_entity_marker": [70, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[227, 228]], "entity_2_idx_in_text_with_entity_marker": [240, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d504.s0_BioInfer.d504.s0.p0", "text": "Purification of a cortical complex containing two unconventional actins from Acanthamoeba by affinity chromatography on profilin-agarose.", "text_with_entity_marker": "Purification of a cortical complex containing two unconventional [E1]actins[/E1] from Acanthamoeba by affinity chromatography on [E2]profilin[/E2]-agarose.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actins", "entity_1_idx": [[65, 71]], "entity_1_idx_in_text_with_entity_marker": [69, 75], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[120, 128]], "entity_2_idx_in_text_with_entity_marker": [133, 141], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d381.s0_BioInfer.d381.s0.p0", "text": "In this study we demonstrate that histone H3 and histone H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.", "text_with_entity_marker": "In this study we demonstrate that [E1]histone[/E1] H3 and histone [E2]H4[/E2] synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[34, 41]], "entity_1_idx_in_text_with_entity_marker": [38, 45], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[57, 59]], "entity_2_idx_in_text_with_entity_marker": [70, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d381.s0_BioInfer.d381.s0.p1", "text": "In this study we demonstrate that histone H3 and histone H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.", "text_with_entity_marker": "In this study we demonstrate that [E1]histone[/E1] [E2]H3[/E2] and histone H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[34, 41]], "entity_1_idx_in_text_with_entity_marker": [38, 45], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[42, 44]], "entity_2_idx_in_text_with_entity_marker": [55, 57], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d381.s0_BioInfer.d381.s0.p2", "text": "In this study we demonstrate that histone H3 and histone H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.", "text_with_entity_marker": "In this study we demonstrate that [E1]histone[/E1] H3 and [E2]histone[/E2] H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[34, 41]], "entity_1_idx_in_text_with_entity_marker": [38, 45], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[49, 56]], "entity_2_idx_in_text_with_entity_marker": [62, 69], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d381.s0_BioInfer.d381.s0.p3", "text": "In this study we demonstrate that histone H3 and histone H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.", "text_with_entity_marker": "In this study we demonstrate that histone [E1]H3[/E1] and histone [E2]H4[/E2] synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "H3", "entity_1_idx": [[42, 44]], "entity_1_idx_in_text_with_entity_marker": [46, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[57, 59]], "entity_2_idx_in_text_with_entity_marker": [70, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d381.s0_BioInfer.d381.s0.p4", "text": "In this study we demonstrate that histone H3 and histone H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.", "text_with_entity_marker": "In this study we demonstrate that histone H3 and [E1]histone[/E1] [E2]H4[/E2] synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[49, 56]], "entity_1_idx_in_text_with_entity_marker": [53, 60], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[57, 59]], "entity_2_idx_in_text_with_entity_marker": [70, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d381.s0_BioInfer.d381.s0.p5", "text": "In this study we demonstrate that histone H3 and histone H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.", "text_with_entity_marker": "In this study we demonstrate that histone [E1]H3[/E1] and [E2]histone[/E2] H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[42, 44]], "entity_1_idx_in_text_with_entity_marker": [46, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[49, 56]], "entity_2_idx_in_text_with_entity_marker": [62, 69], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d150.s0_BioInfer.d150.s0.p0", "text": "CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.", "text_with_entity_marker": "CONCLUSIONS: The expression of alpha-catenin, [E1]beta-catenin[/E1], and gamma-catenin is related to histological type and differentiation in NSCLC, although [E2]catenins[/E2] have no independent prognostic value.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[46, 58]], "entity_1_idx_in_text_with_entity_marker": [50, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "catenins", "entity_2_idx": [[149, 157]], "entity_2_idx_in_text_with_entity_marker": [162, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d150.s0_BioInfer.d150.s0.p1", "text": "CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.", "text_with_entity_marker": "CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and [E1]gamma-catenin[/E1] is related to histological type and differentiation in NSCLC, although [E2]catenins[/E2] have no independent prognostic value.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gamma-catenin", "entity_1_idx": [[64, 77]], "entity_1_idx_in_text_with_entity_marker": [68, 81], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "catenins", "entity_2_idx": [[149, 157]], "entity_2_idx_in_text_with_entity_marker": [162, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d150.s0_BioInfer.d150.s0.p2", "text": "CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.", "text_with_entity_marker": "CONCLUSIONS: The expression of [E1]alpha-catenin[/E1], beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although [E2]catenins[/E2] have no independent prognostic value.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[31, 44]], "entity_1_idx_in_text_with_entity_marker": [35, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "catenins", "entity_2_idx": [[149, 157]], "entity_2_idx_in_text_with_entity_marker": [162, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d150.s0_BioInfer.d150.s0.p3", "text": "CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.", "text_with_entity_marker": "CONCLUSIONS: The expression of alpha-catenin, [E1]beta-catenin[/E1], and [E2]gamma-catenin[/E2] is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[46, 58]], "entity_1_idx_in_text_with_entity_marker": [50, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[64, 77]], "entity_2_idx_in_text_with_entity_marker": [77, 90], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d150.s0_BioInfer.d150.s0.p4", "text": "CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.", "text_with_entity_marker": "CONCLUSIONS: The expression of [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[31, 44]], "entity_1_idx_in_text_with_entity_marker": [35, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[46, 58]], "entity_2_idx_in_text_with_entity_marker": [59, 71], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d150.s0_BioInfer.d150.s0.p5", "text": "CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.", "text_with_entity_marker": "CONCLUSIONS: The expression of [E1]alpha-catenin[/E1], beta-catenin, and [E2]gamma-catenin[/E2] is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[31, 44]], "entity_1_idx_in_text_with_entity_marker": [35, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[64, 77]], "entity_2_idx_in_text_with_entity_marker": [77, 90], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d150.s1_BioInfer.d150.s1.p0", "text": "Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.", "text_with_entity_marker": "Reduced expression of [E1]alpha-catenin[/E1], beta-catenin, and [E2]gamma-catenin[/E2] is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[22, 35]], "entity_1_idx_in_text_with_entity_marker": [26, 39], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[55, 68]], "entity_2_idx_in_text_with_entity_marker": [68, 81], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d150.s1_BioInfer.d150.s1.p1", "text": "Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.", "text_with_entity_marker": "Reduced expression of alpha-catenin, [E1]beta-catenin[/E1], and [E2]gamma-catenin[/E2] is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[37, 49]], "entity_1_idx_in_text_with_entity_marker": [41, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[55, 68]], "entity_2_idx_in_text_with_entity_marker": [68, 81], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d150.s1_BioInfer.d150.s1.p2", "text": "Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.", "text_with_entity_marker": "Reduced expression of [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[22, 35]], "entity_1_idx_in_text_with_entity_marker": [26, 39], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[37, 49]], "entity_2_idx_in_text_with_entity_marker": [50, 62], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d803.s0_BioInfer.d803.s0.p0", "text": "We find that profilin and cofilin regulate actin-filament formation throughout the cell cortex.", "text_with_entity_marker": "We find that [E1]profilin[/E1] and [E2]cofilin[/E2] regulate actin-filament formation throughout the cell cortex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[26, 33]], "entity_2_idx_in_text_with_entity_marker": [39, 46], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d803.s0_BioInfer.d803.s0.p1", "text": "We find that profilin and cofilin regulate actin-filament formation throughout the cell cortex.", "text_with_entity_marker": "We find that profilin and [E1]cofilin[/E1] regulate [E2]actin[/E2]-filament formation throughout the cell cortex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[26, 33]], "entity_1_idx_in_text_with_entity_marker": [30, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[43, 48]], "entity_2_idx_in_text_with_entity_marker": [56, 61], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d803.s0_BioInfer.d803.s0.p2", "text": "We find that profilin and cofilin regulate actin-filament formation throughout the cell cortex.", "text_with_entity_marker": "We find that [E1]profilin[/E1] and cofilin regulate [E2]actin[/E2]-filament formation throughout the cell cortex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[43, 48]], "entity_2_idx_in_text_with_entity_marker": [56, 61], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d70.s0_BioInfer.d70.s0.p0", "text": "Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.", "text_with_entity_marker": "Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by [E1]thrombin[/E1] (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and [E2]myosin heavy chain[/E2] associated with cytoskeletons.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thrombin", "entity_1_idx": [[189, 197]], "entity_1_idx_in_text_with_entity_marker": [193, 201], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[355, 373]], "entity_2_idx_in_text_with_entity_marker": [368, 386], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d70.s0_BioInfer.d70.s0.p1", "text": "Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.", "text_with_entity_marker": "[E1]Aprotinin[/E1] inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and [E2]myosin heavy chain[/E2] associated with cytoskeletons.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Aprotinin", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[355, 373]], "entity_2_idx_in_text_with_entity_marker": [368, 386], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d70.s0_BioInfer.d70.s0.p2", "text": "Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.", "text_with_entity_marker": "Aprotinin inhibited platelet aggregation induced by [E1]thrombin[/E1] (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and [E2]myosin heavy chain[/E2] associated with cytoskeletons.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thrombin", "entity_1_idx": [[52, 60]], "entity_1_idx_in_text_with_entity_marker": [56, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[355, 373]], "entity_2_idx_in_text_with_entity_marker": [368, 386], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d70.s0_BioInfer.d70.s0.p3", "text": "Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.", "text_with_entity_marker": "Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of [E1]actin[/E1] and [E2]myosin heavy chain[/E2] associated with cytoskeletons.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[345, 350]], "entity_1_idx_in_text_with_entity_marker": [349, 354], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[355, 373]], "entity_2_idx_in_text_with_entity_marker": [368, 386], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d70.s0_BioInfer.d70.s0.p4", "text": "Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.", "text_with_entity_marker": "[E1]Aprotinin[/E1] inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by [E2]thrombin[/E2] (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Aprotinin", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thrombin", "entity_2_idx": [[189, 197]], "entity_2_idx_in_text_with_entity_marker": [202, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d70.s0_BioInfer.d70.s0.p5", "text": "Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.", "text_with_entity_marker": "Aprotinin inhibited platelet aggregation induced by [E1]thrombin[/E1] (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by [E2]thrombin[/E2] (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thrombin", "entity_1_idx": [[52, 60]], "entity_1_idx_in_text_with_entity_marker": [56, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thrombin", "entity_2_idx": [[189, 197]], "entity_2_idx_in_text_with_entity_marker": [202, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d70.s0_BioInfer.d70.s0.p6", "text": "Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.", "text_with_entity_marker": "Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by [E1]thrombin[/E1] (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of [E2]actin[/E2] and myosin heavy chain associated with cytoskeletons.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thrombin", "entity_1_idx": [[189, 197]], "entity_1_idx_in_text_with_entity_marker": [193, 201], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[345, 350]], "entity_2_idx_in_text_with_entity_marker": [358, 363], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d70.s0_BioInfer.d70.s0.p7", "text": "Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.", "text_with_entity_marker": "[E1]Aprotinin[/E1] inhibited platelet aggregation induced by [E2]thrombin[/E2] (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Aprotinin", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thrombin", "entity_2_idx": [[52, 60]], "entity_2_idx_in_text_with_entity_marker": [65, 73], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d70.s0_BioInfer.d70.s0.p8", "text": "Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.", "text_with_entity_marker": "[E1]Aprotinin[/E1] inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of [E2]actin[/E2] and myosin heavy chain associated with cytoskeletons.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Aprotinin", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[345, 350]], "entity_2_idx_in_text_with_entity_marker": [358, 363], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d70.s0_BioInfer.d70.s0.p9", "text": "Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.", "text_with_entity_marker": "Aprotinin inhibited platelet aggregation induced by [E1]thrombin[/E1] (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of [E2]actin[/E2] and myosin heavy chain associated with cytoskeletons.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thrombin", "entity_1_idx": [[52, 60]], "entity_1_idx_in_text_with_entity_marker": [56, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[345, 350]], "entity_2_idx_in_text_with_entity_marker": [358, 363], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p0", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with [E1]LEF-1[/E1] and vinculin; (b) [E2]LEF-1[/E2]-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LEF-1", "entity_1_idx": [[117, 122]], "entity_1_idx_in_text_with_entity_marker": [121, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LEF-1", "entity_2_idx": [[141, 146]], "entity_2_idx_in_text_with_entity_marker": [154, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p1", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) [E1]LEF-1[/E1]-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and [E2]alpha-catenin[/E2], can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LEF-1", "entity_1_idx": [[141, 146]], "entity_1_idx_in_text_with_entity_marker": [145, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[278, 291]], "entity_2_idx_in_text_with_entity_marker": [291, 304], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p2", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) [E1]LEF-1[/E1]-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of [E2]beta-catenin[/E2], cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LEF-1", "entity_1_idx": [[141, 146]], "entity_1_idx_in_text_with_entity_marker": [145, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[251, 263]], "entity_2_idx_in_text_with_entity_marker": [264, 276], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p3", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and [E1]vinculin[/E1]; (b) [E2]LEF-1[/E2]-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[127, 135]], "entity_1_idx_in_text_with_entity_marker": [131, 139], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LEF-1", "entity_2_idx": [[141, 146]], "entity_2_idx_in_text_with_entity_marker": [154, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p4", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) [E1]plakoglobin[/E1] and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) [E2]LEF-1[/E2]-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[30, 41]], "entity_1_idx_in_text_with_entity_marker": [34, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LEF-1", "entity_2_idx": [[141, 146]], "entity_2_idx_in_text_with_entity_marker": [154, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p5", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) [E1]LEF-1[/E1]-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, [E2]cadherin[/E2] and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LEF-1", "entity_1_idx": [[141, 146]], "entity_1_idx_in_text_with_entity_marker": [145, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[265, 273]], "entity_2_idx_in_text_with_entity_marker": [278, 286], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p6", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) [E1]LEF-1[/E1]-dependent transactivation is preferentially driven by [E2]beta-catenin[/E2]; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LEF-1", "entity_1_idx": [[141, 146]], "entity_1_idx_in_text_with_entity_marker": [145, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[201, 213]], "entity_2_idx_in_text_with_entity_marker": [214, 226], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p7", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and [E1]beta-catenin[/E1] differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) [E2]LEF-1[/E2]-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[46, 58]], "entity_1_idx_in_text_with_entity_marker": [50, 62], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LEF-1", "entity_2_idx": [[141, 146]], "entity_2_idx_in_text_with_entity_marker": [154, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p8", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with [E1]LEF-1[/E1] and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and [E2]alpha-catenin[/E2], can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LEF-1", "entity_1_idx": [[117, 122]], "entity_1_idx_in_text_with_entity_marker": [121, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[278, 291]], "entity_2_idx_in_text_with_entity_marker": [291, 304], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p9", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with [E1]LEF-1[/E1] and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of [E2]beta-catenin[/E2], cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LEF-1", "entity_1_idx": [[117, 122]], "entity_1_idx_in_text_with_entity_marker": [121, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[251, 263]], "entity_2_idx_in_text_with_entity_marker": [264, 276], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d248.s0_BioInfer.d248.s0.p0", "text": "Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "Here we report that [E1]p120[/E1] associates with a complex containing [E2]E-cadherin[/E2], alpha-catenin, beta-catenin, and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p120", "entity_1_idx": [[20, 24]], "entity_1_idx_in_text_with_entity_marker": [24, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[62, 72]], "entity_2_idx_in_text_with_entity_marker": [75, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d248.s0_BioInfer.d248.s0.p1", "text": "Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "Here we report that p120 associates with a complex containing [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], beta-catenin, and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[62, 72]], "entity_1_idx_in_text_with_entity_marker": [66, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[74, 87]], "entity_2_idx_in_text_with_entity_marker": [87, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d248.s0_BioInfer.d248.s0.p2", "text": "Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "Here we report that p120 associates with a complex containing [E1]E-cadherin[/E1], alpha-catenin, beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[62, 72]], "entity_1_idx_in_text_with_entity_marker": [66, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[107, 118]], "entity_2_idx_in_text_with_entity_marker": [120, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d248.s0_BioInfer.d248.s0.p3", "text": "Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "Here we report that p120 associates with a complex containing [E1]E-cadherin[/E1], alpha-catenin, [E2]beta-catenin[/E2], and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[62, 72]], "entity_1_idx_in_text_with_entity_marker": [66, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[89, 101]], "entity_2_idx_in_text_with_entity_marker": [102, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d248.s0_BioInfer.d248.s0.p4", "text": "Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "Here we report that [E1]p120[/E1] associates with a complex containing E-cadherin, [E2]alpha-catenin[/E2], beta-catenin, and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p120", "entity_1_idx": [[20, 24]], "entity_1_idx_in_text_with_entity_marker": [24, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[74, 87]], "entity_2_idx_in_text_with_entity_marker": [87, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d248.s0_BioInfer.d248.s0.p5", "text": "Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "Here we report that [E1]p120[/E1] associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p120", "entity_1_idx": [[20, 24]], "entity_1_idx_in_text_with_entity_marker": [24, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[107, 118]], "entity_2_idx_in_text_with_entity_marker": [120, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d248.s0_BioInfer.d248.s0.p6", "text": "Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "Here we report that [E1]p120[/E1] associates with a complex containing E-cadherin, alpha-catenin, [E2]beta-catenin[/E2], and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p120", "entity_1_idx": [[20, 24]], "entity_1_idx_in_text_with_entity_marker": [24, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[89, 101]], "entity_2_idx_in_text_with_entity_marker": [102, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d248.s0_BioInfer.d248.s0.p7", "text": "Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "Here we report that p120 associates with a complex containing E-cadherin, [E1]alpha-catenin[/E1], beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[74, 87]], "entity_1_idx_in_text_with_entity_marker": [78, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[107, 118]], "entity_2_idx_in_text_with_entity_marker": [120, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d248.s0_BioInfer.d248.s0.p8", "text": "Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "Here we report that p120 associates with a complex containing E-cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[74, 87]], "entity_1_idx_in_text_with_entity_marker": [78, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[89, 101]], "entity_2_idx_in_text_with_entity_marker": [102, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d248.s0_BioInfer.d248.s0.p9", "text": "Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, [E1]beta-catenin[/E1], and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[89, 101]], "entity_1_idx_in_text_with_entity_marker": [93, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[107, 118]], "entity_2_idx_in_text_with_entity_marker": [120, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d319.s0_BioInfer.d319.s0.p0", "text": "In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.", "text_with_entity_marker": "In a model system, the interacting proteins recruiting [E1]TFIIIC[/E1] to DNA were PRP21 and [E2]PRP9[/E2] or PRP21 and PRP11.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TFIIIC", "entity_1_idx": [[55, 61]], "entity_1_idx_in_text_with_entity_marker": [59, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP9", "entity_2_idx": [[84, 88]], "entity_2_idx_in_text_with_entity_marker": [97, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d319.s0_BioInfer.d319.s0.p1", "text": "In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.", "text_with_entity_marker": "In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and [E1]PRP9[/E1] or [E2]PRP21[/E2] and PRP11.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PRP9", "entity_1_idx": [[84, 88]], "entity_1_idx_in_text_with_entity_marker": [88, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP21", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d319.s0_BioInfer.d319.s0.p2", "text": "In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.", "text_with_entity_marker": "In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and [E1]PRP9[/E1] or PRP21 and [E2]PRP11[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PRP9", "entity_1_idx": [[84, 88]], "entity_1_idx_in_text_with_entity_marker": [88, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP11", "entity_2_idx": [[102, 107]], "entity_2_idx_in_text_with_entity_marker": [115, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d319.s0_BioInfer.d319.s0.p3", "text": "In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.", "text_with_entity_marker": "In a model system, the interacting proteins recruiting TFIIIC to DNA were [E1]PRP21[/E1] and [E2]PRP9[/E2] or PRP21 and PRP11.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRP21", "entity_1_idx": [[74, 79]], "entity_1_idx_in_text_with_entity_marker": [78, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP9", "entity_2_idx": [[84, 88]], "entity_2_idx_in_text_with_entity_marker": [97, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d319.s0_BioInfer.d319.s0.p4", "text": "In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.", "text_with_entity_marker": "In a model system, the interacting proteins recruiting [E1]TFIIIC[/E1] to DNA were PRP21 and PRP9 or [E2]PRP21[/E2] and PRP11.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TFIIIC", "entity_1_idx": [[55, 61]], "entity_1_idx_in_text_with_entity_marker": [59, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP21", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d319.s0_BioInfer.d319.s0.p5", "text": "In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.", "text_with_entity_marker": "In a model system, the interacting proteins recruiting [E1]TFIIIC[/E1] to DNA were PRP21 and PRP9 or PRP21 and [E2]PRP11[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TFIIIC", "entity_1_idx": [[55, 61]], "entity_1_idx_in_text_with_entity_marker": [59, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP11", "entity_2_idx": [[102, 107]], "entity_2_idx_in_text_with_entity_marker": [115, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d319.s0_BioInfer.d319.s0.p6", "text": "In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.", "text_with_entity_marker": "In a model system, the interacting proteins recruiting [E1]TFIIIC[/E1] to DNA were [E2]PRP21[/E2] and PRP9 or PRP21 and PRP11.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TFIIIC", "entity_1_idx": [[55, 61]], "entity_1_idx_in_text_with_entity_marker": [59, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP21", "entity_2_idx": [[74, 79]], "entity_2_idx_in_text_with_entity_marker": [87, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d319.s0_BioInfer.d319.s0.p7", "text": "In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.", "text_with_entity_marker": "In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or [E1]PRP21[/E1] and [E2]PRP11[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRP21", "entity_1_idx": [[92, 97]], "entity_1_idx_in_text_with_entity_marker": [96, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP11", "entity_2_idx": [[102, 107]], "entity_2_idx_in_text_with_entity_marker": [115, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d319.s0_BioInfer.d319.s0.p8", "text": "In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.", "text_with_entity_marker": "In a model system, the interacting proteins recruiting TFIIIC to DNA were [E1]PRP21[/E1] and PRP9 or [E2]PRP21[/E2] and PRP11.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PRP21", "entity_1_idx": [[74, 79]], "entity_1_idx_in_text_with_entity_marker": [78, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP21", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d319.s0_BioInfer.d319.s0.p9", "text": "In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.", "text_with_entity_marker": "In a model system, the interacting proteins recruiting TFIIIC to DNA were [E1]PRP21[/E1] and PRP9 or PRP21 and [E2]PRP11[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PRP21", "entity_1_idx": [[74, 79]], "entity_1_idx_in_text_with_entity_marker": [78, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP11", "entity_2_idx": [[102, 107]], "entity_2_idx_in_text_with_entity_marker": [115, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d638.s0_BioInfer.d638.s0.p0", "text": "The long repeats, which are interdigitated between the PRRs, increased the frequency with which actin-based motility occurred by a mechanism independent of the PRRs, VASP, and profilin.", "text_with_entity_marker": "The long repeats, which are interdigitated between the PRRs, increased the frequency with which [E1]actin[/E1]-based motility occurred by a mechanism independent of the PRRs, VASP, and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[96, 101]], "entity_1_idx_in_text_with_entity_marker": [100, 105], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[176, 184]], "entity_2_idx_in_text_with_entity_marker": [189, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d638.s0_BioInfer.d638.s0.p1", "text": "The long repeats, which are interdigitated between the PRRs, increased the frequency with which actin-based motility occurred by a mechanism independent of the PRRs, VASP, and profilin.", "text_with_entity_marker": "The long repeats, which are interdigitated between the PRRs, increased the frequency with which [E1]actin[/E1]-based motility occurred by a mechanism independent of the PRRs, [E2]VASP[/E2], and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[96, 101]], "entity_1_idx_in_text_with_entity_marker": [100, 105], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "VASP", "entity_2_idx": [[166, 170]], "entity_2_idx_in_text_with_entity_marker": [179, 183], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d638.s0_BioInfer.d638.s0.p2", "text": "The long repeats, which are interdigitated between the PRRs, increased the frequency with which actin-based motility occurred by a mechanism independent of the PRRs, VASP, and profilin.", "text_with_entity_marker": "The long repeats, which are interdigitated between the PRRs, increased the frequency with which actin-based motility occurred by a mechanism independent of the PRRs, [E1]VASP[/E1], and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VASP", "entity_1_idx": [[166, 170]], "entity_1_idx_in_text_with_entity_marker": [170, 174], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[176, 184]], "entity_2_idx_in_text_with_entity_marker": [189, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d638.s1_BioInfer.d638.s1.p0", "text": "The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin.", "text_with_entity_marker": "The tandem repeat domain in the Listeria monocytogenes [E1]ActA[/E1] protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ActA", "entity_1_idx": [[55, 59]], "entity_1_idx_in_text_with_entity_marker": [59, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[212, 220]], "entity_2_idx_in_text_with_entity_marker": [225, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d638.s1_BioInfer.d638.s1.p1", "text": "The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin.", "text_with_entity_marker": "The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of [E1]actin[/E1]-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[89, 94]], "entity_1_idx_in_text_with_entity_marker": [93, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[212, 220]], "entity_2_idx_in_text_with_entity_marker": [225, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d638.s1_BioInfer.d638.s1.p2", "text": "The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin.", "text_with_entity_marker": "The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of [E1]vasodilator-stimulated phosphoprotein[/E1] and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vasodilator-stimulated phosphoprotein", "entity_1_idx": [[170, 207]], "entity_1_idx_in_text_with_entity_marker": [174, 211], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[212, 220]], "entity_2_idx_in_text_with_entity_marker": [225, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d638.s1_BioInfer.d638.s1.p3", "text": "The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin.", "text_with_entity_marker": "The tandem repeat domain in the Listeria monocytogenes [E1]ActA[/E1] protein controls the rate of [E2]actin[/E2]-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ActA", "entity_1_idx": [[55, 59]], "entity_1_idx_in_text_with_entity_marker": [59, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[89, 94]], "entity_2_idx_in_text_with_entity_marker": [102, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d638.s1_BioInfer.d638.s1.p4", "text": "The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin.", "text_with_entity_marker": "The tandem repeat domain in the Listeria monocytogenes [E1]ActA[/E1] protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of [E2]vasodilator-stimulated phosphoprotein[/E2] and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ActA", "entity_1_idx": [[55, 59]], "entity_1_idx_in_text_with_entity_marker": [59, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vasodilator-stimulated phosphoprotein", "entity_2_idx": [[170, 207]], "entity_2_idx_in_text_with_entity_marker": [183, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d638.s1_BioInfer.d638.s1.p5", "text": "The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin.", "text_with_entity_marker": "The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of [E1]actin[/E1]-based motility, the percentage of moving bacteria, and the localization of [E2]vasodilator-stimulated phosphoprotein[/E2] and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[89, 94]], "entity_1_idx_in_text_with_entity_marker": [93, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vasodilator-stimulated phosphoprotein", "entity_2_idx": [[170, 207]], "entity_2_idx_in_text_with_entity_marker": [183, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d658.s0_BioInfer.d658.s0.p0", "text": "The phosphoprotein was identified as cofilin, an actin-binding protein, and the activation-induced changes in its intracellular distribution have been described elsewhere (Suzuki et al., 1995, J Biol Chem 270:19551-19556).", "text_with_entity_marker": "The phosphoprotein was identified as [E1]cofilin[/E1], an [E2]actin-binding protein[/E2], and the activation-induced changes in its intracellular distribution have been described elsewhere (Suzuki et al., 1995, J Biol Chem 270:19551-19556).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[37, 44]], "entity_1_idx_in_text_with_entity_marker": [41, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[49, 70]], "entity_2_idx_in_text_with_entity_marker": [62, 83], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d268.s0_BioInfer.d268.s0.p0", "text": "However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that verprolin establishes and maintains its location independent of the actin cytoskeleton.", "text_with_entity_marker": "However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that [E1]verprolin[/E1] establishes and maintains its location independent of the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "verprolin", "entity_1_idx": [[120, 129]], "entity_1_idx_in_text_with_entity_marker": [124, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[188, 193]], "entity_2_idx_in_text_with_entity_marker": [201, 206], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d268.s0_BioInfer.d268.s0.p1", "text": "However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that verprolin establishes and maintains its location independent of the actin cytoskeleton.", "text_with_entity_marker": "However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter [E1]verprolin[/E1]'s location, indicating that [E2]verprolin[/E2] establishes and maintains its location independent of the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[82, 91]], "entity_1_idx_in_text_with_entity_marker": [86, 95], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "verprolin", "entity_2_idx": [[120, 129]], "entity_2_idx_in_text_with_entity_marker": [133, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d268.s0_BioInfer.d268.s0.p2", "text": "However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that verprolin establishes and maintains its location independent of the actin cytoskeleton.", "text_with_entity_marker": "However, disassembly of the [E1]actin[/E1] cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that [E2]verprolin[/E2] establishes and maintains its location independent of the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[28, 33]], "entity_1_idx_in_text_with_entity_marker": [32, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "verprolin", "entity_2_idx": [[120, 129]], "entity_2_idx_in_text_with_entity_marker": [133, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d268.s0_BioInfer.d268.s0.p3", "text": "However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that verprolin establishes and maintains its location independent of the actin cytoskeleton.", "text_with_entity_marker": "However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter [E1]verprolin[/E1]'s location, indicating that verprolin establishes and maintains its location independent of the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[82, 91]], "entity_1_idx_in_text_with_entity_marker": [86, 95], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[188, 193]], "entity_2_idx_in_text_with_entity_marker": [201, 206], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d268.s0_BioInfer.d268.s0.p4", "text": "However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that verprolin establishes and maintains its location independent of the actin cytoskeleton.", "text_with_entity_marker": "However, disassembly of the [E1]actin[/E1] cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that verprolin establishes and maintains its location independent of the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[28, 33]], "entity_1_idx_in_text_with_entity_marker": [32, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[188, 193]], "entity_2_idx_in_text_with_entity_marker": [201, 206], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d268.s0_BioInfer.d268.s0.p5", "text": "However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that verprolin establishes and maintains its location independent of the actin cytoskeleton.", "text_with_entity_marker": "However, disassembly of the [E1]actin[/E1] cytoskeleton using Latrunculin-A does not alter [E2]verprolin[/E2]'s location, indicating that verprolin establishes and maintains its location independent of the actin cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[28, 33]], "entity_1_idx_in_text_with_entity_marker": [32, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "verprolin", "entity_2_idx": [[82, 91]], "entity_2_idx_in_text_with_entity_marker": [95, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d268.s1_BioInfer.d268.s1.p0", "text": "Using the two-hybrid system, we show that verprolin binds actin.", "text_with_entity_marker": "Using the two-hybrid system, we show that [E1]verprolin[/E1] binds [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "verprolin", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p0", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion ([E1]F[/E1]), phosphoprotein (P), H, nucleocapsid (N) and matrix ([E2]M[/E2]) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[128, 129]], "entity_1_idx_in_text_with_entity_marker": [132, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[184, 185]], "entity_2_idx_in_text_with_entity_marker": [197, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p1", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, [E1]nucleocapsid[/E1] (N) and matrix ([E2]M[/E2]) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[155, 167], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [159, 171], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[184, 185]], "entity_2_idx_in_text_with_entity_marker": [197, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p2", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein ([E1]P[/E1]), H, nucleocapsid (N) and matrix ([E2]M[/E2]) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[148, 149]], "entity_1_idx_in_text_with_entity_marker": [152, 153], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[184, 185]], "entity_2_idx_in_text_with_entity_marker": [197, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p3", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid ([E1]N[/E1]) and matrix ([E2]M[/E2]) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[169, 170]], "entity_1_idx_in_text_with_entity_marker": [173, 174], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[184, 185]], "entity_2_idx_in_text_with_entity_marker": [197, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p4", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), [E1]H[/E1], nucleocapsid (N) and matrix ([E2]M[/E2]) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[152, 153], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [156, 157], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "M", "entity_2_idx": [[184, 185]], "entity_2_idx_in_text_with_entity_marker": [197, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p5", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the [E1]fusion[/E1] (F), phosphoprotein (P), H, nucleocapsid (N) and matrix ([E2]M[/E2]) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[120, 126], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[184, 185]], "entity_2_idx_in_text_with_entity_marker": [197, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p6", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and [E1]matrix[/E1] ([E2]M[/E2]) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix", "entity_1_idx": [[176, 182], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [180, 186], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[184, 185]], "entity_2_idx_in_text_with_entity_marker": [197, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p7", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), [E1]phosphoprotein[/E1] (P), H, nucleocapsid (N) and matrix ([E2]M[/E2]) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[132, 146], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [136, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[184, 185]], "entity_2_idx_in_text_with_entity_marker": [197, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p8", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion ([E1]F[/E1]), phosphoprotein (P), H, [E2]nucleocapsid[/E2] (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[128, 129]], "entity_1_idx_in_text_with_entity_marker": [132, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid", "entity_2_idx": [[155, 167], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [168, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p9", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion ([E1]F[/E1]), phosphoprotein ([E2]P[/E2]), H, nucleocapsid (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[128, 129]], "entity_1_idx_in_text_with_entity_marker": [132, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[148, 149]], "entity_2_idx_in_text_with_entity_marker": [161, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p50", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), [E1]phosphoprotein[/E1] (P; 49 kDa), [E2]matrix[/E2] (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[273, 287], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [277, 291], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[301, 307], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [314, 320], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p51", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein ([E1]P[/E1]; 49 kDa), [E2]matrix[/E2] (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[289, 290]], "entity_1_idx_in_text_with_entity_marker": [293, 294], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[301, 307], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [314, 320], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p52", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), [E1]matrix[/E1] (M; 43 kDa) and non-structural ([E2]V[/E2]; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix", "entity_1_idx": [[301, 307], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [305, 311], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[340, 341]], "entity_2_idx_in_text_with_entity_marker": [353, 354], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p53", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid ([E1]N[/E1]; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), [E2]matrix[/E2] (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[240, 241]], "entity_1_idx_in_text_with_entity_marker": [244, 245], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[301, 307], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [314, 320], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p54", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), [E1]matrix[/E1] ([E2]M[/E2]; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix", "entity_1_idx": [[301, 307], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [305, 311], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[309, 310]], "entity_2_idx_in_text_with_entity_marker": [322, 323], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p55", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] (L; 190 kDa), haemagglutinin neuraminidase ([E2]HN[/E2]; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[213, 215]], "entity_2_idx_in_text_with_entity_marker": [226, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p56", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase ([E1]HN[/E1]; 74 kDa), [E2]nucleocapsid[/E2] (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HN", "entity_1_idx": [[213, 215]], "entity_1_idx_in_text_with_entity_marker": [217, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid", "entity_2_idx": [[226, 238], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [239, 251], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p57", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), [E1]haemagglutinin neuraminidase[/E1] ([E2]HN[/E2]; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin neuraminidase", "entity_1_idx": [[183, 211], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [187, 215], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[213, 215]], "entity_2_idx_in_text_with_entity_marker": [226, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p58", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase ([E1]HN[/E1]; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), [E2]phosphoprotein[/E2] (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HN", "entity_1_idx": [[213, 215]], "entity_1_idx_in_text_with_entity_marker": [217, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[273, 287], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [286, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p59", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase ([E1]HN[/E1]; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein ([E2]P[/E2]; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HN", "entity_1_idx": [[213, 215]], "entity_1_idx_in_text_with_entity_marker": [217, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[289, 290]], "entity_2_idx_in_text_with_entity_marker": [302, 303], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d275.s0_BioInfer.d275.s0.p0", "text": "However, smooth muscle contents of actin (26.0 +/- 1.8 vs. 19.1 +/- 2.2 micrograms/mg wet wt) and myosin heavy chain (5.5 +/- 0.4 vs. 2.0 +/- 0.3 microgram/mg wet wt) were greater (P < 0.04) in myometrium from late-pregnant vs. nonpregnant ewes.", "text_with_entity_marker": "However, smooth muscle contents of [E1]actin[/E1] (26.0 +/- 1.8 vs. 19.1 +/- 2.2 micrograms/mg wet wt) and [E2]myosin heavy chain[/E2] (5.5 +/- 0.4 vs. 2.0 +/- 0.3 microgram/mg wet wt) were greater (P < 0.04) in myometrium from late-pregnant vs. nonpregnant ewes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[35, 40]], "entity_1_idx_in_text_with_entity_marker": [39, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[98, 116]], "entity_2_idx_in_text_with_entity_marker": [111, 129], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d75.s0_BioInfer.d75.s0.p0", "text": "A reconstitution is described that requires not only the growth factor, its receptor with tyrosine kinase activity, and the soluble phospholipase C-gamma 1, but also the small soluble actin-binding protein profilin.", "text_with_entity_marker": "A reconstitution is described that requires not only the growth factor, its receptor with tyrosine kinase activity, and the soluble [E1]phospholipase C-gamma 1[/E1], but also the small soluble [E2]actin-binding protein[/E2] profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phospholipase C-gamma 1", "entity_1_idx": [[132, 155]], "entity_1_idx_in_text_with_entity_marker": [136, 159], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin-binding protein", "entity_2_idx": [[184, 205]], "entity_2_idx_in_text_with_entity_marker": [197, 218], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d75.s0_BioInfer.d75.s0.p1", "text": "A reconstitution is described that requires not only the growth factor, its receptor with tyrosine kinase activity, and the soluble phospholipase C-gamma 1, but also the small soluble actin-binding protein profilin.", "text_with_entity_marker": "A reconstitution is described that requires not only the growth factor, its receptor with tyrosine kinase activity, and the soluble [E1]phospholipase C-gamma 1[/E1], but also the small soluble actin-binding protein [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phospholipase C-gamma 1", "entity_1_idx": [[132, 155]], "entity_1_idx_in_text_with_entity_marker": [136, 159], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[206, 214]], "entity_2_idx_in_text_with_entity_marker": [219, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d75.s0_BioInfer.d75.s0.p2", "text": "A reconstitution is described that requires not only the growth factor, its receptor with tyrosine kinase activity, and the soluble phospholipase C-gamma 1, but also the small soluble actin-binding protein profilin.", "text_with_entity_marker": "A reconstitution is described that requires not only the growth factor, its receptor with [E1]tyrosine kinase[/E1] activity, and the soluble [E2]phospholipase C-gamma 1[/E2], but also the small soluble actin-binding protein profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tyrosine kinase", "entity_1_idx": [[90, 105]], "entity_1_idx_in_text_with_entity_marker": [94, 109], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "phospholipase C-gamma 1", "entity_2_idx": [[132, 155]], "entity_2_idx_in_text_with_entity_marker": [145, 168], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d75.s0_BioInfer.d75.s0.p3", "text": "A reconstitution is described that requires not only the growth factor, its receptor with tyrosine kinase activity, and the soluble phospholipase C-gamma 1, but also the small soluble actin-binding protein profilin.", "text_with_entity_marker": "A reconstitution is described that requires not only the growth factor, its receptor with tyrosine kinase activity, and the soluble phospholipase C-gamma 1, but also the small soluble [E1]actin-binding protein[/E1] [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding protein", "entity_1_idx": [[184, 205]], "entity_1_idx_in_text_with_entity_marker": [188, 209], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[206, 214]], "entity_2_idx_in_text_with_entity_marker": [219, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d75.s0_BioInfer.d75.s0.p4", "text": "A reconstitution is described that requires not only the growth factor, its receptor with tyrosine kinase activity, and the soluble phospholipase C-gamma 1, but also the small soluble actin-binding protein profilin.", "text_with_entity_marker": "A reconstitution is described that requires not only the growth factor, its receptor with [E1]tyrosine kinase[/E1] activity, and the soluble phospholipase C-gamma 1, but also the small soluble [E2]actin-binding protein[/E2] profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tyrosine kinase", "entity_1_idx": [[90, 105]], "entity_1_idx_in_text_with_entity_marker": [94, 109], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin-binding protein", "entity_2_idx": [[184, 205]], "entity_2_idx_in_text_with_entity_marker": [197, 218], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d75.s0_BioInfer.d75.s0.p5", "text": "A reconstitution is described that requires not only the growth factor, its receptor with tyrosine kinase activity, and the soluble phospholipase C-gamma 1, but also the small soluble actin-binding protein profilin.", "text_with_entity_marker": "A reconstitution is described that requires not only the growth factor, its receptor with [E1]tyrosine kinase[/E1] activity, and the soluble phospholipase C-gamma 1, but also the small soluble actin-binding protein [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tyrosine kinase", "entity_1_idx": [[90, 105]], "entity_1_idx_in_text_with_entity_marker": [94, 109], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[206, 214]], "entity_2_idx_in_text_with_entity_marker": [219, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d481.s0_BioInfer.d481.s0.p0", "text": "Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, talin and beta 1-integrin.", "text_with_entity_marker": "Particle aggregates associated with this array of [E1]actin[/E1] microfilaments also labeled with antibodies to vinculin, [E2]talin[/E2] and beta 1-integrin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[50, 55]], "entity_1_idx_in_text_with_entity_marker": [54, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[113, 118]], "entity_2_idx_in_text_with_entity_marker": [126, 131], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d481.s0_BioInfer.d481.s0.p1", "text": "Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, talin and beta 1-integrin.", "text_with_entity_marker": "Particle aggregates associated with this array of [E1]actin[/E1] microfilaments also labeled with antibodies to [E2]vinculin[/E2], talin and beta 1-integrin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[50, 55]], "entity_1_idx_in_text_with_entity_marker": [54, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[103, 111]], "entity_2_idx_in_text_with_entity_marker": [116, 124], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d481.s0_BioInfer.d481.s0.p2", "text": "Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, talin and beta 1-integrin.", "text_with_entity_marker": "Particle aggregates associated with this array of [E1]actin[/E1] microfilaments also labeled with antibodies to vinculin, talin and [E2]beta 1-integrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[50, 55]], "entity_1_idx_in_text_with_entity_marker": [54, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta 1-integrin", "entity_2_idx": [[123, 138]], "entity_2_idx_in_text_with_entity_marker": [136, 151], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d481.s0_BioInfer.d481.s0.p3", "text": "Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, talin and beta 1-integrin.", "text_with_entity_marker": "Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to [E1]vinculin[/E1], [E2]talin[/E2] and beta 1-integrin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[103, 111]], "entity_1_idx_in_text_with_entity_marker": [107, 115], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[113, 118]], "entity_2_idx_in_text_with_entity_marker": [126, 131], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d481.s0_BioInfer.d481.s0.p4", "text": "Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, talin and beta 1-integrin.", "text_with_entity_marker": "Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, [E1]talin[/E1] and [E2]beta 1-integrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[113, 118]], "entity_1_idx_in_text_with_entity_marker": [117, 122], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta 1-integrin", "entity_2_idx": [[123, 138]], "entity_2_idx_in_text_with_entity_marker": [136, 151], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d481.s0_BioInfer.d481.s0.p5", "text": "Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, talin and beta 1-integrin.", "text_with_entity_marker": "Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to [E1]vinculin[/E1], talin and [E2]beta 1-integrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[103, 111]], "entity_1_idx_in_text_with_entity_marker": [107, 115], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta 1-integrin", "entity_2_idx": [[123, 138]], "entity_2_idx_in_text_with_entity_marker": [136, 151], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d470.s0_BioInfer.d470.s0.p0", "text": "p53-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of TnI.", "text_with_entity_marker": "[E1]p53[/E1]-mediated cell injury exhibited proteolysis of the [E2]caspase[/E2] protein substrate lamin B without appreciable breakdown of TnI.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p53", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "caspase", "entity_2_idx": [[54, 61]], "entity_2_idx_in_text_with_entity_marker": [67, 74], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d470.s0_BioInfer.d470.s0.p1", "text": "p53-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of TnI.", "text_with_entity_marker": "[E1]p53[/E1]-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of [E2]TnI[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p53", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TnI", "entity_2_idx": [[121, 124]], "entity_2_idx_in_text_with_entity_marker": [134, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d470.s0_BioInfer.d470.s0.p2", "text": "p53-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of TnI.", "text_with_entity_marker": "[E1]p53[/E1]-mediated cell injury exhibited proteolysis of the caspase protein substrate [E2]lamin B[/E2] without appreciable breakdown of TnI.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p53", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "lamin B", "entity_2_idx": [[80, 87]], "entity_2_idx_in_text_with_entity_marker": [93, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d470.s0_BioInfer.d470.s0.p3", "text": "p53-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of TnI.", "text_with_entity_marker": "p53-mediated cell injury exhibited proteolysis of the [E1]caspase[/E1] protein substrate lamin B without appreciable breakdown of [E2]TnI[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "caspase", "entity_1_idx": [[54, 61]], "entity_1_idx_in_text_with_entity_marker": [58, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TnI", "entity_2_idx": [[121, 124]], "entity_2_idx_in_text_with_entity_marker": [134, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d470.s0_BioInfer.d470.s0.p4", "text": "p53-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of TnI.", "text_with_entity_marker": "p53-mediated cell injury exhibited proteolysis of the [E1]caspase[/E1] protein substrate [E2]lamin B[/E2] without appreciable breakdown of TnI.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "caspase", "entity_1_idx": [[54, 61]], "entity_1_idx_in_text_with_entity_marker": [58, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "lamin B", "entity_2_idx": [[80, 87]], "entity_2_idx_in_text_with_entity_marker": [93, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d470.s0_BioInfer.d470.s0.p5", "text": "p53-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of TnI.", "text_with_entity_marker": "p53-mediated cell injury exhibited proteolysis of the caspase protein substrate [E1]lamin B[/E1] without appreciable breakdown of [E2]TnI[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "lamin B", "entity_1_idx": [[80, 87]], "entity_1_idx_in_text_with_entity_marker": [84, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TnI", "entity_2_idx": [[121, 124]], "entity_2_idx_in_text_with_entity_marker": [134, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d402.s0_BioInfer.d402.s0.p0", "text": "Like actin, the actin-associated proteins filamin, talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "text_with_entity_marker": "Like actin, the actin-associated proteins filamin, [E1]talin[/E1] and the [E2]beta 1 integrin subunit[/E2] were also found to accumulate around entering bacteria.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta 1 integrin subunit", "entity_2_idx": [[65, 88]], "entity_2_idx_in_text_with_entity_marker": [78, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d402.s0_BioInfer.d402.s0.p1", "text": "Like actin, the actin-associated proteins filamin, talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "text_with_entity_marker": "Like actin, the actin-associated proteins [E1]filamin[/E1], talin and the [E2]beta 1 integrin subunit[/E2] were also found to accumulate around entering bacteria.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "filamin", "entity_1_idx": [[42, 49]], "entity_1_idx_in_text_with_entity_marker": [46, 53], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta 1 integrin subunit", "entity_2_idx": [[65, 88]], "entity_2_idx_in_text_with_entity_marker": [78, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d402.s0_BioInfer.d402.s0.p2", "text": "Like actin, the actin-associated proteins filamin, talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "text_with_entity_marker": "Like actin, the [E1]actin[/E1]-associated proteins filamin, talin and the [E2]beta 1 integrin subunit[/E2] were also found to accumulate around entering bacteria.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta 1 integrin subunit", "entity_2_idx": [[65, 88]], "entity_2_idx_in_text_with_entity_marker": [78, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d402.s0_BioInfer.d402.s0.p3", "text": "Like actin, the actin-associated proteins filamin, talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "text_with_entity_marker": "Like [E1]actin[/E1], the actin-associated proteins filamin, talin and the [E2]beta 1 integrin subunit[/E2] were also found to accumulate around entering bacteria.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[5, 10]], "entity_1_idx_in_text_with_entity_marker": [9, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta 1 integrin subunit", "entity_2_idx": [[65, 88]], "entity_2_idx_in_text_with_entity_marker": [78, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d402.s0_BioInfer.d402.s0.p4", "text": "Like actin, the actin-associated proteins filamin, talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "text_with_entity_marker": "Like actin, the actin-associated proteins [E1]filamin[/E1], [E2]talin[/E2] and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "filamin", "entity_1_idx": [[42, 49]], "entity_1_idx_in_text_with_entity_marker": [46, 53], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[51, 56]], "entity_2_idx_in_text_with_entity_marker": [64, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d402.s0_BioInfer.d402.s0.p5", "text": "Like actin, the actin-associated proteins filamin, talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "text_with_entity_marker": "Like actin, the [E1]actin[/E1]-associated proteins filamin, [E2]talin[/E2] and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[51, 56]], "entity_2_idx_in_text_with_entity_marker": [64, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d402.s0_BioInfer.d402.s0.p6", "text": "Like actin, the actin-associated proteins filamin, talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "text_with_entity_marker": "Like [E1]actin[/E1], the actin-associated proteins filamin, [E2]talin[/E2] and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[5, 10]], "entity_1_idx_in_text_with_entity_marker": [9, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[51, 56]], "entity_2_idx_in_text_with_entity_marker": [64, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d402.s0_BioInfer.d402.s0.p7", "text": "Like actin, the actin-associated proteins filamin, talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "text_with_entity_marker": "Like actin, the [E1]actin[/E1]-associated proteins [E2]filamin[/E2], talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "filamin", "entity_2_idx": [[42, 49]], "entity_2_idx_in_text_with_entity_marker": [55, 62], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d402.s0_BioInfer.d402.s0.p8", "text": "Like actin, the actin-associated proteins filamin, talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "text_with_entity_marker": "Like [E1]actin[/E1], the actin-associated proteins [E2]filamin[/E2], talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[5, 10]], "entity_1_idx_in_text_with_entity_marker": [9, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "filamin", "entity_2_idx": [[42, 49]], "entity_2_idx_in_text_with_entity_marker": [55, 62], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d402.s0_BioInfer.d402.s0.p9", "text": "Like actin, the actin-associated proteins filamin, talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "text_with_entity_marker": "Like [E1]actin[/E1], the [E2]actin[/E2]-associated proteins filamin, talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[5, 10]], "entity_1_idx_in_text_with_entity_marker": [9, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[16, 21]], "entity_2_idx_in_text_with_entity_marker": [29, 34], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p20", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of [E1]MKK1[/E1] (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and [E2]MID2[/E2] also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MKK1", "entity_1_idx": [[100, 104]], "entity_1_idx_in_text_with_entity_marker": [104, 108], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MID2", "entity_2_idx": [[290, 294]], "entity_2_idx_in_text_with_entity_marker": [303, 307], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p21", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of [E1]MKK1[/E1] (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, [E2]RHO2[/E2], HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MKK1", "entity_1_idx": [[100, 104]], "entity_1_idx_in_text_with_entity_marker": [104, 108], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RHO2", "entity_2_idx": [[264, 268]], "entity_2_idx_in_text_with_entity_marker": [277, 281], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p22", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of [E1]MKK1[/E1] (MEK) or [E2]MPK1[/E2] (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MKK1", "entity_1_idx": [[100, 104]], "entity_1_idx_in_text_with_entity_marker": [104, 108], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MPK1", "entity_2_idx": [[114, 118]], "entity_2_idx_in_text_with_entity_marker": [127, 131], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p23", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of [E1]MKK1[/E1] (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as [E2]ROM2[/E2], RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MKK1", "entity_1_idx": [[100, 104]], "entity_1_idx_in_text_with_entity_marker": [104, 108], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "ROM2", "entity_2_idx": [[258, 262]], "entity_2_idx_in_text_with_entity_marker": [271, 275], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p24", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of [E1]MKK1[/E1] (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed [E2]glc7-10[/E2] effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MKK1", "entity_1_idx": [[100, 104]], "entity_1_idx_in_text_with_entity_marker": [104, 108], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[311, 318]], "entity_2_idx_in_text_with_entity_marker": [324, 331], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p25", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of [E1]MKK1[/E1] (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a [E2]glc7-10[/E2] dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MKK1", "entity_1_idx": [[100, 104]], "entity_1_idx_in_text_with_entity_marker": [104, 108], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[151, 158]], "entity_2_idx_in_text_with_entity_marker": [164, 171], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p26", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of [E1]MKK1[/E1] (MEK) or MPK1 (MAP kinase) mimicked [E2]PKC1[/E2] as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MKK1", "entity_1_idx": [[100, 104]], "entity_1_idx_in_text_with_entity_marker": [104, 108], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "PKC1", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p27", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of [E1]MKK1[/E1] (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/[E2]SLG1[/E2] and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MKK1", "entity_1_idx": [[100, 104]], "entity_1_idx_in_text_with_entity_marker": [104, 108], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SLG1", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p28", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 ([E1]MEKK[/E1]) by the dominant BCK1-20 mutation nor increased dosage of [E2]MKK1[/E2] (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEKK", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "MKK1", "entity_2_idx": [[100, 104]], "entity_2_idx_in_text_with_entity_marker": [113, 117], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p29", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of [E1]MKK1[/E1] ([E2]MEK[/E2]) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MKK1", "entity_1_idx": [[100, 104]], "entity_1_idx_in_text_with_entity_marker": [104, 108], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MEK", "entity_2_idx": [[106, 109]], "entity_2_idx_in_text_with_entity_marker": [119, 122], "entity_2_type": "DNA_family_or_group", "entity_2_type_id": 4}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p100", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or [E1]MPK1[/E1] (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as [E2]ROM2[/E2], RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MPK1", "entity_1_idx": [[114, 118]], "entity_1_idx_in_text_with_entity_marker": [118, 122], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "ROM2", "entity_2_idx": [[258, 262]], "entity_2_idx_in_text_with_entity_marker": [271, 275], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p101", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or [E1]MPK1[/E1] (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed [E2]glc7-10[/E2] effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MPK1", "entity_1_idx": [[114, 118]], "entity_1_idx_in_text_with_entity_marker": [118, 122], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[311, 318]], "entity_2_idx_in_text_with_entity_marker": [324, 331], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p102", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or [E1]MPK1[/E1] (MAP kinase) mimicked PKC1 as a [E2]glc7-10[/E2] dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MPK1", "entity_1_idx": [[114, 118]], "entity_1_idx_in_text_with_entity_marker": [118, 122], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[151, 158]], "entity_2_idx_in_text_with_entity_marker": [164, 171], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p103", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or [E1]MPK1[/E1] (MAP kinase) mimicked [E2]PKC1[/E2] as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MPK1", "entity_1_idx": [[114, 118]], "entity_1_idx_in_text_with_entity_marker": [118, 122], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "PKC1", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p104", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or [E1]MPK1[/E1] (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/[E2]SLG1[/E2] and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MPK1", "entity_1_idx": [[114, 118]], "entity_1_idx_in_text_with_entity_marker": [118, 122], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SLG1", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p105", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 ([E1]MEKK[/E1]) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or [E2]MPK1[/E2] (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEKK", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "MPK1", "entity_2_idx": [[114, 118]], "entity_2_idx_in_text_with_entity_marker": [127, 131], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p106", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 ([E1]MEK[/E1]) or [E2]MPK1[/E2] (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEK", "entity_1_idx": [[106, 109]], "entity_1_idx_in_text_with_entity_marker": [110, 113], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "MPK1", "entity_2_idx": [[114, 118]], "entity_2_idx_in_text_with_entity_marker": [127, 131], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p107", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or [E1]MPK1[/E1] ([E2]MAP kinase[/E2]) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MPK1", "entity_1_idx": [[114, 118]], "entity_1_idx_in_text_with_entity_marker": [118, 122], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MAP kinase", "entity_2_idx": [[120, 130]], "entity_2_idx_in_text_with_entity_marker": [133, 143], "entity_2_type": "DNA_family_or_group", "entity_2_type_id": 4}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p108", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as [E1]ROM2[/E1], RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed [E2]glc7-10[/E2] effectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ROM2", "entity_1_idx": [[258, 262]], "entity_1_idx_in_text_with_entity_marker": [262, 266], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[311, 318]], "entity_2_idx_in_text_with_entity_marker": [324, 331], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p109", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a [E1]glc7-10[/E1] dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as [E2]ROM2[/E2], RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "glc7-10", "entity_1_idx": [[151, 158]], "entity_1_idx_in_text_with_entity_marker": [155, 162], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "ROM2", "entity_2_idx": [[258, 262]], "entity_2_idx_in_text_with_entity_marker": [271, 275], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p130", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 ([E1]MEKK[/E1]) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/[E2]SLG1[/E2] and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEKK", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "SLG1", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p131", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 ([E1]MEK[/E1]) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/[E2]SLG1[/E2] and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEK", "entity_1_idx": [[106, 109]], "entity_1_idx_in_text_with_entity_marker": [110, 113], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "SLG1", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p132", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 ([E1]MAP kinase[/E1]) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/[E2]SLG1[/E2] and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MAP kinase", "entity_1_idx": [[120, 130]], "entity_1_idx_in_text_with_entity_marker": [124, 134], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "SLG1", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p133", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 ([E1]MEKK[/E1]) by the dominant BCK1-20 mutation nor increased dosage of MKK1 ([E2]MEK[/E2]) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEKK", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "MEK", "entity_2_idx": [[106, 109]], "entity_2_idx_in_text_with_entity_marker": [119, 122], "entity_2_type": "DNA_family_or_group", "entity_2_type_id": 4}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p134", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 ([E1]MEKK[/E1]) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 ([E2]MAP kinase[/E2]) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEKK", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "MAP kinase", "entity_2_idx": [[120, 130]], "entity_2_idx_in_text_with_entity_marker": [133, 143], "entity_2_type": "DNA_family_or_group", "entity_2_type_id": 4}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p135", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 ([E1]MEK[/E1]) or MPK1 ([E2]MAP kinase[/E2]) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEK", "entity_1_idx": [[106, 109]], "entity_1_idx_in_text_with_entity_marker": [110, 113], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "MAP kinase", "entity_2_idx": [[120, 130]], "entity_2_idx_in_text_with_entity_marker": [133, 143], "entity_2_type": "DNA_family_or_group", "entity_2_type_id": 4}], "directed": false, "reverse": false}
{"id": "BioInfer.d534.s0_BioInfer.d534.s0.p0", "text": "Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.", "text_with_entity_marker": "Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and [E1]plakoglobin[/E1], are tightly associated with these [E2]cadherins[/E2] and serve to link them to the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[91, 102]], "entity_1_idx_in_text_with_entity_marker": [95, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherins", "entity_2_idx": [[138, 147]], "entity_2_idx_in_text_with_entity_marker": [151, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d534.s0_BioInfer.d534.s0.p1", "text": "Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.", "text_with_entity_marker": "Several intracellular proteins termed [E1]catenins[/E1], including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these [E2]cadherins[/E2] and serve to link them to the cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "catenins", "entity_1_idx": [[38, 46]], "entity_1_idx_in_text_with_entity_marker": [42, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherins", "entity_2_idx": [[138, 147]], "entity_2_idx_in_text_with_entity_marker": [151, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d534.s0_BioInfer.d534.s0.p2", "text": "Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.", "text_with_entity_marker": "Several intracellular proteins termed catenins, including [E1]alpha-catenin[/E1], beta-catenin, and plakoglobin, are tightly associated with these [E2]cadherins[/E2] and serve to link them to the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[58, 71]], "entity_1_idx_in_text_with_entity_marker": [62, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherins", "entity_2_idx": [[138, 147]], "entity_2_idx_in_text_with_entity_marker": [151, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d534.s0_BioInfer.d534.s0.p3", "text": "Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.", "text_with_entity_marker": "Several intracellular proteins termed catenins, including alpha-catenin, [E1]beta-catenin[/E1], and plakoglobin, are tightly associated with these [E2]cadherins[/E2] and serve to link them to the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[73, 85]], "entity_1_idx_in_text_with_entity_marker": [77, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherins", "entity_2_idx": [[138, 147]], "entity_2_idx_in_text_with_entity_marker": [151, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d534.s0_BioInfer.d534.s0.p4", "text": "Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.", "text_with_entity_marker": "Several intracellular proteins termed [E1]catenins[/E1], including alpha-catenin, beta-catenin, and [E2]plakoglobin[/E2], are tightly associated with these cadherins and serve to link them to the cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "catenins", "entity_1_idx": [[38, 46]], "entity_1_idx_in_text_with_entity_marker": [42, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[91, 102]], "entity_2_idx_in_text_with_entity_marker": [104, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d534.s0_BioInfer.d534.s0.p5", "text": "Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.", "text_with_entity_marker": "Several intracellular proteins termed catenins, including [E1]alpha-catenin[/E1], beta-catenin, and [E2]plakoglobin[/E2], are tightly associated with these cadherins and serve to link them to the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[58, 71]], "entity_1_idx_in_text_with_entity_marker": [62, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[91, 102]], "entity_2_idx_in_text_with_entity_marker": [104, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d534.s0_BioInfer.d534.s0.p6", "text": "Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.", "text_with_entity_marker": "Several intracellular proteins termed catenins, including alpha-catenin, [E1]beta-catenin[/E1], and [E2]plakoglobin[/E2], are tightly associated with these cadherins and serve to link them to the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[73, 85]], "entity_1_idx_in_text_with_entity_marker": [77, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[91, 102]], "entity_2_idx_in_text_with_entity_marker": [104, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d534.s0_BioInfer.d534.s0.p7", "text": "Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.", "text_with_entity_marker": "Several intracellular proteins termed [E1]catenins[/E1], including [E2]alpha-catenin[/E2], beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "catenins", "entity_1_idx": [[38, 46]], "entity_1_idx_in_text_with_entity_marker": [42, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[58, 71]], "entity_2_idx_in_text_with_entity_marker": [71, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d534.s0_BioInfer.d534.s0.p8", "text": "Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.", "text_with_entity_marker": "Several intracellular proteins termed [E1]catenins[/E1], including alpha-catenin, [E2]beta-catenin[/E2], and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "catenins", "entity_1_idx": [[38, 46]], "entity_1_idx_in_text_with_entity_marker": [42, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[73, 85]], "entity_2_idx_in_text_with_entity_marker": [86, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d534.s0_BioInfer.d534.s0.p9", "text": "Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.", "text_with_entity_marker": "Several intracellular proteins termed catenins, including [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[58, 71]], "entity_1_idx_in_text_with_entity_marker": [62, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[73, 85]], "entity_2_idx_in_text_with_entity_marker": [86, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d353.s0_BioInfer.d353.s0.p0", "text": "In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast RAD51, RAD52, and RAD54 genes.", "text_with_entity_marker": "In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast [E1]RAD51[/E1], RAD52, and [E2]RAD54[/E2] genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[140, 145]], "entity_1_idx_in_text_with_entity_marker": [144, 149], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[158, 163]], "entity_2_idx_in_text_with_entity_marker": [171, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d353.s0_BioInfer.d353.s0.p1", "text": "In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast RAD51, RAD52, and RAD54 genes.", "text_with_entity_marker": "In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast RAD51, [E1]RAD52[/E1], and [E2]RAD54[/E2] genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[147, 152]], "entity_1_idx_in_text_with_entity_marker": [151, 156], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[158, 163]], "entity_2_idx_in_text_with_entity_marker": [171, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d353.s0_BioInfer.d353.s0.p2", "text": "In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast RAD51, RAD52, and RAD54 genes.", "text_with_entity_marker": "In search for genes which might participate in chicken [E1]immunoglobulin[/E1] gene conversion, we have identified chicken counterparts of the yeast RAD51, RAD52, and [E2]RAD54[/E2] genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "immunoglobulin", "entity_1_idx": [[55, 69]], "entity_1_idx_in_text_with_entity_marker": [59, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[158, 163]], "entity_2_idx_in_text_with_entity_marker": [171, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d353.s0_BioInfer.d353.s0.p3", "text": "In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast RAD51, RAD52, and RAD54 genes.", "text_with_entity_marker": "In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast [E1]RAD51[/E1], [E2]RAD52[/E2], and RAD54 genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[140, 145]], "entity_1_idx_in_text_with_entity_marker": [144, 149], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d353.s0_BioInfer.d353.s0.p4", "text": "In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast RAD51, RAD52, and RAD54 genes.", "text_with_entity_marker": "In search for genes which might participate in chicken [E1]immunoglobulin[/E1] gene conversion, we have identified chicken counterparts of the yeast [E2]RAD51[/E2], RAD52, and RAD54 genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "immunoglobulin", "entity_1_idx": [[55, 69]], "entity_1_idx_in_text_with_entity_marker": [59, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[140, 145]], "entity_2_idx_in_text_with_entity_marker": [153, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d353.s0_BioInfer.d353.s0.p5", "text": "In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast RAD51, RAD52, and RAD54 genes.", "text_with_entity_marker": "In search for genes which might participate in chicken [E1]immunoglobulin[/E1] gene conversion, we have identified chicken counterparts of the yeast RAD51, [E2]RAD52[/E2], and RAD54 genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "immunoglobulin", "entity_1_idx": [[55, 69]], "entity_1_idx_in_text_with_entity_marker": [59, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d642.s0_BioInfer.d642.s0.p0", "text": "The map locates the N-terminal calcium-binding domain and identifies actin-binding site residues on the two calponin-homology domains of fimbrin.", "text_with_entity_marker": "The map locates the N-terminal calcium-binding domain and identifies [E1]actin[/E1]-binding site residues on the two [E2]calponin[/E2]-homology domains of fimbrin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[69, 74]], "entity_1_idx_in_text_with_entity_marker": [73, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calponin", "entity_2_idx": [[108, 116]], "entity_2_idx_in_text_with_entity_marker": [121, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d642.s0_BioInfer.d642.s0.p1", "text": "The map locates the N-terminal calcium-binding domain and identifies actin-binding site residues on the two calponin-homology domains of fimbrin.", "text_with_entity_marker": "The map locates the N-terminal calcium-binding domain and identifies actin-binding site residues on the two [E1]calponin[/E1]-homology domains of [E2]fimbrin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "calponin", "entity_1_idx": [[108, 116]], "entity_1_idx_in_text_with_entity_marker": [112, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[137, 144]], "entity_2_idx_in_text_with_entity_marker": [150, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d642.s0_BioInfer.d642.s0.p2", "text": "The map locates the N-terminal calcium-binding domain and identifies actin-binding site residues on the two calponin-homology domains of fimbrin.", "text_with_entity_marker": "The map locates the N-terminal calcium-binding domain and identifies [E1]actin[/E1]-binding site residues on the two calponin-homology domains of [E2]fimbrin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[69, 74]], "entity_1_idx_in_text_with_entity_marker": [73, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[137, 144]], "entity_2_idx_in_text_with_entity_marker": [150, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s0_BioInfer.d245.s0.p0", "text": "Here we have now identified the reciprocal complementary binding site in alpha-catenin which mediates its interaction with beta-catenin and plakoglobin.", "text_with_entity_marker": "Here we have now identified the reciprocal complementary binding site in [E1]alpha-catenin[/E1] which mediates its interaction with [E2]beta-catenin[/E2] and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[73, 86]], "entity_1_idx_in_text_with_entity_marker": [77, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[123, 135]], "entity_2_idx_in_text_with_entity_marker": [136, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s0_BioInfer.d245.s0.p1", "text": "Here we have now identified the reciprocal complementary binding site in alpha-catenin which mediates its interaction with beta-catenin and plakoglobin.", "text_with_entity_marker": "Here we have now identified the reciprocal complementary binding site in [E1]alpha-catenin[/E1] which mediates its interaction with beta-catenin and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[73, 86]], "entity_1_idx_in_text_with_entity_marker": [77, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[140, 151]], "entity_2_idx_in_text_with_entity_marker": [153, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s0_BioInfer.d245.s0.p2", "text": "Here we have now identified the reciprocal complementary binding site in alpha-catenin which mediates its interaction with beta-catenin and plakoglobin.", "text_with_entity_marker": "Here we have now identified the reciprocal complementary binding site in alpha-catenin which mediates its interaction with [E1]beta-catenin[/E1] and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[123, 135]], "entity_1_idx_in_text_with_entity_marker": [127, 139], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[140, 151]], "entity_2_idx_in_text_with_entity_marker": [153, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s1_BioInfer.d245.s1.p0", "text": "It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or plakoglobin, which both can assemble alpha-catenin into the complex.", "text_with_entity_marker": "It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or [E1]plakoglobin[/E1], which both can assemble [E2]alpha-catenin[/E2] into the complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "plakoglobin", "entity_1_idx": [[94, 105]], "entity_1_idx_in_text_with_entity_marker": [98, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[131, 144]], "entity_2_idx_in_text_with_entity_marker": [144, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s1_BioInfer.d245.s1.p1", "text": "It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or plakoglobin, which both can assemble alpha-catenin into the complex.", "text_with_entity_marker": "It is well established that the cytoplasmic domain of E-cadherin binds either [E1]beta-catenin[/E1] or [E2]plakoglobin[/E2], which both can assemble alpha-catenin into the complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[78, 90]], "entity_1_idx_in_text_with_entity_marker": [82, 94], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[94, 105]], "entity_2_idx_in_text_with_entity_marker": [107, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s1_BioInfer.d245.s1.p2", "text": "It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or plakoglobin, which both can assemble alpha-catenin into the complex.", "text_with_entity_marker": "It is well established that the cytoplasmic domain of [E1]E-cadherin[/E1] binds either beta-catenin or [E2]plakoglobin[/E2], which both can assemble alpha-catenin into the complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[94, 105]], "entity_2_idx_in_text_with_entity_marker": [107, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s1_BioInfer.d245.s1.p3", "text": "It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or plakoglobin, which both can assemble alpha-catenin into the complex.", "text_with_entity_marker": "It is well established that the cytoplasmic domain of E-cadherin binds either [E1]beta-catenin[/E1] or plakoglobin, which both can assemble [E2]alpha-catenin[/E2] into the complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[78, 90]], "entity_1_idx_in_text_with_entity_marker": [82, 94], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[131, 144]], "entity_2_idx_in_text_with_entity_marker": [144, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s1_BioInfer.d245.s1.p4", "text": "It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or plakoglobin, which both can assemble alpha-catenin into the complex.", "text_with_entity_marker": "It is well established that the cytoplasmic domain of [E1]E-cadherin[/E1] binds either beta-catenin or plakoglobin, which both can assemble [E2]alpha-catenin[/E2] into the complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[131, 144]], "entity_2_idx_in_text_with_entity_marker": [144, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s1_BioInfer.d245.s1.p5", "text": "It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or plakoglobin, which both can assemble alpha-catenin into the complex.", "text_with_entity_marker": "It is well established that the cytoplasmic domain of [E1]E-cadherin[/E1] binds either [E2]beta-catenin[/E2] or plakoglobin, which both can assemble alpha-catenin into the complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[78, 90]], "entity_2_idx_in_text_with_entity_marker": [91, 103], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s2_BioInfer.d245.s2.p0", "text": "Recently we have identified an alpha-catenin binding site in beta-catenin and plakoglobin and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.", "text_with_entity_marker": "Recently we have identified an [E1]alpha-catenin[/E1] binding site in [E2]beta-catenin[/E2] and plakoglobin and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[31, 44]], "entity_1_idx_in_text_with_entity_marker": [35, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[61, 73]], "entity_2_idx_in_text_with_entity_marker": [74, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s2_BioInfer.d245.s2.p1", "text": "Recently we have identified an alpha-catenin binding site in beta-catenin and plakoglobin and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.", "text_with_entity_marker": "Recently we have identified an [E1]alpha-catenin[/E1] binding site in beta-catenin and [E2]plakoglobin[/E2] and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[31, 44]], "entity_1_idx_in_text_with_entity_marker": [35, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[78, 89]], "entity_2_idx_in_text_with_entity_marker": [91, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s2_BioInfer.d245.s2.p2", "text": "Recently we have identified an alpha-catenin binding site in beta-catenin and plakoglobin and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.", "text_with_entity_marker": "Recently we have identified an alpha-catenin binding site in [E1]beta-catenin[/E1] and [E2]plakoglobin[/E2] and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[61, 73]], "entity_1_idx_in_text_with_entity_marker": [65, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[78, 89]], "entity_2_idx_in_text_with_entity_marker": [91, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d753.s0_BioInfer.d753.s0.p0", "text": "Thus, profilin and actin expression are not co-regulated in all cells.", "text_with_entity_marker": "Thus, [E1]profilin[/E1] and [E2]actin[/E2] expression are not co-regulated in all cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[6, 14]], "entity_1_idx_in_text_with_entity_marker": [10, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[19, 24]], "entity_2_idx_in_text_with_entity_marker": [32, 37], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d637.s0_BioInfer.d637.s0.p0", "text": "The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.", "text_with_entity_marker": "The junctional multidomain protein [E1]AF-6[/E1] is a binding partner of the [E2]Rap1A[/E2] GTPase and associates with the actin cytoskeletal regulator profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AF-6", "entity_1_idx": [[35, 39]], "entity_1_idx_in_text_with_entity_marker": [39, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Rap1A", "entity_2_idx": [[68, 73]], "entity_2_idx_in_text_with_entity_marker": [81, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d637.s0_BioInfer.d637.s0.p1", "text": "The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.", "text_with_entity_marker": "The junctional multidomain protein [E1]AF-6[/E1] is a binding partner of the Rap1A GTPase and associates with the [E2]actin[/E2] cytoskeletal regulator profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AF-6", "entity_1_idx": [[35, 39]], "entity_1_idx_in_text_with_entity_marker": [39, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d637.s0_BioInfer.d637.s0.p2", "text": "The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.", "text_with_entity_marker": "The junctional multidomain protein [E1]AF-6[/E1] is a binding partner of the Rap1A [E2]GTPase[/E2] and associates with the actin cytoskeletal regulator profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AF-6", "entity_1_idx": [[35, 39]], "entity_1_idx_in_text_with_entity_marker": [39, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "GTPase", "entity_2_idx": [[74, 80]], "entity_2_idx_in_text_with_entity_marker": [87, 93], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d637.s0_BioInfer.d637.s0.p3", "text": "The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.", "text_with_entity_marker": "The junctional multidomain protein [E1]AF-6[/E1] is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AF-6", "entity_1_idx": [[35, 39]], "entity_1_idx_in_text_with_entity_marker": [39, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[134, 142]], "entity_2_idx_in_text_with_entity_marker": [147, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d637.s0_BioInfer.d637.s0.p4", "text": "The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.", "text_with_entity_marker": "The junctional multidomain protein AF-6 is a binding partner of the [E1]Rap1A[/E1] GTPase and associates with the [E2]actin[/E2] cytoskeletal regulator profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rap1A", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d637.s0_BioInfer.d637.s0.p5", "text": "The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.", "text_with_entity_marker": "The junctional multidomain protein AF-6 is a binding partner of the [E1]Rap1A[/E1] [E2]GTPase[/E2] and associates with the actin cytoskeletal regulator profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Rap1A", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "GTPase", "entity_2_idx": [[74, 80]], "entity_2_idx_in_text_with_entity_marker": [87, 93], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d637.s0_BioInfer.d637.s0.p6", "text": "The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.", "text_with_entity_marker": "The junctional multidomain protein AF-6 is a binding partner of the [E1]Rap1A[/E1] GTPase and associates with the actin cytoskeletal regulator [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rap1A", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[134, 142]], "entity_2_idx_in_text_with_entity_marker": [147, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d637.s0_BioInfer.d637.s0.p7", "text": "The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.", "text_with_entity_marker": "The junctional multidomain protein AF-6 is a binding partner of the Rap1A [E1]GTPase[/E1] and associates with the [E2]actin[/E2] cytoskeletal regulator profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GTPase", "entity_1_idx": [[74, 80]], "entity_1_idx_in_text_with_entity_marker": [78, 84], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d637.s0_BioInfer.d637.s0.p8", "text": "The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.", "text_with_entity_marker": "The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the [E1]actin[/E1] cytoskeletal regulator [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[105, 110]], "entity_1_idx_in_text_with_entity_marker": [109, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[134, 142]], "entity_2_idx_in_text_with_entity_marker": [147, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d637.s0_BioInfer.d637.s0.p9", "text": "The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.", "text_with_entity_marker": "The junctional multidomain protein AF-6 is a binding partner of the Rap1A [E1]GTPase[/E1] and associates with the actin cytoskeletal regulator [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GTPase", "entity_1_idx": [[74, 80]], "entity_1_idx_in_text_with_entity_marker": [78, 84], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[134, 142]], "entity_2_idx_in_text_with_entity_marker": [147, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d637.s1_BioInfer.d637.s1.p0", "text": "To our knowledge, AF-6 is the only integral component in cell-cell junctions discovered thus far that interacts with profilin and thus could modulate actin modeling proximal to adhesion complexes.", "text_with_entity_marker": "To our knowledge, [E1]AF-6[/E1] is the only integral component in cell-cell junctions discovered thus far that interacts with [E2]profilin[/E2] and thus could modulate actin modeling proximal to adhesion complexes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AF-6", "entity_1_idx": [[18, 22]], "entity_1_idx_in_text_with_entity_marker": [22, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[117, 125]], "entity_2_idx_in_text_with_entity_marker": [130, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d637.s1_BioInfer.d637.s1.p1", "text": "To our knowledge, AF-6 is the only integral component in cell-cell junctions discovered thus far that interacts with profilin and thus could modulate actin modeling proximal to adhesion complexes.", "text_with_entity_marker": "To our knowledge, [E1]AF-6[/E1] is the only integral component in cell-cell junctions discovered thus far that interacts with profilin and thus could modulate [E2]actin[/E2] modeling proximal to adhesion complexes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AF-6", "entity_1_idx": [[18, 22]], "entity_1_idx_in_text_with_entity_marker": [22, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[150, 155]], "entity_2_idx_in_text_with_entity_marker": [163, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d637.s1_BioInfer.d637.s1.p2", "text": "To our knowledge, AF-6 is the only integral component in cell-cell junctions discovered thus far that interacts with profilin and thus could modulate actin modeling proximal to adhesion complexes.", "text_with_entity_marker": "To our knowledge, AF-6 is the only integral component in cell-cell junctions discovered thus far that interacts with [E1]profilin[/E1] and thus could modulate [E2]actin[/E2] modeling proximal to adhesion complexes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[117, 125]], "entity_1_idx_in_text_with_entity_marker": [121, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[150, 155]], "entity_2_idx_in_text_with_entity_marker": [163, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p20", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the [E1]actin[/E1] gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), [E2]fimbrin[/E2] (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[98, 105]], "entity_2_idx_in_text_with_entity_marker": [111, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p21", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), [E1]fimbrin[/E1] (SAC6), Abp1p (ABP1), and capping protein ([E2]CAP1[/E2] and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[98, 105]], "entity_1_idx_in_text_with_entity_marker": [102, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CAP1", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p22", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), [E1]fimbrin[/E1] (SAC6), [E2]Abp1p[/E2] (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[98, 105]], "entity_1_idx_in_text_with_entity_marker": [102, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Abp1p", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p23", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), [E1]fimbrin[/E1] (SAC6), Abp1p (ABP1), and [E2]capping protein[/E2] (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[98, 105]], "entity_1_idx_in_text_with_entity_marker": [102, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "capping protein", "entity_2_idx": [[132, 147]], "entity_2_idx_in_text_with_entity_marker": [145, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p24", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), [E1]fimbrin[/E1] (SAC6), Abp1p ([E2]ABP1[/E2]), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[98, 105]], "entity_1_idx_in_text_with_entity_marker": [102, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ABP1", "entity_2_idx": [[121, 125]], "entity_2_idx_in_text_with_entity_marker": [134, 138], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p25", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene ([E1]ACT1[/E1]) is lethal, but null mutations in the tropomyosin (TPM1), [E2]fimbrin[/E2] (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ACT1", "entity_1_idx": [[35, 39]], "entity_1_idx_in_text_with_entity_marker": [39, 43], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "fimbrin", "entity_2_idx": [[98, 105]], "entity_2_idx_in_text_with_entity_marker": [111, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p26", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin ([E1]TPM1[/E1]), [E2]fimbrin[/E2] (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TPM1", "entity_1_idx": [[91, 95]], "entity_1_idx_in_text_with_entity_marker": [95, 99], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "fimbrin", "entity_2_idx": [[98, 105]], "entity_2_idx_in_text_with_entity_marker": [111, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p27", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the [E1]actin[/E1] gene (ACT1) is lethal, but null mutations in the [E2]tropomyosin[/E2] (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "tropomyosin", "entity_2_idx": [[78, 89]], "entity_2_idx_in_text_with_entity_marker": [91, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p28", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the [E1]tropomyosin[/E1] (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein ([E2]CAP1[/E2] and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[78, 89]], "entity_1_idx_in_text_with_entity_marker": [82, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CAP1", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p29", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the [E1]tropomyosin[/E1] (TPM1), fimbrin (SAC6), [E2]Abp1p[/E2] (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[78, 89]], "entity_1_idx_in_text_with_entity_marker": [82, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Abp1p", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d74.s0_BioInfer.d74.s0.p0", "text": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "text_with_entity_marker": "Archaeal [E1]histones[/E1] are most similar to the globular histone fold region of eukaryal [E2]histone[/E2] H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[83, 90]], "entity_2_idx_in_text_with_entity_marker": [96, 103], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d74.s0_BioInfer.d74.s0.p1", "text": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "text_with_entity_marker": "Archaeal histones are most similar to the globular [E1]histone[/E1] fold region of eukaryal [E2]histone[/E2] H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[51, 58]], "entity_1_idx_in_text_with_entity_marker": [55, 62], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[83, 90]], "entity_2_idx_in_text_with_entity_marker": [96, 103], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d74.s0_BioInfer.d74.s0.p2", "text": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "text_with_entity_marker": "Archaeal histones are most similar to the globular histone fold region of eukaryal [E1]histone[/E1] H4, and the results reported are consistent with archaeal [E2]nucleosomes[/E2] resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[83, 90]], "entity_1_idx_in_text_with_entity_marker": [87, 94], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "nucleosomes", "entity_2_idx": [[149, 160]], "entity_2_idx_in_text_with_entity_marker": [162, 173], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d74.s0_BioInfer.d74.s0.p3", "text": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "text_with_entity_marker": "Archaeal histones are most similar to the globular histone fold region of eukaryal [E1]histone[/E1] H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+[E2]H4[/E2])2tetramers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[83, 90]], "entity_1_idx_in_text_with_entity_marker": [87, 94], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[217, 219]], "entity_2_idx_in_text_with_entity_marker": [230, 232], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d74.s0_BioInfer.d74.s0.p4", "text": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "text_with_entity_marker": "Archaeal histones are most similar to the globular histone fold region of eukaryal [E1]histone[/E1] [E2]H4[/E2], and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[83, 90]], "entity_1_idx_in_text_with_entity_marker": [87, 94], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[91, 93]], "entity_2_idx_in_text_with_entity_marker": [104, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d74.s0_BioInfer.d74.s0.p5", "text": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "text_with_entity_marker": "Archaeal histones are most similar to the globular histone fold region of eukaryal [E1]histone[/E1] H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone ([E2]H3[/E2]+H4)2tetramers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[83, 90]], "entity_1_idx_in_text_with_entity_marker": [87, 94], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[214, 216]], "entity_2_idx_in_text_with_entity_marker": [227, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d74.s0_BioInfer.d74.s0.p6", "text": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "text_with_entity_marker": "Archaeal histones are most similar to the globular histone fold region of eukaryal [E1]histone[/E1] H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal [E2]histone[/E2] (H3+H4)2tetramers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[83, 90]], "entity_1_idx_in_text_with_entity_marker": [87, 94], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[205, 212]], "entity_2_idx_in_text_with_entity_marker": [218, 225], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d74.s0_BioInfer.d74.s0.p7", "text": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "text_with_entity_marker": "Archaeal [E1]histones[/E1] are most similar to the globular [E2]histone[/E2] fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[51, 58]], "entity_2_idx_in_text_with_entity_marker": [64, 71], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d74.s0_BioInfer.d74.s0.p8", "text": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "text_with_entity_marker": "Archaeal [E1]histones[/E1] are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal [E2]nucleosomes[/E2] resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleosomes", "entity_2_idx": [[149, 160]], "entity_2_idx_in_text_with_entity_marker": [162, 173], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d74.s0_BioInfer.d74.s0.p9", "text": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "text_with_entity_marker": "Archaeal [E1]histones[/E1] are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+[E2]H4[/E2])2tetramers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[217, 219]], "entity_2_idx_in_text_with_entity_marker": [230, 232], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s0_BioInfer.d14.s0.p0", "text": "Actin-binding proteins such as profilin and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.", "text_with_entity_marker": "Actin-binding proteins such as profilin and [E1]gelsolin[/E1] bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[44, 52]], "entity_1_idx_in_text_with_entity_marker": [48, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[160, 165]], "entity_2_idx_in_text_with_entity_marker": [173, 178], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s0_BioInfer.d14.s0.p1", "text": "Actin-binding proteins such as profilin and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.", "text_with_entity_marker": "[E1]Actin-binding proteins[/E1] such as profilin and [E2]gelsolin[/E2] bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Actin-binding proteins", "entity_1_idx": [[0, 22]], "entity_1_idx_in_text_with_entity_marker": [4, 26], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "gelsolin", "entity_2_idx": [[44, 52]], "entity_2_idx_in_text_with_entity_marker": [57, 65], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s0_BioInfer.d14.s0.p2", "text": "Actin-binding proteins such as profilin and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.", "text_with_entity_marker": "Actin-binding proteins such as [E1]profilin[/E1] and [E2]gelsolin[/E2] bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[31, 39]], "entity_1_idx_in_text_with_entity_marker": [35, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[44, 52]], "entity_2_idx_in_text_with_entity_marker": [57, 65], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s0_BioInfer.d14.s0.p3", "text": "Actin-binding proteins such as profilin and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.", "text_with_entity_marker": "[E1]Actin-binding proteins[/E1] such as profilin and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Actin-binding proteins", "entity_1_idx": [[0, 22]], "entity_1_idx_in_text_with_entity_marker": [4, 26], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[160, 165]], "entity_2_idx_in_text_with_entity_marker": [173, 178], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s0_BioInfer.d14.s0.p4", "text": "Actin-binding proteins such as profilin and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.", "text_with_entity_marker": "Actin-binding proteins such as [E1]profilin[/E1] and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[31, 39]], "entity_1_idx_in_text_with_entity_marker": [35, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[160, 165]], "entity_2_idx_in_text_with_entity_marker": [173, 178], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s0_BioInfer.d14.s0.p5", "text": "Actin-binding proteins such as profilin and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.", "text_with_entity_marker": "[E1]Actin-binding proteins[/E1] such as [E2]profilin[/E2] and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Actin-binding proteins", "entity_1_idx": [[0, 22]], "entity_1_idx_in_text_with_entity_marker": [4, 26], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[31, 39]], "entity_2_idx_in_text_with_entity_marker": [44, 52], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s1_BioInfer.d14.s1.p0", "text": "These studies suggest that profilin and gelsolin may control the generation of 3-OH phosphorylated phosphoinositides, which in turn may regulate the actin polymerization.", "text_with_entity_marker": "These studies suggest that [E1]profilin[/E1] and gelsolin may control the generation of 3-OH phosphorylated phosphoinositides, which in turn may regulate the [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[27, 35]], "entity_1_idx_in_text_with_entity_marker": [31, 39], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[149, 154]], "entity_2_idx_in_text_with_entity_marker": [162, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s1_BioInfer.d14.s1.p1", "text": "These studies suggest that profilin and gelsolin may control the generation of 3-OH phosphorylated phosphoinositides, which in turn may regulate the actin polymerization.", "text_with_entity_marker": "These studies suggest that [E1]profilin[/E1] and [E2]gelsolin[/E2] may control the generation of 3-OH phosphorylated phosphoinositides, which in turn may regulate the actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[27, 35]], "entity_1_idx_in_text_with_entity_marker": [31, 39], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gelsolin", "entity_2_idx": [[40, 48]], "entity_2_idx_in_text_with_entity_marker": [53, 61], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s1_BioInfer.d14.s1.p2", "text": "These studies suggest that profilin and gelsolin may control the generation of 3-OH phosphorylated phosphoinositides, which in turn may regulate the actin polymerization.", "text_with_entity_marker": "These studies suggest that profilin and [E1]gelsolin[/E1] may control the generation of 3-OH phosphorylated phosphoinositides, which in turn may regulate the [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[40, 48]], "entity_1_idx_in_text_with_entity_marker": [44, 52], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[149, 154]], "entity_2_idx_in_text_with_entity_marker": [162, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s2_BioInfer.d14.s2.p0", "text": "This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.", "text_with_entity_marker": "This effect is specific to [E1]profilin[/E1] and gelsolin because other cytoskeletal proteins such as tau or actin do not affect [E2]PI 3-kinase[/E2] activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[27, 35]], "entity_1_idx_in_text_with_entity_marker": [31, 39], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PI 3-kinase", "entity_2_idx": [[120, 131]], "entity_2_idx_in_text_with_entity_marker": [133, 144], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s2_BioInfer.d14.s2.p1", "text": "This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.", "text_with_entity_marker": "This effect is specific to [E1]profilin[/E1] and gelsolin because other cytoskeletal proteins such as [E2]tau[/E2] or actin do not affect PI 3-kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[27, 35]], "entity_1_idx_in_text_with_entity_marker": [31, 39], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tau", "entity_2_idx": [[93, 96]], "entity_2_idx_in_text_with_entity_marker": [106, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s2_BioInfer.d14.s2.p2", "text": "This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.", "text_with_entity_marker": "This effect is specific to [E1]profilin[/E1] and gelsolin because other cytoskeletal proteins such as tau or [E2]actin[/E2] do not affect PI 3-kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[27, 35]], "entity_1_idx_in_text_with_entity_marker": [31, 39], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s2_BioInfer.d14.s2.p3", "text": "This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.", "text_with_entity_marker": "This effect is specific to [E1]profilin[/E1] and [E2]gelsolin[/E2] because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[27, 35]], "entity_1_idx_in_text_with_entity_marker": [31, 39], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gelsolin", "entity_2_idx": [[40, 48]], "entity_2_idx_in_text_with_entity_marker": [53, 61], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s2_BioInfer.d14.s2.p4", "text": "This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.", "text_with_entity_marker": "This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as [E1]tau[/E1] or actin do not affect [E2]PI 3-kinase[/E2] activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "tau", "entity_1_idx": [[93, 96]], "entity_1_idx_in_text_with_entity_marker": [97, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PI 3-kinase", "entity_2_idx": [[120, 131]], "entity_2_idx_in_text_with_entity_marker": [133, 144], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s2_BioInfer.d14.s2.p5", "text": "This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.", "text_with_entity_marker": "This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or [E1]actin[/E1] do not affect [E2]PI 3-kinase[/E2] activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[100, 105]], "entity_1_idx_in_text_with_entity_marker": [104, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PI 3-kinase", "entity_2_idx": [[120, 131]], "entity_2_idx_in_text_with_entity_marker": [133, 144], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s2_BioInfer.d14.s2.p6", "text": "This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.", "text_with_entity_marker": "This effect is specific to profilin and [E1]gelsolin[/E1] because other cytoskeletal proteins such as tau or actin do not affect [E2]PI 3-kinase[/E2] activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[40, 48]], "entity_1_idx_in_text_with_entity_marker": [44, 52], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PI 3-kinase", "entity_2_idx": [[120, 131]], "entity_2_idx_in_text_with_entity_marker": [133, 144], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s2_BioInfer.d14.s2.p7", "text": "This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.", "text_with_entity_marker": "This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as [E1]tau[/E1] or [E2]actin[/E2] do not affect PI 3-kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tau", "entity_1_idx": [[93, 96]], "entity_1_idx_in_text_with_entity_marker": [97, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s2_BioInfer.d14.s2.p8", "text": "This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.", "text_with_entity_marker": "This effect is specific to profilin and [E1]gelsolin[/E1] because other cytoskeletal proteins such as [E2]tau[/E2] or actin do not affect PI 3-kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[40, 48]], "entity_1_idx_in_text_with_entity_marker": [44, 52], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tau", "entity_2_idx": [[93, 96]], "entity_2_idx_in_text_with_entity_marker": [106, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s2_BioInfer.d14.s2.p9", "text": "This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.", "text_with_entity_marker": "This effect is specific to profilin and [E1]gelsolin[/E1] because other cytoskeletal proteins such as tau or [E2]actin[/E2] do not affect PI 3-kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[40, 48]], "entity_1_idx_in_text_with_entity_marker": [44, 52], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d668.s0_BioInfer.d668.s0.p0", "text": "The procedure allows for the simultaneous quantification of myosin heavy chain, myosin light chain, phosphorylatable myosin light chain and actin from as little as 50 mg of tissue.", "text_with_entity_marker": "The procedure allows for the simultaneous quantification of [E1]myosin heavy chain[/E1], myosin light chain, [E2]phosphorylatable myosin light chain[/E2] and actin from as little as 50 mg of tissue.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[60, 78]], "entity_1_idx_in_text_with_entity_marker": [64, 82], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "phosphorylatable myosin light chain", "entity_2_idx": [[100, 135]], "entity_2_idx_in_text_with_entity_marker": [113, 148], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d668.s0_BioInfer.d668.s0.p1", "text": "The procedure allows for the simultaneous quantification of myosin heavy chain, myosin light chain, phosphorylatable myosin light chain and actin from as little as 50 mg of tissue.", "text_with_entity_marker": "The procedure allows for the simultaneous quantification of myosin heavy chain, myosin light chain, [E1]phosphorylatable myosin light chain[/E1] and [E2]actin[/E2] from as little as 50 mg of tissue.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphorylatable myosin light chain", "entity_1_idx": [[100, 135]], "entity_1_idx_in_text_with_entity_marker": [104, 139], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[140, 145]], "entity_2_idx_in_text_with_entity_marker": [153, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d668.s0_BioInfer.d668.s0.p2", "text": "The procedure allows for the simultaneous quantification of myosin heavy chain, myosin light chain, phosphorylatable myosin light chain and actin from as little as 50 mg of tissue.", "text_with_entity_marker": "The procedure allows for the simultaneous quantification of myosin heavy chain, [E1]myosin light chain[/E1], [E2]phosphorylatable myosin light chain[/E2] and actin from as little as 50 mg of tissue.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin light chain", "entity_1_idx": [[80, 98]], "entity_1_idx_in_text_with_entity_marker": [84, 102], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "phosphorylatable myosin light chain", "entity_2_idx": [[100, 135]], "entity_2_idx_in_text_with_entity_marker": [113, 148], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d668.s0_BioInfer.d668.s0.p3", "text": "The procedure allows for the simultaneous quantification of myosin heavy chain, myosin light chain, phosphorylatable myosin light chain and actin from as little as 50 mg of tissue.", "text_with_entity_marker": "The procedure allows for the simultaneous quantification of [E1]myosin heavy chain[/E1], myosin light chain, phosphorylatable myosin light chain and [E2]actin[/E2] from as little as 50 mg of tissue.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[60, 78]], "entity_1_idx_in_text_with_entity_marker": [64, 82], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[140, 145]], "entity_2_idx_in_text_with_entity_marker": [153, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d668.s0_BioInfer.d668.s0.p4", "text": "The procedure allows for the simultaneous quantification of myosin heavy chain, myosin light chain, phosphorylatable myosin light chain and actin from as little as 50 mg of tissue.", "text_with_entity_marker": "The procedure allows for the simultaneous quantification of [E1]myosin heavy chain[/E1], [E2]myosin light chain[/E2], phosphorylatable myosin light chain and actin from as little as 50 mg of tissue.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[60, 78]], "entity_1_idx_in_text_with_entity_marker": [64, 82], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin light chain", "entity_2_idx": [[80, 98]], "entity_2_idx_in_text_with_entity_marker": [93, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d668.s0_BioInfer.d668.s0.p5", "text": "The procedure allows for the simultaneous quantification of myosin heavy chain, myosin light chain, phosphorylatable myosin light chain and actin from as little as 50 mg of tissue.", "text_with_entity_marker": "The procedure allows for the simultaneous quantification of myosin heavy chain, [E1]myosin light chain[/E1], phosphorylatable myosin light chain and [E2]actin[/E2] from as little as 50 mg of tissue.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin light chain", "entity_1_idx": [[80, 98]], "entity_1_idx_in_text_with_entity_marker": [84, 102], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[140, 145]], "entity_2_idx_in_text_with_entity_marker": [153, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p60", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), [E1]histone[/E1] H1, histone [E2]H[/E2]2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[193, 200]], "entity_1_idx_in_text_with_entity_marker": [197, 204], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H", "entity_2_idx": [[213, 214], [219, 221]], "entity_2_idx_in_text_with_entity_marker": [226, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p61", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), [E1]histone[/E1] H1, histone H2A + 2B, histone H3, and histone [E2]H4[/E2], was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[193, 200]], "entity_1_idx_in_text_with_entity_marker": [197, 204], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[247, 249]], "entity_2_idx_in_text_with_entity_marker": [260, 262], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p62", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase ([E1]PNR[/E1]), proliferating cell nuclear antigen (PCNA), [E2]histone[/E2] H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PNR", "entity_1_idx": [[144, 147]], "entity_1_idx_in_text_with_entity_marker": [148, 151], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[193, 200]], "entity_2_idx_in_text_with_entity_marker": [206, 213], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p63", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including [E1]thymidylate synthase[/E1] (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), [E2]histone[/E2] H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymidylate synthase", "entity_1_idx": [[59, 79]], "entity_1_idx_in_text_with_entity_marker": [63, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[193, 200]], "entity_2_idx_in_text_with_entity_marker": [206, 213], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p64", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), [E1]dihydrofolate reductase[/E1] (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), [E2]histone[/E2] H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dihydrofolate reductase", "entity_1_idx": [[86, 109]], "entity_1_idx_in_text_with_entity_marker": [90, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[193, 200]], "entity_2_idx_in_text_with_entity_marker": [206, 213], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p65", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), [E1]ribonucleotide reductase[/E1] (PNR), proliferating cell nuclear antigen (PCNA), [E2]histone[/E2] H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonucleotide reductase", "entity_1_idx": [[118, 142]], "entity_1_idx_in_text_with_entity_marker": [122, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[193, 200]], "entity_2_idx_in_text_with_entity_marker": [206, 213], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p66", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), [E1]histone[/E1] H1, histone [E2]H2A[/E2] + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[193, 200]], "entity_1_idx_in_text_with_entity_marker": [197, 204], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2A", "entity_2_idx": [[213, 216]], "entity_2_idx_in_text_with_entity_marker": [226, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p67", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), [E1]histone[/E1] [E2]H1[/E2], histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[193, 200]], "entity_1_idx_in_text_with_entity_marker": [197, 204], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H1", "entity_2_idx": [[201, 203]], "entity_2_idx_in_text_with_entity_marker": [214, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p68", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), [E1]proliferating cell nuclear antigen[/E1] (PCNA), [E2]histone[/E2] H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "proliferating cell nuclear antigen", "entity_1_idx": [[150, 184]], "entity_1_idx_in_text_with_entity_marker": [154, 188], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[193, 200]], "entity_2_idx_in_text_with_entity_marker": [206, 213], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p69", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), [E1]histone[/E1] H1, histone H2A + 2B, histone [E2]H3[/E2], and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[193, 200]], "entity_1_idx_in_text_with_entity_marker": [197, 204], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[231, 233]], "entity_2_idx_in_text_with_entity_marker": [244, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p80", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone [E1]H3[/E1], and [E2]histone[/E2] H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[231, 233]], "entity_1_idx_in_text_with_entity_marker": [235, 237], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[239, 246]], "entity_2_idx_in_text_with_entity_marker": [252, 259], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p81", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone [E1]H[/E1]2A + 2B, [E2]histone[/E2] H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[213, 214], [219, 221]], "entity_1_idx_in_text_with_entity_marker": [217, 218], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[223, 230]], "entity_2_idx_in_text_with_entity_marker": [236, 243], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p82", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, [E1]histone[/E1] H3, and histone [E2]H4[/E2], was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[223, 230]], "entity_1_idx_in_text_with_entity_marker": [227, 234], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[247, 249]], "entity_2_idx_in_text_with_entity_marker": [260, 262], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p83", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase ([E1]PNR[/E1]), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, [E2]histone[/E2] H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PNR", "entity_1_idx": [[144, 147]], "entity_1_idx_in_text_with_entity_marker": [148, 151], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[223, 230]], "entity_2_idx_in_text_with_entity_marker": [236, 243], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p84", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including [E1]thymidylate synthase[/E1] (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, [E2]histone[/E2] H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymidylate synthase", "entity_1_idx": [[59, 79]], "entity_1_idx_in_text_with_entity_marker": [63, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[223, 230]], "entity_2_idx_in_text_with_entity_marker": [236, 243], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p85", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), [E1]dihydrofolate reductase[/E1] (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, [E2]histone[/E2] H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dihydrofolate reductase", "entity_1_idx": [[86, 109]], "entity_1_idx_in_text_with_entity_marker": [90, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[223, 230]], "entity_2_idx_in_text_with_entity_marker": [236, 243], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p86", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), [E1]ribonucleotide reductase[/E1] (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, [E2]histone[/E2] H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonucleotide reductase", "entity_1_idx": [[118, 142]], "entity_1_idx_in_text_with_entity_marker": [122, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[223, 230]], "entity_2_idx_in_text_with_entity_marker": [236, 243], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p87", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone [E1]H2A[/E1] + 2B, [E2]histone[/E2] H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A", "entity_1_idx": [[213, 216]], "entity_1_idx_in_text_with_entity_marker": [217, 220], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[223, 230]], "entity_2_idx_in_text_with_entity_marker": [236, 243], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p88", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone [E1]H1[/E1], histone H2A + 2B, [E2]histone[/E2] H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1", "entity_1_idx": [[201, 203]], "entity_1_idx_in_text_with_entity_marker": [205, 207], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[223, 230]], "entity_2_idx_in_text_with_entity_marker": [236, 243], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p89", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), [E1]proliferating cell nuclear antigen[/E1] (PCNA), histone H1, histone H2A + 2B, [E2]histone[/E2] H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "proliferating cell nuclear antigen", "entity_1_idx": [[150, 184]], "entity_1_idx_in_text_with_entity_marker": [154, 188], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[223, 230]], "entity_2_idx_in_text_with_entity_marker": [236, 243], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p130", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone [E1]H1[/E1], histone [E2]H2A[/E2] + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1", "entity_1_idx": [[201, 203]], "entity_1_idx_in_text_with_entity_marker": [205, 207], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A", "entity_2_idx": [[213, 216]], "entity_2_idx_in_text_with_entity_marker": [226, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p131", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), [E1]proliferating cell nuclear antigen[/E1] (PCNA), histone H1, histone [E2]H2A[/E2] + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "proliferating cell nuclear antigen", "entity_1_idx": [[150, 184]], "entity_1_idx_in_text_with_entity_marker": [154, 188], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A", "entity_2_idx": [[213, 216]], "entity_2_idx_in_text_with_entity_marker": [226, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p132", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone [E1]H2A[/E1] + 2B, histone [E2]H3[/E2], and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A", "entity_1_idx": [[213, 216]], "entity_1_idx_in_text_with_entity_marker": [217, 220], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[231, 233]], "entity_2_idx_in_text_with_entity_marker": [244, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p133", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), [E1]proliferating cell nuclear antigen[/E1] (PCNA), histone [E2]H1[/E2], histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "proliferating cell nuclear antigen", "entity_1_idx": [[150, 184]], "entity_1_idx_in_text_with_entity_marker": [154, 188], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H1", "entity_2_idx": [[201, 203]], "entity_2_idx_in_text_with_entity_marker": [214, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p134", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone [E1]H1[/E1], histone H2A + 2B, histone [E2]H3[/E2], and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1", "entity_1_idx": [[201, 203]], "entity_1_idx_in_text_with_entity_marker": [205, 207], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[231, 233]], "entity_2_idx_in_text_with_entity_marker": [244, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p135", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), [E1]proliferating cell nuclear antigen[/E1] (PCNA), histone H1, histone H2A + 2B, histone [E2]H3[/E2], and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "proliferating cell nuclear antigen", "entity_1_idx": [[150, 184]], "entity_1_idx_in_text_with_entity_marker": [154, 188], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[231, 233]], "entity_2_idx_in_text_with_entity_marker": [244, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d640.s0_BioInfer.d640.s0.p0", "text": "The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for E-CD; 86 per cent for alpha-catenin; 91 per cent for beta-catenin) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.", "text_with_entity_marker": "The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for [E1]E-CD[/E1]; 86 per cent for [E2]alpha-catenin[/E2]; 91 per cent for beta-catenin) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-CD", "entity_1_idx": [[127, 131]], "entity_1_idx_in_text_with_entity_marker": [131, 135], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[149, 162]], "entity_2_idx_in_text_with_entity_marker": [162, 175], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d640.s0_BioInfer.d640.s0.p1", "text": "The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for E-CD; 86 per cent for alpha-catenin; 91 per cent for beta-catenin) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.", "text_with_entity_marker": "The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for E-CD; 86 per cent for [E1]alpha-catenin[/E1]; 91 per cent for [E2]beta-catenin[/E2]) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[149, 162]], "entity_1_idx_in_text_with_entity_marker": [153, 166], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[180, 192]], "entity_2_idx_in_text_with_entity_marker": [193, 205], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d640.s0_BioInfer.d640.s0.p2", "text": "The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for E-CD; 86 per cent for alpha-catenin; 91 per cent for beta-catenin) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.", "text_with_entity_marker": "The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for [E1]E-CD[/E1]; 86 per cent for alpha-catenin; 91 per cent for [E2]beta-catenin[/E2]) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-CD", "entity_1_idx": [[127, 131]], "entity_1_idx_in_text_with_entity_marker": [131, 135], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[180, 192]], "entity_2_idx_in_text_with_entity_marker": [193, 205], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d321.s0_BioInfer.d321.s0.p0", "text": "In cancerous tissues, the frequency of reduced expression of beta-catenin (28 of 86, 33%) was similar to that of E-cadherin (19 of 86, 22%), but less than that of alpha-catenin (47 of 86, 55%).", "text_with_entity_marker": "In cancerous tissues, the frequency of reduced expression of beta-catenin (28 of 86, 33%) was similar to that of [E1]E-cadherin[/E1] (19 of 86, 22%), but less than that of [E2]alpha-catenin[/E2] (47 of 86, 55%).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[113, 123]], "entity_1_idx_in_text_with_entity_marker": [117, 127], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[163, 176]], "entity_2_idx_in_text_with_entity_marker": [176, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d321.s0_BioInfer.d321.s0.p1", "text": "In cancerous tissues, the frequency of reduced expression of beta-catenin (28 of 86, 33%) was similar to that of E-cadherin (19 of 86, 22%), but less than that of alpha-catenin (47 of 86, 55%).", "text_with_entity_marker": "In cancerous tissues, the frequency of reduced expression of [E1]beta-catenin[/E1] (28 of 86, 33%) was similar to that of [E2]E-cadherin[/E2] (19 of 86, 22%), but less than that of alpha-catenin (47 of 86, 55%).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[61, 73]], "entity_1_idx_in_text_with_entity_marker": [65, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[113, 123]], "entity_2_idx_in_text_with_entity_marker": [126, 136], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d321.s0_BioInfer.d321.s0.p2", "text": "In cancerous tissues, the frequency of reduced expression of beta-catenin (28 of 86, 33%) was similar to that of E-cadherin (19 of 86, 22%), but less than that of alpha-catenin (47 of 86, 55%).", "text_with_entity_marker": "In cancerous tissues, the frequency of reduced expression of [E1]beta-catenin[/E1] (28 of 86, 33%) was similar to that of E-cadherin (19 of 86, 22%), but less than that of [E2]alpha-catenin[/E2] (47 of 86, 55%).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[61, 73]], "entity_1_idx_in_text_with_entity_marker": [65, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[163, 176]], "entity_2_idx_in_text_with_entity_marker": [176, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d321.s1_BioInfer.d321.s1.p0", "text": "In this study, we immunohistochemically investigated the expression of beta-catenin as well as E-cadherin and alpha-catenin in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.", "text_with_entity_marker": "In this study, we immunohistochemically investigated the expression of [E1]beta-catenin[/E1] as well as E-cadherin and [E2]alpha-catenin[/E2] in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[71, 83]], "entity_1_idx_in_text_with_entity_marker": [75, 87], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[110, 123]], "entity_2_idx_in_text_with_entity_marker": [123, 136], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d321.s1_BioInfer.d321.s1.p1", "text": "In this study, we immunohistochemically investigated the expression of beta-catenin as well as E-cadherin and alpha-catenin in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.", "text_with_entity_marker": "In this study, we immunohistochemically investigated the expression of [E1]beta-catenin[/E1] as well as [E2]E-cadherin[/E2] and alpha-catenin in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[71, 83]], "entity_1_idx_in_text_with_entity_marker": [75, 87], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[95, 105]], "entity_2_idx_in_text_with_entity_marker": [108, 118], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d321.s1_BioInfer.d321.s1.p2", "text": "In this study, we immunohistochemically investigated the expression of beta-catenin as well as E-cadherin and alpha-catenin in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.", "text_with_entity_marker": "In this study, we immunohistochemically investigated the expression of beta-catenin as well as [E1]E-cadherin[/E1] and [E2]alpha-catenin[/E2] in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[95, 105]], "entity_1_idx_in_text_with_entity_marker": [99, 109], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[110, 123]], "entity_2_idx_in_text_with_entity_marker": [123, 136], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d598.s0_BioInfer.d598.s0.p0", "text": "The contents of myosin heavy chain, myosin light chain 2, actin, troponin-I in 125-week-old rats decreased compared with those of 12-week-old rats.", "text_with_entity_marker": "The contents of myosin heavy chain, [E1]myosin light chain 2[/E1], actin, [E2]troponin-I[/E2] in 125-week-old rats decreased compared with those of 12-week-old rats.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin light chain 2", "entity_1_idx": [[36, 56]], "entity_1_idx_in_text_with_entity_marker": [40, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "troponin-I", "entity_2_idx": [[65, 75]], "entity_2_idx_in_text_with_entity_marker": [78, 88], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d598.s0_BioInfer.d598.s0.p1", "text": "The contents of myosin heavy chain, myosin light chain 2, actin, troponin-I in 125-week-old rats decreased compared with those of 12-week-old rats.", "text_with_entity_marker": "The contents of myosin heavy chain, myosin light chain 2, [E1]actin[/E1], [E2]troponin-I[/E2] in 125-week-old rats decreased compared with those of 12-week-old rats.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "troponin-I", "entity_2_idx": [[65, 75]], "entity_2_idx_in_text_with_entity_marker": [78, 88], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d598.s0_BioInfer.d598.s0.p2", "text": "The contents of myosin heavy chain, myosin light chain 2, actin, troponin-I in 125-week-old rats decreased compared with those of 12-week-old rats.", "text_with_entity_marker": "The contents of [E1]myosin heavy chain[/E1], myosin light chain 2, actin, [E2]troponin-I[/E2] in 125-week-old rats decreased compared with those of 12-week-old rats.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[16, 34]], "entity_1_idx_in_text_with_entity_marker": [20, 38], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "troponin-I", "entity_2_idx": [[65, 75]], "entity_2_idx_in_text_with_entity_marker": [78, 88], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d598.s0_BioInfer.d598.s0.p3", "text": "The contents of myosin heavy chain, myosin light chain 2, actin, troponin-I in 125-week-old rats decreased compared with those of 12-week-old rats.", "text_with_entity_marker": "The contents of myosin heavy chain, [E1]myosin light chain 2[/E1], [E2]actin[/E2], troponin-I in 125-week-old rats decreased compared with those of 12-week-old rats.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin light chain 2", "entity_1_idx": [[36, 56]], "entity_1_idx_in_text_with_entity_marker": [40, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d598.s0_BioInfer.d598.s0.p4", "text": "The contents of myosin heavy chain, myosin light chain 2, actin, troponin-I in 125-week-old rats decreased compared with those of 12-week-old rats.", "text_with_entity_marker": "The contents of [E1]myosin heavy chain[/E1], [E2]myosin light chain 2[/E2], actin, troponin-I in 125-week-old rats decreased compared with those of 12-week-old rats.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[16, 34]], "entity_1_idx_in_text_with_entity_marker": [20, 38], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin light chain 2", "entity_2_idx": [[36, 56]], "entity_2_idx_in_text_with_entity_marker": [49, 69], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d598.s0_BioInfer.d598.s0.p5", "text": "The contents of myosin heavy chain, myosin light chain 2, actin, troponin-I in 125-week-old rats decreased compared with those of 12-week-old rats.", "text_with_entity_marker": "The contents of [E1]myosin heavy chain[/E1], myosin light chain 2, [E2]actin[/E2], troponin-I in 125-week-old rats decreased compared with those of 12-week-old rats.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[16, 34]], "entity_1_idx_in_text_with_entity_marker": [20, 38], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d96.s0_BioInfer.d96.s0.p0", "text": "Between day 1 and day 3 in culture, the specific synthetic activities of total proteins and of electrophoretically purified myosin heavy chain and actin ([14C] phenylalanine incorporation into protein, in disintegrations per minute per microgram protein) decreased (-19%,-32%, and -73%, respectively).", "text_with_entity_marker": "Between day 1 and day 3 in culture, the specific synthetic activities of total proteins and of electrophoretically purified [E1]myosin heavy chain[/E1] and [E2]actin[/E2] ([14C] phenylalanine incorporation into protein, in disintegrations per minute per microgram protein) decreased (-19%,-32%, and -73%, respectively).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[124, 142]], "entity_1_idx_in_text_with_entity_marker": [128, 146], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
